{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 2762, "items": [{"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T01:34:06Z", "timestamp": 1574300046942}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CLIN INFECT DIS"], "published-print": {"date-parts": [[2009, 6, 15]]}, "DOI": "10.1086/599105", "type": "journal-article", "created": {"date-parts": [[2009, 5, 12]], "date-time": "2009-05-12T21:57:39Z", "timestamp": 1242165459000}, "page": "1743-1751", "source": "Crossref", "is-referenced-by-count": 231, "title": ["Recent Advances in the Management of Mucormycosis: From Bench to Bedside"], "prefix": "10.1093", "volume": "48", "author": [{"given": "Brad", "family": "Spellberg", "sequence": "first", "affiliation": []}, {"given": "Thomas\u00a0J.", "family": "Walsh", "sequence": "additional", "affiliation": []}, {"given": "Dimitrios\u00a0P.", "family": "Kontoyiannis", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "Edwards, Jr.,", "sequence": "additional", "affiliation": []}, {"given": "Ashraf\u00a0S.", "family": "Ibrahim", "sequence": "additional", "affiliation": []}], "member": "286", "container-title": ["Clinical Infectious Diseases"], "language": "en", "link": [{"URL": "http://academic.oup.com/cid/article-pdf/48/12/1743/915216/48-12-1743.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 22]], "date-time": "2017-08-22T21:39:42Z", "timestamp": 1503437982000}, "score": 55.810204, "issued": {"date-parts": [[2009, 6, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2009, 6, 15]]}, "issue": "12"}, "alternative-id": ["10.1086/599105"], "URL": "http://dx.doi.org/10.1086/599105", "ISSN": ["1058-4838", "1537-6591"], "issn-type": [{"value": "1058-4838", "type": "print"}, {"value": "1537-6591", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T20:22:18Z", "timestamp": 1574454138884}, "reference-count": 94, "publisher": "Springer Science and Business Media LLC", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Curr Infect Dis Rep"], "published-print": {"date-parts": [[2010, 11]]}, "DOI": "10.1007/s11908-010-0129-9", "type": "journal-article", "created": {"date-parts": [[2010, 8, 9]], "date-time": "2010-08-09T00:28:05Z", "timestamp": 1281313685000}, "page": "423-429", "source": "Crossref", "is-referenced-by-count": 52, "title": ["Recent Advances in the Treatment of Mucormycosis"], "prefix": "10.1007", "volume": "12", "author": [{"given": "Brad", "family": "Spellberg", "sequence": "first", "affiliation": []}, {"given": "Ashraf S.", "family": "Ibrahim", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 8, 10]]}, "reference": [{"key": "129_CR1", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1016/j.mycres.2007.03.004", "volume": "111", "author": "DS Hibbett", "year": "2007", "unstructured": "Hibbett DS, Binder M, Bischoff JF, et al.: A higher-level phylogenetic classification of the fungi. Mycol Res 2007, 111:509\u2013547.", "journal-title": "Mycol Res"}, {"key": "129_CR2", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1086/432579", "volume": "41", "author": "MM Roden", "year": "2005", "unstructured": "Roden MM, Zaoutis TE, Buchanan WL, et al.: Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005, 41:634\u2013653.", "journal-title": "Clin Infect Dis"}, {"key": "129_CR3", "doi-asserted-by": "crossref", "first-page": "556", "DOI": "10.1128/CMR.18.3.556-569.2005", "volume": "18", "author": "B Spellberg", "year": "2005", "unstructured": "Spellberg B, Edwards J Jr, Ibrahim A: Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005, 18:556\u2013569.", "journal-title": "Clin Microbiol Rev"}, {"key": "129_CR4", "doi-asserted-by": "crossref", "first-page": "1350", "DOI": "10.1086/428780", "volume": "191", "author": "DP Kontoyiannis", "year": "2005", "unstructured": "Kontoyiannis DP, Lionakis MS, Lewis RE, et al.: Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 2005, 191:1350\u20131360.", "journal-title": "J Infect Dis"}, {"key": "129_CR5", "doi-asserted-by": "crossref", "first-page": "851", "DOI": "10.1086/313803", "volume": "30", "author": "DP Kontoyiannis", "year": "2000", "unstructured": "Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV: Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000, 30:851\u2013856.", "journal-title": "Clin Infect Dis"}, {"key": "129_CR6", "doi-asserted-by": "crossref", "first-page": "909", "DOI": "10.1086/339202", "volume": "34", "author": "KA Marr", "year": "2002", "unstructured": "Marr KA, Carter RA, Crippa F, et al.: Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002, 34:909\u2013917.", "journal-title": "Clin Infect Dis"}, {"key": "129_CR7", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.3109/13693780903059477", "volume": "48", "author": "V Saegeman", "year": "2010", "unstructured": "Saegeman V, Maertens J, Ectors N, et al.: Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital. Med Mycol 2010, 48:245\u2013254.", "journal-title": "Med Mycol"}, {"key": "129_CR8", "unstructured": "Ambrosioni J, Bouchuiguir-Wafa K, Garbino J: Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors. Int J Infect Dis 2010 (Epub ahead of print).", "DOI": "10.1016/j.ijid.2009.11.024", "doi-asserted-by": "crossref"}, {"key": "129_CR9", "doi-asserted-by": "crossref", "first-page": "1351", "DOI": "10.1080/10428190310001653691", "volume": "45", "author": "B Gleissner", "year": "2004", "unstructured": "Gleissner B, Schilling A, Anagnostopolous I, et al.: Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma 2004, 45:1351\u20131360.", "journal-title": "Leuk Lymphoma"}, {"key": "129_CR10", "doi-asserted-by": "crossref", "first-page": "1395", "DOI": "10.3201/eid1509.090334", "volume": "15", "author": "D Bitar", "year": "2009", "unstructured": "Bitar D, Van Cauteren D, Lanternier F, et al.: Increasing incidence of zygomycosis (mucormycosis), France, 1997\u20132006. Emerg Infect Dis 2009, 15:1395\u20131401.", "journal-title": "Emerg Infect Dis"}, {"key": "129_CR11", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.1128/CMR.13.2.236", "volume": "13", "author": "JA Ribes", "year": "2000", "unstructured": "Ribes JA, Vanover-Sams CL, Baker DJ: Zygomycetes in human disease. Clin Microbiol Rev 2000, 13:236\u2013301.", "journal-title": "Clin Microbiol Rev"}, {"key": "129_CR12", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1086/595846", "volume": "48", "author": "D Neofytos", "year": "2009", "unstructured": "Neofytos D, Horn D, Anaissie E, et al.: Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009, 48:265\u2013273.", "journal-title": "Clin Infect Dis"}, {"key": "129_CR13", "doi-asserted-by": "crossref", "first-page": "296", "DOI": "10.1093/jac/dkp430", "volume": "65", "author": "MJ Ruping", "year": "2010", "unstructured": "Ruping MJ, Heinz WJ, Kindo AJ, et al.: Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother 2010, 65:296\u2013302.", "journal-title": "J Antimicrob Chemother"}, {"key": "129_CR14", "doi-asserted-by": "crossref", "first-page": "2166", "DOI": "10.1111/j.1600-6143.2009.02754.x", "volume": "9", "author": "HY Sun", "year": "2009", "unstructured": "Sun HY, Aguado JM, Bonatti H, et al.: Pulmonary zygomycosis in solid organ transplant recipients in the current era. Am J Transplant 2009, 9:2166\u20132171.", "journal-title": "Am J Transplant"}, {"key": "129_CR15", "unstructured": "\u2022\u2022 Chamilos G, Lewis RE, Kontoyiannis DP: Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008, 47:503\u2013509. This article describes a very compelling study precisely defining the necessary timing of initiation of therapy for mucormycosis to maximize outcomes in the cancer setting.", "DOI": "10.1086/590004", "doi-asserted-by": "crossref"}, {"key": "129_CR16", "doi-asserted-by": "crossref", "first-page": "1978", "DOI": "10.1128/JCM.02246-07", "volume": "46", "author": "A Francesconi", "year": "2008", "unstructured": "Francesconi A, Kasai M, Harrington SM, et al.: Automated and manual methods of DNA extraction for Aspergillus fumigatus and Rhizopus oryzae analyzed by quantitative real-time PCR. J Clin Microbiol 2008, 46:1978\u20131984.", "journal-title": "J Clin Microbiol"}, {"key": "129_CR17", "doi-asserted-by": "crossref", "first-page": "2353", "DOI": "10.1128/JCM.02331-07", "volume": "46", "author": "DJ Hata", "year": "2008", "unstructured": "Hata DJ, Buckwalter SP, Pritt BS, et al.: Real-time PCR method for detection of zygomycetes. J Clin Microbiol 2008, 46:2353\u20132358.", "journal-title": "J Clin Microbiol"}, {"key": "129_CR18", "doi-asserted-by": "crossref", "first-page": "3690", "DOI": "10.1128/JCM.00917-08", "volume": "46", "author": "M Kasai", "year": "2008", "unstructured": "Kasai M, Harrington SM, Francesconi A, et al.: Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. J Clin Microbiol 2008, 46:3690\u20133702.", "journal-title": "J Clin Microbiol"}, {"key": "129_CR19", "doi-asserted-by": "crossref", "first-page": "2043", "DOI": "10.1128/JCM.02319-09", "volume": "48", "author": "E Dannaoui", "year": "2010", "unstructured": "Dannaoui E, Schwarz P, Slany M, et al.: Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) evaluation. J Clin Microbiol 2010, 48:2043\u20132046.", "journal-title": "J Clin Microbiol"}, {"key": "129_CR20", "unstructured": "\u2022\u2022 Reed C, Bryant R, Ibrahim AS, et al.: Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 2008, 47:364\u2013371. This retrospective study describes superior outcomes in patients with mucormycosis treated with combination polyene-echinocandin therapy.", "DOI": "10.1086/589857", "doi-asserted-by": "crossref"}, {"key": "129_CR21", "doi-asserted-by": "crossref", "first-page": "60", "DOI": "10.1086/430710", "volume": "41", "author": "G Chamilos", "year": "2005", "unstructured": "Chamilos G, Marom EM, Lewis RE, et al.: Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 2005, 41:60\u201366.", "journal-title": "Clin Infect Dis"}, {"key": "129_CR22", "doi-asserted-by": "crossref", "first-page": "1979", "DOI": "10.1172/JCI116419", "volume": "91", "author": "JR Boelaert", "year": "1993", "unstructured": "Boelaert JR, de Locht M, Van Cutsem J, et al.: Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest 1993, 91:1979\u20131986.", "journal-title": "J Clin Invest"}, {"key": "129_CR23", "doi-asserted-by": "crossref", "first-page": "1061", "DOI": "10.1038/ki.1989.301", "volume": "36", "author": "J Cutsem Van", "year": "1989", "unstructured": "Van Cutsem J, Boelaert JR: Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis). Kidney Int 1989, 36:1061\u20131068.", "journal-title": "Kidney Int"}, {"key": "129_CR24", "unstructured": "\u2022\u2022 Ibrahim AS, Gebermariam T, Fu Y, et al.: The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest 2007, 117:2649\u20132657. This seminal study defines the potential for iron chelation to serve as synergistic, adjunctive therapy for mucormycosis.", "DOI": "10.1172/JCI32338", "doi-asserted-by": "crossref"}, {"key": "129_CR25", "first-page": "231", "volume": "51", "author": "S Nithyanandam", "year": "2003", "unstructured": "Nithyanandam S, Jacob MS, Battu RR, et al.: Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol 2003, 51:231\u2013236.", "journal-title": "Indian J Ophthalmol"}, {"key": "129_CR26", "doi-asserted-by": "crossref", "first-page": "855", "DOI": "10.1097/00005537-199707000-00004", "volume": "107", "author": "KL Peterson", "year": "1997", "unstructured": "Peterson KL, Wang M, Canalis RF, Abemayor E: Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope 1997, 107:855\u2013862.", "journal-title": "Laryngoscope"}, {"key": "129_CR27", "first-page": "266", "volume": "36", "author": "BS Khor", "year": "2003", "unstructured": "Khor BS, Lee MH, Leu HS, Liu JW: Rhinocerebral mucormycosis in Taiwan. J Microbiol Immunol Infect 2003, 36:266\u2013269.", "journal-title": "J Microbiol Immunol Infect"}, {"key": "129_CR28", "doi-asserted-by": "crossref", "first-page": "753", "DOI": "10.1007/s10096-003-1035-y", "volume": "22", "author": "G Petrikkos", "year": "2003", "unstructured": "Petrikkos G, Skiada A, Sambatakou H, et al.: Mucormycosis: ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis 2003, 22:753\u2013756.", "journal-title": "Eur J Clin Microbiol Infect Dis"}, {"key": "129_CR29", "doi-asserted-by": "crossref", "first-page": "1044", "DOI": "10.1016/0003-4975(94)90243-7", "volume": "57", "author": "M Tedder", "year": "1994", "unstructured": "Tedder M, Spratt JA, Anstadt MP, et al.: Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994, 57:1044\u20131050.", "journal-title": "Ann Thorac Surg"}, {"key": "129_CR30", "doi-asserted-by": "crossref", "first-page": "767", "DOI": "10.1080/00365540410021081a", "volume": "36", "author": "J Pavie", "year": "2004", "unstructured": "Pavie J, Lafaurie M, Lacroix C, et al.: Successful treatment of pulmonary mucormycosis in an allogenic bone-marrow transplant recipient with combined medical and surgical therapy. Scand J Infect Dis 2004, 36:767\u2013769.", "journal-title": "Scand J Infect Dis"}, {"key": "129_CR31", "doi-asserted-by": "crossref", "first-page": "1449", "DOI": "10.1016/S0003-4975(03)01406-1", "volume": "78", "author": "VJ Reid", "year": "2004", "unstructured": "Reid VJ, Solnik DL, Daskalakis T, Sheka KP: Management of bronchovascular mucormycosis in a diabetic: a surgical success. Ann Thorac Surg 2004, 78:1449\u20131451.", "journal-title": "Ann Thorac Surg"}, {"key": "129_CR32", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1007/s11748-003-0055-y", "volume": "51", "author": "K Asai", "year": "2003", "unstructured": "Asai K, Suzuki K, Takahashi T, et al.: Pulmonary resection with chest wall removal and reconstruction for invasive pulmonary mucormycosis during antileukemia chemotherapy. Jpn J Thorac Cardiovasc Surg 2003, 51:163\u2013166.", "journal-title": "Jpn J Thorac Cardiovasc Surg"}, {"key": "129_CR33", "doi-asserted-by": "crossref", "first-page": "e64", "DOI": "10.1016/j.tripleo.2009.11.012", "volume": "109", "author": "NE McDermott", "year": "2010", "unstructured": "McDermott NE, Barrett J, Hipp J, et al.: Successful treatment of periodontal mucormycosis: report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 109:e64\u2013e69.", "journal-title": "Oral Surg Oral Med Oral Pathol Oral Radiol Endod"}, {"key": "129_CR34", "doi-asserted-by": "crossref", "first-page": "1383", "DOI": "10.1086/516353", "volume": "26", "author": "TJ Walsh", "year": "1998", "unstructured": "Walsh TJ, Hiemenz JW, Seibel NL, et al.: Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998, 26:1383\u20131396.", "journal-title": "Clin Infect Dis"}, {"key": "129_CR35", "doi-asserted-by": "crossref", "first-page": "322", "DOI": "10.1179/joc.2009.21.3.322", "volume": "21", "author": "L Pagano", "year": "2009", "unstructured": "Pagano L, Valentini CG, Posteraro B, et al.: Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J Chemother 2009, 21:322\u2013329.", "journal-title": "J Chemother"}, {"key": "129_CR36", "doi-asserted-by": "crossref", "first-page": "1002", "DOI": "10.1086/605445", "volume": "200", "author": "N Singh", "year": "2009", "unstructured": "Singh N, Aguado JM, Bonatti H, et al.: Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis 2009, 200:1002\u20131011.", "journal-title": "J Infect Dis"}, {"key": "129_CR37", "doi-asserted-by": "crossref", "first-page": "274", "DOI": "10.1086/315643", "volume": "182", "author": "AH Groll", "year": "2000", "unstructured": "Groll AH, Giri N, Petraitis V, et al.: Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis 2000, 182:274\u2013282.", "journal-title": "J Infect Dis"}, {"key": "129_CR38", "doi-asserted-by": "crossref", "first-page": "1573", "DOI": "10.1128/AAC.01488-07", "volume": "52", "author": "AS Ibrahim", "year": "2008", "unstructured": "Ibrahim AS, Gebremariam T, Husseiny MI, et al.: Comparison of lipid amphotericin B preparations in treating murine zygomycosis. Antimicrob Agents Chemother 2008, 52:1573\u20131576.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR39", "doi-asserted-by": "crossref", "first-page": "1253", "DOI": "10.1128/AAC.01449-06", "volume": "51", "author": "RE Lewis", "year": "2007", "unstructured": "Lewis RE, Liao G, Hou J, et al.: Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis. Antimicrob Agents Chemother 2007, 51:1253\u20131258.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR40", "doi-asserted-by": "crossref", "first-page": "1289", "DOI": "10.1086/514341", "volume": "44", "author": "OA Cornely", "year": "2007", "unstructured": "Cornely OA, Maertens J, Bresnik M, et al.: Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis 2007, 44:1289\u20131297.", "journal-title": "Clin Infect Dis"}, {"key": "129_CR41", "doi-asserted-by": "crossref", "first-page": "3487", "DOI": "10.1128/AAC.45.12.3487-3496.2001", "volume": "45", "author": "TJ Walsh", "year": "2001", "unstructured": "Walsh TJ, Goodman JL, Pappas P, et al.: Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother 2001, 45:3487\u20133496.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR42", "doi-asserted-by": "crossref", "first-page": "1581", "DOI": "10.1128/AAC.46.5.1581-1582.2002", "volume": "46", "author": "QN Sun", "year": "2002", "unstructured": "Sun QN, Fothergill AW, McCarthy DI, et al.: In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother 2002, 46:1581\u20131582.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR43", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1038/sj.bmt.1705614", "volume": "39", "author": "SM Trifilio", "year": "2007", "unstructured": "Trifilio SM, Bennett CL, Yarnold PR, et al.: Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant 2007, 39:425\u2013429.", "journal-title": "Bone Marrow Transplant"}, {"key": "129_CR44", "doi-asserted-by": "crossref", "first-page": "950", "DOI": "10.1056/NEJM200402263500923", "volume": "350", "author": "FM Marty", "year": "2004", "unstructured": "Marty FM, Cosimi LA, Baden LR: Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004, 350:950\u2013952.", "journal-title": "N Engl J Med"}, {"key": "129_CR45", "doi-asserted-by": "crossref", "first-page": "588", "DOI": "10.1086/422729", "volume": "39", "author": "CA Kauffman", "year": "2004", "unstructured": "Kauffman CA: Zygomycosis: reemergence of an old pathogen. Clin Infect Dis 2004, 39:588\u2013590.", "journal-title": "Clin Infect Dis"}, {"key": "129_CR46", "doi-asserted-by": "crossref", "first-page": "743", "DOI": "10.1086/423274", "volume": "39", "author": "A Imhof", "year": "2004", "unstructured": "Imhof A, Balajee SA, Fredricks DN, et al.: Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004, 39:743\u2013746.", "journal-title": "Clin Infect Dis"}, {"key": "129_CR47", "doi-asserted-by": "crossref", "first-page": "862", "DOI": "10.1111/j.1469-0691.2004.00945.x", "volume": "10", "author": "L Ide", "year": "2004", "unstructured": "Ide L, Buysschaert I, Demuynck H, et al.: Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole? Clin Microbiol Infect 2004, 10:862\u2013863.", "journal-title": "Clin Microbiol Infect"}, {"key": "129_CR48", "doi-asserted-by": "crossref", "first-page": "e35", "DOI": "10.1086/427752", "volume": "40", "author": "S Vigouroux", "year": "2005", "unstructured": "Vigouroux S, Morin O, Moreau P, et al.: Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin Infect Dis 2005, 40:e35\u2013e37.", "journal-title": "Clin Infect Dis"}, {"issue": "Suppl 1", "key": "129_CR49", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1111/j.1439-0507.2002.tb04542.x", "volume": "45", "author": "V Rickerts", "year": "2002", "unstructured": "Rickerts V, B\u00f6hme A, Just-N\u00fcbling G: Risk factor for invasive zygomycosis in patients with hematologic malignancies [in German]. Mycoses 2002, 45(Suppl 1):27\u201330.", "journal-title": "Mycoses"}, {"key": "129_CR50", "doi-asserted-by": "crossref", "first-page": "3647", "DOI": "10.1128/AAC.47.11.3647-3650.2003", "volume": "47", "author": "E Dannaoui", "year": "2003", "unstructured": "Dannaoui E, Meis JF, Loebenberg D, Verweij PE: Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob Agents Chemother 2003, 47:3647\u20133650.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR51", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1093/jac/dkg020", "volume": "51", "author": "E Dannaoui", "year": "2003", "unstructured": "Dannaoui E, Meletiadis J, Mouton JW, et al.: In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003, 51:45\u201352.", "journal-title": "J Antimicrob Chemother"}, {"key": "129_CR52", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1159/000238681", "volume": "35", "author": "J Cutsem Van", "year": "1989", "unstructured": "Van Cutsem J, Van Gerven F, Fransen J, Janssen PA: Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B. Chemotherapy 1989, 35:267\u2013272.", "journal-title": "Chemotherapy"}, {"key": "129_CR53", "doi-asserted-by": "crossref", "first-page": "1032", "DOI": "10.1128/AAC.46.4.1032-1037.2002", "volume": "46", "author": "MA Pfaller", "year": "2002", "unstructured": "Pfaller MA, Messer SA, Hollis RJ, Jones RN: Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother 2002, 46:1032\u20131037.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR54", "doi-asserted-by": "crossref", "first-page": "2587", "DOI": "10.1128/AAC.00452-07", "volume": "51", "author": "NG Almyroudis", "year": "2007", "unstructured": "Almyroudis NG, Sutton DA, Fothergill AW, et al.: In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother 2007, 51:2587\u20132590.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR55", "doi-asserted-by": "crossref", "first-page": "3637", "DOI": "10.1128/AAC.00662-08", "volume": "52", "author": "C Lass-Fl\u00f6rl", "year": "2008", "unstructured": "Lass-Fl\u00f6rl C, Mayr A, Perkhofer S, et al.: Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother 2008, 52:3637\u20133641.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR56", "first-page": "1", "volume": "12", "author": "S Arikan", "year": "2008", "unstructured": "Arikan S, Sancak B, Alp S, et al.: Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus. Med Mycol 2008, 12:1\u20137.", "journal-title": "Med Mycol"}, {"key": "129_CR57", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.1128/AAC.50.2.658-666.2006", "volume": "50", "author": "AJ Ullmann", "year": "2006", "unstructured": "Ullmann AJ, Cornely OA, Burchardt A, et al.: Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother 2006, 50:658\u2013666.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR58", "doi-asserted-by": "crossref", "first-page": "812", "DOI": "10.1128/AAC.00454-06", "volume": "51", "author": "G Krishna", "year": "2007", "unstructured": "Krishna G, Sansone-Parsons A, Martinho M, et al.: Posaconazole plasma concentrations in juvenile patients with invasive fungal infection. Antimicrob Agents Chemother 2007, 51:812\u2013818.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR59", "doi-asserted-by": "crossref", "first-page": "1627", "DOI": "10.1592/phco.27.12.1627", "volume": "27", "author": "G Krishna", "year": "2007", "unstructured": "Krishna G, Martinho M, Chandrasekar P, et al.: Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease. Pharmacotherapy 2007, 27:1627\u20131636.", "journal-title": "Pharmacotherapy"}, {"key": "129_CR60", "doi-asserted-by": "crossref", "first-page": "2310", "DOI": "10.1128/AAC.46.7.2310-2312.2002", "volume": "46", "author": "QN Sun", "year": "2002", "unstructured": "Sun QN, Najvar LK, Bocanegra R, et al.: In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother 2002, 46:2310\u20132312.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR61", "doi-asserted-by": "crossref", "first-page": "3786", "DOI": "10.1128/AAC.00628-08", "volume": "52", "author": "MM Rodriguez", "year": "2008", "unstructured": "Rodriguez MM, Serena C, Marine M, et al.: Posaconazole combined with amphotericin B, an effective therapy for a murine-disseminated infection caused by Rhizopus oryzae. Antimicrob Agents Chemother 2008, 52:3786\u20133788.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR62", "doi-asserted-by": "crossref", "first-page": "772", "DOI": "10.1128/AAC.01124-08", "volume": "53", "author": "AS Ibrahim", "year": "2009", "unstructured": "Ibrahim AS, Gebremariam T, Schwartz JA, et al.: Posaconazole mono- or combination therapy for murine mucormycosis. Antimicrob Agents Chemother 2009, 53:772\u2013775.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR63", "doi-asserted-by": "crossref", "first-page": "991", "DOI": "10.1016/j.bbmt.2009.04.007", "volume": "15", "author": "LJ Lekakis", "year": "2009", "unstructured": "Lekakis LJ, Lawson A, Prante J, et al.: Fatal rhizopus pneumonia in allogeneic stem cell transplant patients despite posaconazole prophylaxis: two cases and review of the literature. Biol Blood Marrow Transplant 2009, 15:991\u2013995.", "journal-title": "Biol Blood Marrow Transplant"}, {"key": "129_CR64", "unstructured": "Mousset S, Bug G, Heinz WJ, et al.: Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation. Transpl Infect Dis 2009 (Epub ahead of print).", "DOI": "10.1111/j.1399-3062.2009.00479.x", "doi-asserted-by": "crossref"}, {"key": "129_CR65", "doi-asserted-by": "crossref", "first-page": "551", "DOI": "10.1038/bmt.2008.199", "volume": "42", "author": "F Schlemmer", "year": "2008", "unstructured": "Schlemmer F, Lagrange-Xelot M, Lacroix C, et al.: Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation. Bone Marrow Transplant 2008, 42:551\u2013552.", "journal-title": "Bone Marrow Transplant"}, {"key": "129_CR66", "doi-asserted-by": "crossref", "first-page": "e61", "DOI": "10.1086/500212", "volume": "42", "author": "JA Burik van", "year": "2006", "unstructured": "van Burik JA, Hare RS, Solomon HF, et al.: Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006, 42:e61\u2013e65.", "journal-title": "Clin Infect Dis"}, {"key": "129_CR67", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1128/AAC.50.1.126-133.2006", "volume": "50", "author": "RN Greenberg", "year": "2006", "unstructured": "Greenberg RN, Mullane K, van Burik JA, et al.: Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006, 50:126\u2013133.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR68", "doi-asserted-by": "crossref", "first-page": "721", "DOI": "10.1128/AAC.49.2.721-727.2005", "volume": "49", "author": "AS Ibrahim", "year": "2005", "unstructured": "Ibrahim AS, Bowman JC, Avanessian V, et al.: Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob Agents Chemother 2005, 49:721\u2013727.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR69", "doi-asserted-by": "crossref", "first-page": "830", "DOI": "10.1128/AAC.49.2.830-832.2005", "volume": "49", "author": "B Spellberg", "year": "2005", "unstructured": "Spellberg B, Fu Y, Edwards JE Jr, Ibrahim AS: Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice. Antimicrob Agents Chemother 2005, 49:830\u2013832.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR70", "doi-asserted-by": "crossref", "first-page": "1556", "DOI": "10.1128/AAC.01458-07", "volume": "52", "author": "AS Ibrahim", "year": "2008", "unstructured": "Ibrahim AS, Gebremariam T, Fu Y, et al.: Combination echinocandin-polyene treatment of murine mucormycosis. Antimicrob Agents Chemother 2008, 52:1556\u20131558.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR71", "doi-asserted-by": "crossref", "first-page": "592", "DOI": "10.1080/13693780802326001", "volume": "47", "author": "AS Ibrahim", "year": "2009", "unstructured": "Ibrahim AS, Edwards JE Jr, Bryant R, Spellberg B: Economic burden of mucormycosis in the United States: can a vaccine be cost-effective? Med Mycol 2009, 47:592\u2013600.", "journal-title": "Med Mycol"}, {"key": "129_CR72", "doi-asserted-by": "crossref", "first-page": "667", "DOI": "10.1038/ki.1994.89", "volume": "45", "author": "JR Boelaert", "year": "1994", "unstructured": "Boelaert JR, Van Cutsem J, de Locht M, et al.: Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney Int 1994, 45:667\u2013671.", "journal-title": "Kidney Int"}, {"key": "129_CR73", "doi-asserted-by": "crossref", "first-page": "1843", "DOI": "10.1016/0006-2952(94)90314-X", "volume": "47", "author": "M Locht de", "year": "1994", "unstructured": "de Locht M, Boelaert JR, Schneider YJ: Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus. Biochem Pharmacol 1994, 47:1843\u20131850.", "journal-title": "Biochem Pharmacol"}, {"key": "129_CR74", "doi-asserted-by": "crossref", "first-page": "1070", "DOI": "10.1093/jac/dkl350", "volume": "58", "author": "AS Ibrahim", "year": "2006", "unstructured": "Ibrahim AS, Edwards JE Jr, Fu Y, Spellberg B: Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother 2006, 58:1070\u20131073.", "journal-title": "J Antimicrob Chemother"}, {"key": "129_CR75", "unstructured": "Ibrahim AS, Gebremariam T, Lin L, et al.: The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis. Mol Microbiol 2010 (Epub ahead of print).", "DOI": "10.1111/j.1365-2958.2010.07234.x", "doi-asserted-by": "crossref"}, {"key": "129_CR76", "unstructured": "\u2022\u2022 Liu M, Spellberg B, Phan QT, et al.: The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J Clin Invest 2010, 120:1914\u20131924. This study elucidates a primary mechanism by which iron regulates host susceptibility to mucormycosis.", "DOI": "10.1172/JCI42164", "doi-asserted-by": "crossref"}, {"key": "129_CR77", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1016/j.beha.2004.09.002", "volume": "18", "author": "MD Cappellini", "year": "2005", "unstructured": "Cappellini MD: Iron-chelating therapy with the new oral agent ICL670 (Exjade). Best Pract Res Clin Haematol 2005, 18:289\u2013298.", "journal-title": "Best Pract Res Clin Haematol"}, {"key": "129_CR78", "first-page": "873", "volume": "91", "author": "A Piga", "year": "2006", "unstructured": "Piga A, Galanello R, Forni GL, et al.: Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload. Haematologica 2006, 91:873\u2013880.", "journal-title": "Haematologica"}, {"key": "129_CR79", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1007/s12185-008-0115-2", "volume": "88", "author": "K Miyazawa", "year": "2008", "unstructured": "Miyazawa K, Ohyashiki K, Urabe A, et al.: A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade, ICL670) in patients with transfusion-dependent anemias and iron-overload: a phase I study in Japan. Int J Hematol 2008, 88:73\u201381.", "journal-title": "Int J Hematol"}, {"key": "129_CR80", "doi-asserted-by": "crossref", "first-page": "3968", "DOI": "10.1128/AAC.01065-06", "volume": "50", "author": "C Reed", "year": "2006", "unstructured": "Reed C, Ibrahim A, Edwards JE Jr, et al.: Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis. Antimicrob Agents Chemother 2006, 50:3968\u20133969.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR81", "doi-asserted-by": "crossref", "first-page": "3122", "DOI": "10.1128/AAC.00361-09", "volume": "53", "author": "B Spellberg", "year": "2009", "unstructured": "Spellberg B, Andes D, Perez M, et al.: Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis. Antimicrob Agents Chemother 2009, 53:3122\u20133125.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR82", "doi-asserted-by": "crossref", "first-page": "398", "DOI": "10.1002/ajh.21119", "volume": "83", "author": "E Vichinsky", "year": "2007", "unstructured": "Vichinsky E: Clinical application of deferasirox: practical patient management. Am J Hematol 2007, 83:398\u2013402.", "journal-title": "Am J Hematol"}, {"key": "129_CR83", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1007/978-1-4615-0593-8_10", "volume": "509", "author": "H Nick", "year": "2002", "unstructured": "Nick H, Wong A, Acklin P, et al.: ICL670A: preclinical profile. Adv Exp Med Biol 2002, 509:185\u2013203.", "journal-title": "Adv Exp Med Biol"}, {"key": "129_CR84", "doi-asserted-by": "crossref", "first-page": "3455", "DOI": "10.1182/blood-2005-08-3430", "volume": "107", "author": "MD Cappellini", "year": "2006", "unstructured": "Cappellini MD, Cohen A, Piga A, et al.: A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood 2006, 107:3455\u20133462.", "journal-title": "Blood"}, {"key": "129_CR85", "unstructured": "US Food and Drug Administration: Important information about Exjade (deferasirox) tablets for oral suspension (Novartis, 2007). Available at http://www.fda.gov/downloads/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM154395.pdf . Accessed June 2010."}, {"key": "129_CR86", "doi-asserted-by": "crossref", "first-page": "484", "DOI": "10.1128/AAC.00956-09", "volume": "54", "author": "R Ben-Ami", "year": "2010", "unstructured": "Ben-Ami R, Lewis RE, Tarrand J, et al.: Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection. Antimicrob Agents Chemother 2010, 54:484\u2013490.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "129_CR87", "doi-asserted-by": "crossref", "first-page": "1180", "DOI": "10.1086/428503", "volume": "191", "author": "C Gil-Lamaignere", "year": "2005", "unstructured": "Gil-Lamaignere C, Simitsopoulou M, Roilides E, et al.: Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis 2005, 191:1180\u20131187.", "journal-title": "J Infect Dis"}, {"key": "129_CR88", "doi-asserted-by": "crossref", "first-page": "769", "DOI": "10.1097/01.inf.0000134314.65398.bf", "volume": "23", "author": "MJ Abzug", "year": "2004", "unstructured": "Abzug MJ, Walsh TJ: Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children. Pediatr Infect Dis J 2004, 23:769\u2013773.", "journal-title": "Pediatr Infect Dis J"}, {"key": "129_CR89", "doi-asserted-by": "crossref", "first-page": "192", "DOI": "10.1093/clinids/24.2.192", "volume": "24", "author": "CE Gonzalez", "year": "1997", "unstructured": "Gonzalez CE, Couriel DR, Walsh TJ: Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Clin Infect Dis 1997, 24:192\u2013196.", "journal-title": "Clin Infect Dis"}, {"key": "129_CR90", "doi-asserted-by": "crossref", "first-page": "478", "DOI": "10.1016/S0923-2494(98)80771-2", "volume": "149", "author": "BJ Kullberg", "year": "1998", "unstructured": "Kullberg BJ, Anaissie EJ: Cytokines as therapy for opportunistic fungal infections. Res Immunol 1998, 149:478\u2013488; discussion 515.", "journal-title": "Res Immunol"}, {"key": "129_CR91", "doi-asserted-by": "crossref", "first-page": "783", "DOI": "10.1007/s00520-005-0910-8", "volume": "14", "author": "L Grigull", "year": "2006", "unstructured": "Grigull L, Beilken A, Schmid H, et al.: Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies. Support Care Cancer 2006, 14:783\u2013786.", "journal-title": "Support Care Cancer"}, {"key": "129_CR92", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1111/j.1469-0691.2005.01170.x", "volume": "11", "author": "BV John", "year": "2005", "unstructured": "John BV, Chamilos G, Kontoyiannis DP: Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect 2005, 11:515\u2013517.", "journal-title": "Clin Microbiol Infect"}, {"key": "129_CR93", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1111/j.1439-0507.2009.01708.x", "volume": "53", "author": "A Busca", "year": "2010", "unstructured": "Busca A, Marmont F, Locatelli F, et al.: Combined antifungal therapy, iron chelation and surgical resection as treatment of hepatic zygomycosis in a patient with haematological malignancy. Mycoses 2010, 53:275\u2013278.", "journal-title": "Mycoses"}, {"key": "129_CR94", "doi-asserted-by": "crossref", "first-page": "5022", "DOI": "10.1128/AAC.01026-09", "volume": "53", "author": "MM Rodriguez", "year": "2009", "unstructured": "Rodriguez MM, Pastor FJ, Calvo E, et al.: Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection. Antimicrob Agents Chemother 2009, 53:5022\u20135025.", "journal-title": "Antimicrob Agents Chemother"}], "container-title": ["Current Infectious Disease Reports"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/s11908-010-0129-9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 1]], "date-time": "2019-06-01T12:55:26Z", "timestamp": 1559393726000}, "score": 42.860176, "issued": {"date-parts": [[2010, 8, 10]]}, "references-count": 94, "journal-issue": {"published-print": {"date-parts": [[2010, 11]]}, "issue": "6"}, "alternative-id": ["129"], "URL": "http://dx.doi.org/10.1007/s11908-010-0129-9", "relation": {"cites": []}, "ISSN": ["1523-3847", "1534-3146"], "issn-type": [{"value": "1523-3847", "type": "print"}, {"value": "1534-3146", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T02:52:14Z", "timestamp": 1574823134836}, "reference-count": 14, "publisher": "Informa UK Limited", "issue": "8", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Virulence"], "published-print": {"date-parts": [[2017, 11, 17]]}, "DOI": "10.1080/21505594.2017.1364335", "type": "journal-article", "created": {"date-parts": [[2017, 8, 14]], "date-time": "2017-08-14T20:03:56Z", "timestamp": 1502741036000}, "page": "1481-1482", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Mucormycosis pathogenesis: Beyond Rhizopus"], "prefix": "10.1080", "volume": "8", "author": [{"given": "Brad", "family": "Spellberg", "sequence": "first", "affiliation": [{"name": "Division of Infectious Diseases, Los Angeles County + University of Southern California (LAC+USC) Medical Center, Los Angeles, CA, USA"}, {"name": "Keck School of Medicine at University of Southern California, Los Angeles, CA, USA"}]}], "member": "301", "published-online": {"date-parts": [[2017, 8, 25]]}, "reference": [{"key": "cit0001", "DOI": "10.1093/cid/cir865", "doi-asserted-by": "publisher"}, {"key": "cit0002", "DOI": "10.1128/CMR.18.3.556-569.2005", "doi-asserted-by": "publisher"}, {"key": "cit0003", "DOI": "10.1080/21505594.2015.1009732", "doi-asserted-by": "publisher"}, {"key": "cit0004", "DOI": "10.1111/j.1365-2958.2010.07234.x", "doi-asserted-by": "publisher"}, {"key": "cit0005", "DOI": "10.1172/JCI32338", "doi-asserted-by": "publisher"}, {"key": "cit0006", "DOI": "10.3109/13693786.2012.669502", "doi-asserted-by": "publisher"}, {"key": "cit0007", "DOI": "10.1093/jac/dkr375", "doi-asserted-by": "publisher"}, {"key": "cit0008", "DOI": "10.1086/432579", "doi-asserted-by": "publisher"}, {"key": "cit0009", "DOI": "10.1172/JCI71349", "doi-asserted-by": "publisher"}, {"key": "cit0010", "DOI": "10.1111/myc.12149", "doi-asserted-by": "publisher"}, {"key": "cit0011", "DOI": "10.1128/CMR.00056-10", "doi-asserted-by": "publisher"}, {"key": "cit0012", "author": "Schulze B", "journal-title": "Virulence."}, {"key": "cit0013", "DOI": "10.1086/599105", "doi-asserted-by": "publisher"}, {"key": "cit0014", "DOI": "10.1093/cid/cir885", "doi-asserted-by": "publisher"}], "container-title": ["Virulence"], "language": "en", "link": [{"URL": "https://www.tandfonline.com/doi/pdf/10.1080/21505594.2017.1364335", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 3, 12]], "date-time": "2018-03-12T18:35:29Z", "timestamp": 1520879729000}, "score": 40.792137, "issued": {"date-parts": [[2017, 8, 25]]}, "references-count": 14, "journal-issue": {"published-online": {"date-parts": [[2017, 8, 16]]}, "published-print": {"date-parts": [[2017, 11, 17]]}, "issue": "8"}, "alternative-id": ["10.1080/21505594.2017.1364335"], "URL": "http://dx.doi.org/10.1080/21505594.2017.1364335", "relation": {"cites": []}, "ISSN": ["2150-5594", "2150-5608"], "issn-type": [{"value": "2150-5594", "type": "print"}, {"value": "2150-5608", "type": "electronic"}], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=kvir20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=kvir20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:45:50Z", "timestamp": 1574891150349}, "publisher-location": "New York, NY", "reference-count": 138, "publisher": "Springer New York", "isbn-type": [{"value": "9781493990320", "type": "print"}, {"value": "9781493990344", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2019, 1, 1]], "date-time": "2019-01-01T00:00:00Z", "timestamp": 1546300800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "published-print": {"date-parts": [[2019]]}, "DOI": "10.1007/978-1-4939-9034-4_34", "type": "book-chapter", "created": {"date-parts": [[2019, 6, 13]], "date-time": "2019-06-13T19:03:16Z", "timestamp": 1560452596000}, "page": "577-589", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Mucormycosis"], "prefix": "10.1007", "author": [{"given": "Brad", "family": "Spellberg", "sequence": "first", "affiliation": []}, {"given": "Johan", "family": "Maertens", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2019, 6, 14]]}, "reference": [{"issue": "Pt 5", "key": "34_CR1", "doi-asserted-by": "publisher", "first-page": "509", "DOI": "10.1016/j.mycres.2007.03.004", "volume": "111", "author": "DS Hibbett", "year": "2007", "unstructured": "Hibbett DS, Binder M, Bischoff JF, Blackwell M, Cannon PF, Eriksson OE, et al. A higher-level phylogenetic classification of the Fungi. Mycolog Res. 2007;111(Pt 5):509\u201347.", "journal-title": "Mycolog Res"}, {"issue": "2", "key": "34_CR2", "doi-asserted-by": "publisher", "first-page": "236", "DOI": "10.1128/CMR.13.2.236", "volume": "13", "author": "JA Ribes", "year": "2000", "unstructured": "Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13(2):236\u2013301.", "journal-title": "Clin Microbiol Rev"}, {"issue": "2", "key": "34_CR3", "doi-asserted-by": "publisher", "first-page": "411", "DOI": "10.1128/CMR.00056-10", "volume": "24", "author": "MZ Gomes", "year": "2011", "unstructured": "Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, \u2212Mucor, and -Lichtheimia species. Clin Microbiol Rev. 2011;24(2):411\u201345.", "journal-title": "Clin Microbiol Rev"}, {"issue": "5", "key": "34_CR4", "doi-asserted-by": "publisher", "first-page": "634", "DOI": "10.1086/432579", "volume": "41", "author": "MM Roden", "year": "2005", "unstructured": "Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634\u201353.", "journal-title": "Clin Infect Dis"}, {"issue": "2", "key": "34_CR5", "doi-asserted-by": "publisher", "first-page": "173", "DOI": "10.1093/clinids/17.2.173", "volume": "17", "author": "A Cohen-Abbo", "year": "1993", "unstructured": "Cohen-Abbo A, Bozeman PM, Patrick CC. Cunninghamella infections: review and report of two cases of Cunninghamella pneumonia in immunocompromised children. Clin Infect Dis. 1993;17(2):173\u20137.", "journal-title": "Clin Infect Dis"}, {"issue": "4", "key": "34_CR6", "doi-asserted-by": "publisher", "first-page": "544", "DOI": "10.1093/ajcp/64.4.544", "volume": "64", "author": "KJ Kwon-Chung", "year": "1975", "unstructured": "Kwon-Chung KJ, Young RC, Orlando M. Pulmonary mucormycosis caused by Cunninghamella elegans in a patient with chronic myelogenous leukemia. Am J Clin Pathol. 1975;64(4):544\u20138.", "journal-title": "Am J Clin Pathol"}, {"issue": "6", "key": "34_CR7", "doi-asserted-by": "publisher", "first-page": "925", "DOI": "10.1093/clinids/18.6.925", "volume": "18", "author": "DP Kontoyianis", "year": "1994", "unstructured": "Kontoyianis DP, Vartivarian S, Anaissie EJ, Samonis G, Bodey GP, Rinaldi M. Infections due to Cunninghamella bertholletiae in patients with cancer: report of three cases and review. Clin Infect Dis. 1994;18(6):925\u20138.", "journal-title": "Clin Infect Dis"}, {"issue": "7", "key": "34_CR8", "doi-asserted-by": "publisher", "first-page": "1534", "DOI": "10.1002/1097-0142(19861001)58:7<1534::AID-CNCR2820580725>3.0.CO;2-0", "volume": "58", "author": "GJ Ventura", "year": "1986", "unstructured": "Ventura GJ, Kantarjian HM, Anaissie E, Hopfer RL, Fainstein V. Pneumonia with Cunninghamella species in patients with hematologic malignancies. A case report and review of the literature. Cancer. 1986;58(7):1534\u20136.", "journal-title": "Cancer"}, {"issue": "7", "key": "34_CR9", "first-page": "1823", "volume": "32", "author": "EA Bearer", "year": "1994", "unstructured": "Bearer EA, Nelson PR, Chowers MY, Davis CE. Cutaneous zygomycosis caused by Saksenaea vasiformis in a diabetic patient. J Clin Microbiol. 1994;32(7):1823\u20134.", "journal-title": "J Clin Microbiol"}, {"issue": "4", "key": "34_CR10", "doi-asserted-by": "publisher", "first-page": "364", "DOI": "10.1080/00313029600169364", "volume": "28", "author": "GR Lye", "year": "1996", "unstructured": "Lye GR, Wood G, Nimmo G. Subcutaneous zygomycosis due to Saksenaea vasiformis: rapid isolate identification using a modified sporulation technique. Pathology. 1996;28(4):364\u20135.", "journal-title": "Pathology"}, {"issue": "3", "key": "34_CR11", "first-page": "843", "volume": "32", "author": "ME Kemna", "year": "1994", "unstructured": "Kemna ME, Neri RC, Ali R, Salkin IF. Cokeromyces recurvatus, a mucoraceous zygomycete rarely isolated in clinical laboratories. J Clin Microbiol. 1994;32(3):843\u20135.", "journal-title": "J Clin Microbiol"}, {"issue": "1", "key": "34_CR12", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1080/00362178085380051", "volume": "18", "author": "A Kamalam", "year": "1980", "unstructured": "Kamalam A, Thambiah AS. Cutaneous infection by Syncephalastrum. Sabouraudia. 1980;18(1):19\u201320.", "journal-title": "Sabouraudia"}, {"issue": "5", "key": "34_CR13", "doi-asserted-by": "publisher", "first-page": "1138", "DOI": "10.1093/clinids/27.5.1138", "volume": "27", "author": "JR Rees", "year": "1998", "unstructured": "Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis. 1998;27(5):1138\u201347.", "journal-title": "Clin Infect Dis"}, {"issue": "4", "key": "34_CR14", "doi-asserted-by": "publisher", "first-page": "410", "DOI": "10.1093/ajcp/74.4.410", "volume": "74", "author": "M Hotchi", "year": "1980", "unstructured": "Hotchi M, Okada M, Nasu T. Present state of fungal infections in autopsy cases in Japan. Am J Clin Pathol. 1980;74(4):410\u20136.", "journal-title": "Am J Clin Pathol"}, {"issue": "Suppl 2", "key": "34_CR15", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1111/j.1439-0507.1998.tb00609.x", "volume": "41", "author": "HJ Tietz", "year": "1998", "unstructured": "Tietz HJ, Brehmer D, Janisch W, Martin H. Incidence of endomycoses in the autopsy material of the Berlin Charite Hospital. Mycoses. 1998;41(Suppl 2):81\u20135.", "journal-title": "Mycoses"}, {"issue": "6", "key": "34_CR16", "first-page": "1732", "volume": "37", "author": "T Yamazaki", "year": "1999", "unstructured": "Yamazaki T, Kume H, Murase S, Yamashita E, Arisawa M. Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan. J Clin Microbiol. 1999;37(6):1732\u20138.", "journal-title": "J Clin Microbiol"}, {"issue": "7", "key": "34_CR17", "doi-asserted-by": "publisher", "first-page": "1163", "DOI": "10.3201/eid2007.140087", "volume": "20", "author": "D Bitar", "year": "2014", "unstructured": "Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, et al. Population-based analysis of invasive fungal infections, France, 2001-2010. Emerg Infect Dis. 2014;20(7):1163\u20139.", "journal-title": "Emerg Infect Dis"}, {"issue": "2", "key": "34_CR18", "doi-asserted-by": "publisher", "first-page": "152", "DOI": "10.1016/0090-3019(94)90114-7", "volume": "41", "author": "ES Nussbaum", "year": "1994", "unstructured": "Nussbaum ES, Hall WA. Rhinocerebral mucormycosis: changing patterns of disease. Surg Neurol. 1994;41(2):152\u20136.", "journal-title": "Surg Neurol"}, {"key": "34_CR19", "unstructured": "Maertens J, Demuynck H, Verbeken EK, Zachee P, Verhoef GE, Vandenberghe P, Boogaerts MA. Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Dermatology, Bone Marrow Transplant. 1999;24(3):307\u201312.", "DOI": "10.1038/sj.bmt.1701885", "doi-asserted-by": "crossref"}, {"issue": "9", "key": "34_CR20", "doi-asserted-by": "publisher", "first-page": "950", "DOI": "10.1056/NEJM200402263500923", "volume": "350", "author": "FM Marty", "year": "2004", "unstructured": "Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med. 2004;350(9):950\u20132.", "journal-title": "N Engl J Med"}, {"issue": "10", "key": "34_CR21", "doi-asserted-by": "publisher", "first-page": "E396", "DOI": "10.1111/j.1469-0691.2012.03908.x", "volume": "18", "author": "A Xhaard", "year": "2012", "unstructured": "Xhaard A, Lanternier F, Porcher R, Dannaoui E, Bergeron A, Clement L, et al. Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008). Clin Microbiol Infect. 2012;18(10):E396\u2013400.", "journal-title": "Clin Microbiol Infect"}, {"issue": "Suppl 1", "key": "34_CR22", "doi-asserted-by": "publisher", "first-page": "S44", "DOI": "10.1093/cid/cir867", "volume": "54", "author": "B Rammaert", "year": "2012", "unstructured": "Rammaert B, Lanternier F, Zahar JR, Dannaoui E, Bougnoux ME, Lecuit M, Lortholary O. Healthcare-associated mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S44\u201354.", "journal-title": "Clin Infect Dis"}, {"issue": "11", "key": "34_CR23", "doi-asserted-by": "publisher", "first-page": "1629", "DOI": "10.1093/cid/cis195", "volume": "54", "author": "F Lanternier", "year": "2012", "unstructured": "Lanternier F, Sun HY, Ribaud P, Singh N, Kontoyiannis DP, Lortholary O. Mucormycosis in organ and stem cell transplant recipients. Clin Infect Dis. 2012;54(11):1629\u201336.", "journal-title": "Clin Infect Dis"}, {"issue": "Suppl 1", "key": "34_CR24", "doi-asserted-by": "publisher", "first-page": "S35", "DOI": "10.1093/cid/cir880", "volume": "54", "author": "F Lanternier", "year": "2012", "unstructured": "Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, et al. A global analysis of mucormycosis in France: the RetroZygo study (2005-2007). Clin Infect Dis. 2012;54(Suppl 1):S35\u201343.", "journal-title": "Clin Infect Dis"}, {"issue": "9", "key": "34_CR25", "doi-asserted-by": "publisher", "first-page": "1456", "DOI": "10.3201/eid1609.100276", "volume": "16", "author": "V Saegeman", "year": "2010", "unstructured": "Saegeman V, Maertens J, Meersseman W, Spriet I, Verbeken E, Lagrou K. Increasing incidence of mucormycosis in University Hospital, Belgium. Emerg Infect Dis. 2010;16(9):1456\u20138.", "journal-title": "Emerg Infect Dis"}, {"issue": "4", "key": "34_CR26", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1053/jinf.2001.0831", "volume": "42", "author": "A Chakrabarti", "year": "2001", "unstructured": "Chakrabarti A, Das A, Sharma A, Panda N, Das S, Gupta KL, Sakhuja V. Ten years\u2019 experience in zygomycosis at a tertiary care centre in India. J Infect. 2001;42(4):261\u20136.", "journal-title": "J Infect"}, {"issue": "4", "key": "34_CR27", "doi-asserted-by": "publisher", "first-page": "335", "DOI": "10.1080/13693780500464930", "volume": "44", "author": "A Chakrabarti", "year": "2006", "unstructured": "Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006;44(4):335\u201342.", "journal-title": "Med Mycol"}, {"issue": "4", "key": "34_CR28", "doi-asserted-by": "publisher", "first-page": "584", "DOI": "10.1086/422723", "volume": "39", "author": "GT Siwek", "year": "2004", "unstructured": "Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL, et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis. 2004;39(4):584\u20137.", "journal-title": "Clin Infect Dis"}, {"issue": "4", "key": "34_CR29", "doi-asserted-by": "publisher", "first-page": "588", "DOI": "10.1086/422729", "volume": "39", "author": "CA Kauffman", "year": "2004", "unstructured": "Kauffman CA. Zygomycosis: reemergence of an old pathogen. Clin Infect Dis. 2004;39(4):588\u201390.", "journal-title": "Clin Infect Dis"}, {"issue": "7", "key": "34_CR30", "doi-asserted-by": "publisher", "first-page": "909", "DOI": "10.1086/339202", "volume": "34", "author": "KA Marr", "year": "2002", "unstructured": "Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34(7):909\u201317.", "journal-title": "Clin Infect Dis"}, {"issue": "6", "key": "34_CR31", "doi-asserted-by": "publisher", "first-page": "851", "DOI": "10.1086/313803", "volume": "30", "author": "DP Kontoyiannis", "year": "2000", "unstructured": "Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis. 2000;30(6):851\u20136.", "journal-title": "Clin Infect Dis"}, {"issue": "10", "key": "34_CR32", "doi-asserted-by": "publisher", "first-page": "1855", "DOI": "10.3201/eid1710.110087", "volume": "17", "author": "BJ Park", "year": "2011", "unstructured": "Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR, et al. Invasive non-aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis. 2011;17(10):1855\u201364.", "journal-title": "Emerg Infect Dis"}, {"issue": "8", "key": "34_CR33", "doi-asserted-by": "publisher", "first-page": "1101", "DOI": "10.1086/651262", "volume": "50", "author": "PG Pappas", "year": "2010", "unstructured": "Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50(8):1101\u201311.", "journal-title": "Clin Infect Dis"}, {"issue": "10", "key": "34_CR34", "doi-asserted-by": "publisher", "first-page": "767", "DOI": "10.1080/00365540410021081a", "volume": "36", "author": "J Pavie", "year": "2004", "unstructured": "Pavie J, Lafaurie M, Lacroix C, Marie Zagdanski A, Debrosse D, Socie G, et al. Successful treatment of pulmonary mucormycosis in an allogenic bone-marrow transplant recipient with combined medical and surgical therapy. Scand J Infect Dis. 2004;36(10):767\u20139.", "journal-title": "Scand J Infect Dis"}, {"issue": "10", "key": "34_CR35", "doi-asserted-by": "publisher", "first-page": "2365", "DOI": "10.1111/j.1600-6143.2006.01496.x", "volume": "6", "author": "NG Almyroudis", "year": "2006", "unstructured": "Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006;6(10):2365\u201374.", "journal-title": "Am J Transplant"}, {"issue": "Suppl 1", "key": "34_CR36", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1111/j.1439-0507.2002.tb04542.x", "volume": "45", "author": "V Rickerts", "year": "2002", "unstructured": "Rickerts V, Bohme A, Just-Nubling G. Risk factor for invasive zygomycosis in patients with hematologic malignancies. Mycoses. 2002;45(Suppl 1):27\u201330.", "journal-title": "Mycoses"}, {"issue": "5", "key": "34_CR37", "doi-asserted-by": "publisher", "first-page": "743", "DOI": "10.1086/423274", "volume": "39", "author": "A Imhof", "year": "2004", "unstructured": "Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis. 2004;39(5):743\u20136.", "journal-title": "Clin Infect Dis"}, {"issue": "9", "key": "34_CR38", "doi-asserted-by": "publisher", "first-page": "862", "DOI": "10.1111/j.1469-0691.2004.00945.x", "volume": "10", "author": "L Ide", "year": "2004", "unstructured": "Ide L, Buysschaert I, Demuynck H, De Man R, Verlinde A, De Laere E, Surmont I. Zygomycosis in neutropenic patients with past aspergillus infection: a role for posaconazole? Clin Microbiol Infect. 2004;10(9):862\u20133.", "journal-title": "Clin Microbiol Infect"}, {"issue": "4", "key": "34_CR39", "doi-asserted-by": "publisher", "first-page": "e35", "DOI": "10.1086/427752", "volume": "40", "author": "S Vigouroux", "year": "2005", "unstructured": "Vigouroux S, Morin O, Moreau P, Mechinaud F, Morineau N, Mahe B, et al. Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin Infect Dis. 2005;40(4):e35\u20137.", "journal-title": "Clin Infect Dis"}, {"issue": "5", "key": "34_CR40", "first-page": "383", "volume": "11", "author": "VA Morrison", "year": "1993", "unstructured": "Morrison VA, McGlave PB. Mucormycosis in the BMT population. Bone Marrow Transplant. 1993;11(5):383\u20138.", "journal-title": "Bone Marrow Transplant"}, {"issue": "8", "key": "34_CR41", "doi-asserted-by": "publisher", "first-page": "880", "DOI": "10.1007/BF03017426", "volume": "49", "author": "K Alsuwaida", "year": "2002", "unstructured": "Alsuwaida K. Primary cutaneous mucormycosis complicating the use of adhesive tape to secure the endotracheal tube. Can J Anaesth. 2002;49(8):880\u20132.", "journal-title": "Can J Anaesth"}, {"issue": "12", "key": "34_CR42", "doi-asserted-by": "publisher", "first-page": "753", "DOI": "10.1007/s10096-003-1035-y", "volume": "22", "author": "G Petrikkos", "year": "2003", "unstructured": "Petrikkos G, Skiada A, Sambatakou H, Toskas A, Vaiopoulos G, Giannopoulou M, Katsilambros N. Mucormycosis: ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis. 2003;22(12):753\u20136.", "journal-title": "Eur J Clin Microbiol Infect Dis"}, {"issue": "1", "key": "34_CR43", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1093/clinids/19.1.67", "volume": "19", "author": "RD Adam", "year": "1994", "unstructured": "Adam RD, Hunter G, DiTomasso J, Comerci G Jr. Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis. 1994;19(1):67\u201376.", "journal-title": "Clin Infect Dis"}, {"issue": "6", "key": "34_CR44", "doi-asserted-by": "publisher", "first-page": "1212", "DOI": "10.1111/j.1365-2133.2004.05826.x", "volume": "150", "author": "OA Kerr", "year": "2004", "unstructured": "Kerr OA, Bong C, Wallis C, Tidman MJ. Primary cutaneous mucormycosis masquerading as pyoderma gangrenosum. Br J Dermatol. 2004;150(6):1212\u20133.", "journal-title": "Br J Dermatol"}, {"issue": "2", "key": "34_CR45", "doi-asserted-by": "publisher", "first-page": "177", "DOI": "10.1080/13693780310001644644", "volume": "42", "author": "D Quinio", "year": "2004", "unstructured": "Quinio D, Karam A, Leroy JP, Moal MC, Bourbigot B, Masure O, et al. Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient. Med Mycol. 2004;42(2):177\u201380.", "journal-title": "Med Mycol"}, {"issue": "20", "key": "34_CR46", "doi-asserted-by": "publisher", "first-page": "1115", "DOI": "10.1056/NEJM197811162992007", "volume": "299", "author": "G Gartenberg", "year": "1978", "unstructured": "Gartenberg G, Bottone EJ, Keusch GT, Weitzman I. Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment. N Engl J Med. 1978;299(20):1115\u20138.", "journal-title": "N Engl J Med"}, {"issue": "3", "key": "34_CR47", "doi-asserted-by": "publisher", "first-page": "272", "DOI": "10.1001/jama.1979.03300030044022", "volume": "242", "author": "JH Mead", "year": "1979", "unstructured": "Mead JH, Lupton GP, Dillavou CL, Odom RB. Cutaneous Rhizopus infection. Occurrence as a postoperative complication associated with an elasticized adhesive dressing. JAMA. 1979;242(3):272\u20134.", "journal-title": "JAMA"}, {"issue": "10", "key": "34_CR48", "doi-asserted-by": "publisher", "first-page": "1251", "DOI": "10.1017/ice.2016.157", "volume": "37", "author": "LJ Teal", "year": "2016", "unstructured": "Teal LJ, Schultz KM, Weber DJ, Gergen MF, Miller MB, DiBiase LM, et al. Invasive cutaneous Rhizopus infections in an immunocompromised patient population associated with hospital laundry carts. Infect Control Hosp Epidemiol. 2016;37(10):1251\u20133.", "journal-title": "Infect Control Hosp Epidemiol"}, {"issue": "5", "key": "34_CR49", "doi-asserted-by": "publisher", "first-page": "472", "DOI": "10.1097/INF.0000000000000261", "volume": "33", "author": "J Duffy", "year": "2014", "unstructured": "Duffy J, Harris J, Gade L, Sehulster L, Newhouse E, O\u2019Connell H, et al. Mucormycosis outbreak associated with hospital linens. Pediatr Infect Dis J. 2014;33(5):472\u20136.", "journal-title": "Pediatr Infect Dis J"}, {"issue": "4", "key": "34_CR50", "doi-asserted-by": "publisher", "first-page": "724", "DOI": "10.1007/s00134-003-2132-1", "volume": "30", "author": "E Maravi-Poma", "year": "2004", "unstructured": "Maravi-Poma E, Rodriguez-Tudela JL, de Jalon JG, Manrique-Larralde A, Torroba L, Urtasun J, et al. Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients. Intensive Care Med. 2004;30(4):724\u20138.", "journal-title": "Intensive Care Med"}, {"issue": "6", "key": "34_CR51", "doi-asserted-by": "publisher", "first-page": "1002", "DOI": "10.1086/605445", "volume": "200", "author": "N Singh", "year": "2009", "unstructured": "Singh N, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, et al. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis. 2009;200(6):1002\u201311.", "journal-title": "J Infect Dis"}, {"issue": "3", "key": "34_CR52", "doi-asserted-by": "publisher", "first-page": "556", "DOI": "10.1128/CMR.18.3.556-569.2005", "volume": "18", "author": "B Spellberg", "year": "2005", "unstructured": "Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18(3):556\u201369.", "journal-title": "Clin Microbiol Rev"}, {"issue": "Suppl 1", "key": "34_CR53", "doi-asserted-by": "publisher", "first-page": "S23", "DOI": "10.1093/cid/cir866", "volume": "54", "author": "G Petrikkos", "year": "2012", "unstructured": "Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23\u201334.", "journal-title": "Clin Infect Dis"}, {"issue": "9", "key": "34_CR54", "doi-asserted-by": "publisher", "first-page": "2166", "DOI": "10.1111/j.1600-6143.2009.02754.x", "volume": "9", "author": "HY Sun", "year": "2009", "unstructured": "Sun HY, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, et al. Pulmonary zygomycosis in solid organ transplant recipients in the current era. Am J Transplant. 2009;9(9):2166\u201371.", "journal-title": "Am J Transplant"}, {"issue": "1", "key": "34_CR55", "doi-asserted-by": "publisher", "first-page": "60", "DOI": "10.1086/430710", "volume": "41", "author": "G Chamilos", "year": "2005", "unstructured": "Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis. 2005;41(1):60\u20136.", "journal-title": "Clin Infect Dis"}, {"issue": "4", "key": "34_CR56", "doi-asserted-by": "publisher", "first-page": "348", "DOI": "10.4161/viru.2.4.17074", "volume": "2", "author": "RE Lewis", "year": "2011", "unstructured": "Lewis RE, Liao G, Wang W, Prince RA, Kontoyiannis DP. Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of aspergillus fumigatus-Rhizopus oryzae pulmonary infection. Virulence. 2011;2(4):348\u201355.", "journal-title": "Virulence"}, {"issue": "9", "key": "34_CR57", "doi-asserted-by": "publisher", "first-page": "1399", "DOI": "10.1086/597615", "volume": "199", "author": "GA Lamaris", "year": "2009", "unstructured": "Lamaris GA, Ben-Ami R, Lewis RE, Chamilos G, Samonis G, Kontoyiannis DP. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis. J Infect Dis. 2009;199(9):1399\u2013406.", "journal-title": "J Infect Dis"}, {"issue": "6", "key": "34_CR58", "doi-asserted-by": "publisher", "first-page": "1914", "DOI": "10.1172/JCI42164", "volume": "120", "author": "M Liu", "year": "2010", "unstructured": "Liu M, Spellberg B, Phan QT, Fu Y, Fu Y, Lee AS, et al. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J Clin Invest. 2010;120(6):1914\u201324.", "journal-title": "J Clin Invest"}, {"issue": "6", "key": "34_CR59", "doi-asserted-by": "publisher", "first-page": "R122", "DOI": "10.1186/cc6184", "volume": "11", "author": "EC Lutterloh", "year": "2007", "unstructured": "Lutterloh EC, Opal SM, Pittman DD, Keith JC Jr, Tan XY, Clancy BM, et al. Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Crit Care. 2007;11(6):R122.", "journal-title": "Crit Care"}, {"issue": "11", "key": "34_CR60", "doi-asserted-by": "publisher", "first-page": "1641", "DOI": "10.1172/JCI200418704", "volume": "113", "author": "B Liliensiek", "year": "2004", "unstructured": "Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M, Hofer S, et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest. 2004;113(11):1641\u201350.", "journal-title": "J Clin Invest"}, {"issue": "5", "key": "34_CR61", "doi-asserted-by": "publisher", "first-page": "e20132", "DOI": "10.1371/journal.pone.0020132", "volume": "6", "author": "L Ramsgaard", "year": "2011", "unstructured": "Ramsgaard L, Englert JM, Manni ML, Milutinovic PS, Gefter J, Tobolewski J, et al. Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice. PLoS One. 2011;6(5):e20132.", "journal-title": "PLoS One"}, {"key": "34_CR62", "doi-asserted-by": "publisher", "first-page": "364", "DOI": "10.1086/589857", "volume": "47", "author": "R C", "year": "2008", "unstructured": "C R, Bryant R, Ibrahim AS, Edwards J Jr, Filler SG, Goldberg R, Spellberg B. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008;47:364\u201371.", "journal-title": "Clin Infect Dis"}, {"issue": "4", "key": "34_CR63", "doi-asserted-by": "publisher", "first-page": "503", "DOI": "10.1086/590004", "volume": "47", "author": "G Chamilos", "year": "2008", "unstructured": "Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47(4):503\u20139.", "journal-title": "Clin Infect Dis"}, {"issue": "5", "key": "34_CR64", "doi-asserted-by": "publisher", "first-page": "1979", "DOI": "10.1172/JCI116419", "volume": "91", "author": "JR Boelaert", "year": "1993", "unstructured": "Boelaert JR, de Locht M, Van Cutsem J, Kerrels V, Cantinieaux B, Verdonck A, et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Investig. 1993;91(5):1979\u201386.", "journal-title": "J Clin Investig"}, {"issue": "6", "key": "34_CR65", "doi-asserted-by": "publisher", "first-page": "1061", "DOI": "10.1038/ki.1989.301", "volume": "36", "author": "J Cutsem Van", "year": "1989", "unstructured": "Van Cutsem J, Boelaert JR. Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis). Kidney Int. 1989;36(6):1061\u20138.", "journal-title": "Kidney Int"}, {"issue": "9", "key": "34_CR66", "doi-asserted-by": "publisher", "first-page": "2649", "DOI": "10.1172/JCI32338", "volume": "117", "author": "AS Ibrahim", "year": "2007", "unstructured": "Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, French SW, et al. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest. 2007;117(9):2649\u201357.", "journal-title": "J Clin Invest"}, {"issue": "6", "key": "34_CR67", "doi-asserted-by": "publisher", "first-page": "611", "DOI": "10.3109/13693786.2012.669502", "volume": "50", "author": "B Spellberg", "year": "2012", "unstructured": "Spellberg B, Kontoyiannis DP, Fredricks D, Morris MI, Perfect JR, Chin-Hong PV, et al. Risk factors for mortality in patients with mucormycosis. Med Mycol. 2012;50(6):611\u20138.", "journal-title": "Med Mycol"}, {"issue": "4", "key": "34_CR68", "doi-asserted-by": "publisher", "first-page": "468", "DOI": "10.1016/S0002-9343(89)80836-8", "volume": "87", "author": "AL Daly", "year": "1989", "unstructured": "Daly AL, Velazquez LA, Bradley SF, Kauffman CA. Mucormycosis: association with deferoxamine therapy. Am J Med. 1989;87(4):468\u201371.", "journal-title": "Am J Med"}, {"issue": "1", "key": "34_CR69", "doi-asserted-by": "publisher", "first-page": "231", "DOI": "10.1093/infdis/169.1.231", "volume": "169", "author": "JR Boelaert", "year": "1994", "unstructured": "Boelaert JR, de Locht M, Schneider YJ. The effect of deferoxamine on different zygomycetes. J Infect Dis. 1994;169(1):231\u20132.", "journal-title": "J Infect Dis"}, {"issue": "3", "key": "34_CR70", "doi-asserted-by": "publisher", "first-page": "667", "DOI": "10.1038/ki.1994.89", "volume": "45", "author": "JR Boelaert", "year": "1994", "unstructured": "Boelaert JR, Van Cutsem J, de Locht M, Schneider YJ, Crichton RR. Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney Int. 1994;45(3):667\u201371.", "journal-title": "Kidney Int"}, {"issue": "3", "key": "34_CR71", "first-page": "231", "volume": "51", "author": "S Nithyanandam", "year": "2003", "unstructured": "Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, D'Souza O. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol. 2003;51(3):231\u20136.", "journal-title": "Indian J Ophthalmol"}, {"issue": "7", "key": "34_CR72", "doi-asserted-by": "publisher", "first-page": "855", "DOI": "10.1097/00005537-199707000-00004", "volume": "107", "author": "KL Peterson", "year": "1997", "unstructured": "Peterson KL, Wang M, Canalis RF, Abemayor E. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope. 1997;107(7):855\u201362.", "journal-title": "Laryngoscope"}, {"issue": "4", "key": "34_CR73", "first-page": "266", "volume": "36", "author": "BS Khor", "year": "2003", "unstructured": "Khor BS, Lee MH, Leu HS, Liu JW. Rhinocerebral mucormycosis in Taiwan. J Microbiol Immunol Infect. 2003;36(4):266\u20139.", "journal-title": "J Microbiol Immunol Infect"}, {"issue": "4", "key": "34_CR74", "doi-asserted-by": "publisher", "first-page": "1044", "DOI": "10.1016/0003-4975(94)90243-7", "volume": "57", "author": "M Tedder", "year": "1994", "unstructured": "Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994;57(4):1044\u201350.", "journal-title": "Ann Thorac Surg"}, {"issue": "4", "key": "34_CR75", "doi-asserted-by": "publisher", "first-page": "1449", "DOI": "10.1016/S0003-4975(03)01406-1", "volume": "78", "author": "VJ Reid", "year": "2004", "unstructured": "Reid VJ, Solnik DL, Daskalakis T, Sheka KP. Management of bronchovascular mucormycosis in a diabetic: a surgical success. Ann Thorac Surg. 2004;78(4):1449\u201351.", "journal-title": "Ann Thorac Surg"}, {"issue": "4", "key": "34_CR76", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1007/s11748-003-0055-y", "volume": "51", "author": "K Asai", "year": "2003", "unstructured": "Asai K, Suzuki K, Takahashi T, Ito Y, Kazui T, Kita Y. Pulmonary resection with chest wall removal and reconstruction for invasive pulmonary mucormycosis during antileukemia chemotherapy. Jpn J Thorac Cardiovasc Surg. 2003;51(4):163\u20136.", "journal-title": "Jpn J Thorac Cardiovasc Surg"}, {"issue": "3", "key": "34_CR77", "doi-asserted-by": "publisher", "first-page": "e64", "DOI": "10.1016/j.tripleo.2009.11.012", "volume": "109", "author": "NE McDermott", "year": "2010", "unstructured": "McDermott NE, Barrett J, Hipp J, Merino MJ, Richard Lee CC, Waterman P, et al. Successful treatment of periodontal mucormycosis: report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109(3):e64\u20139.", "journal-title": "Oral Surg Oral Med Oral Pathol Oral Radiol Endod"}, {"issue": "6", "key": "34_CR78", "doi-asserted-by": "publisher", "first-page": "1383", "DOI": "10.1086/516353", "volume": "26", "author": "TJ Walsh", "year": "1998", "unstructured": "Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis. 1998;26(6):1383\u201396.", "journal-title": "Clin Infect Dis"}, {"issue": "7", "key": "34_CR79", "doi-asserted-by": "publisher", "first-page": "1351", "DOI": "10.1080/10428190310001653691", "volume": "45", "author": "B Gleissner", "year": "2004", "unstructured": "Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma. 2004;45(7):1351\u201360.", "journal-title": "Leuk Lymphoma"}, {"issue": "2", "key": "34_CR80", "doi-asserted-by": "publisher", "first-page": "296", "DOI": "10.1093/jac/dkp430", "volume": "65", "author": "MJ Ruping", "year": "2010", "unstructured": "Ruping MJ, Heinz WJ, Kindo AJ, Rickerts V, Lass-Florl C, Beisel C, et al. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother. 2010;65(2):296\u2013302.", "journal-title": "J Antimicrob Chemother"}, {"issue": "3", "key": "34_CR81", "doi-asserted-by": "publisher", "first-page": "322", "DOI": "10.1179/joc.2009.21.3.322", "volume": "21", "author": "L Pagano", "year": "2009", "unstructured": "Pagano L, Valentini CG, Posteraro B, Girmenia C, Ossi C, Pan A, et al. Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J Chemother. 2009;21(3):322\u20139.", "journal-title": "J Chemother"}, {"issue": "Suppl 3", "key": "34_CR82", "doi-asserted-by": "publisher", "first-page": "5", "DOI": "10.1111/1469-0691.12371", "volume": "20", "author": "OA Cornely", "year": "2014", "unstructured": "Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014;20(Suppl 3):5\u201326.", "journal-title": "Clin Microbiol Infect"}, {"issue": "1", "key": "34_CR83", "doi-asserted-by": "publisher", "first-page": "274", "DOI": "10.1086/315643", "volume": "182", "author": "AH Groll", "year": "2000", "unstructured": "Groll AH, Giri N, Petraitis V, Petraitiene R, Candelario M, Bacher JS, et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis. 2000;182(1):274\u201382.", "journal-title": "J Infect Dis"}, {"issue": "4", "key": "34_CR84", "doi-asserted-by": "publisher", "first-page": "1573", "DOI": "10.1128/AAC.01488-07", "volume": "52", "author": "AS Ibrahim", "year": "2008", "unstructured": "Ibrahim AS, Gebremariam T, Husseiny MI, Stevens DA, Fu Y, Edwards JE Jr, Spellberg B. Comparison of lipid amphotericin B preparations in treating murine zygomycosis. Antimicrob Agents Chemother. 2008;52(4):1573\u20136.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "4", "key": "34_CR85", "doi-asserted-by": "publisher", "first-page": "1253", "DOI": "10.1128/AAC.01449-06", "volume": "51", "author": "RE Lewis", "year": "2007", "unstructured": "Lewis RE, Liao G, Hou J, Chamilos G, Prince RA, Kontoyiannis DP. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 2007;51(4):1253\u20138.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "10", "key": "34_CR86", "doi-asserted-by": "publisher", "first-page": "1289", "DOI": "10.1086/514341", "volume": "44", "author": "OA Cornely", "year": "2007", "unstructured": "Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis. 2007;44(10):1289\u201397.", "journal-title": "Clin Infect Dis"}, {"issue": "12", "key": "34_CR87", "doi-asserted-by": "publisher", "first-page": "3487", "DOI": "10.1128/AAC.45.12.3487-3496.2001", "volume": "45", "author": "TJ Walsh", "year": "2001", "unstructured": "Walsh TJ, Goodman JL, Pappas P, Bekersky I, Buell DN, Roden M, et al. Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother. 2001;45(12):3487\u201396.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "4", "key": "34_CR88", "doi-asserted-by": "publisher", "first-page": "1645", "DOI": "10.1128/AAC.01530-08", "volume": "53", "author": "S Perkhofer", "year": "2009", "unstructured": "Perkhofer S, Lechner V, Lass-Florl C. European committee on antimicrobial susceptibility T. in vitro activity of Isavuconazole against aspergillus species and zygomycetes according to the methodology of the European committee on antimicrobial susceptibility testing. Antimicrob Agents Chemother. 2009;53(4):1645\u20137.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "3", "key": "34_CR89", "doi-asserted-by": "publisher", "first-page": "272", "DOI": "10.1179/joc.2009.21.3.272", "volume": "21", "author": "PE Verweij", "year": "2009", "unstructured": "Verweij PE, Gonzalez GM, Wiedrhold NP, Lass-Florl C, Warn P, Heep M, et al. In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries. J Chemother. 2009;21(3):272\u201381.", "journal-title": "J Chemother"}, {"issue": "1\u20132", "key": "34_CR90", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1007/s11046-014-9772-2", "volume": "178", "author": "M Castanheira", "year": "2014", "unstructured": "Castanheira M, Messer SA, Rhomberg PR, Dietrich RR, Jones RN, Pfaller MA. Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values. Mycopathologia. 2014;178(1\u20132):1\u20139.", "journal-title": "Mycopathologia"}, {"issue": "12", "key": "34_CR91", "doi-asserted-by": "publisher", "first-page": "7735", "DOI": "10.1128/AAC.01919-15", "volume": "59", "author": "MC Arendrup", "year": "2015", "unstructured": "Arendrup MC, Jensen RH, Meletiadis J. In vitro activity of isavuconazole and comparators against clinical isolates of the mucorales order. Antimicrob Agents Chemother. 2015;59(12):7735\u201342.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "8", "key": "34_CR92", "doi-asserted-by": "publisher", "first-page": "4568", "DOI": "10.1128/AAC.00514-16", "volume": "60", "author": "LL Kovanda", "year": "2016", "unstructured": "Kovanda LL, Desai AV, Lu Q, Townsend RW, Akhtar S, Bonate P, Hope WW. Isavuconazole population pharmacokinetic analysis using nonparametric estimation in patients with invasive fungal disease (results from the VITAL study). Antimicrob Agents Chemother. 2016;60(8):4568\u201376.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "7", "key": "34_CR93", "doi-asserted-by": "publisher", "first-page": "828", "DOI": "10.1016/S1473-3099(16)00071-2", "volume": "16", "author": "FM Marty", "year": "2016", "unstructured": "Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR 3rd, et al. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis. 2016;16(7):828\u201337.", "journal-title": "Lancet Infect Dis"}, {"issue": "8", "key": "34_CR94", "doi-asserted-by": "publisher", "first-page": "886", "DOI": "10.1016/S1473-3099(16)30154-2", "volume": "16", "author": "B Spellberg", "year": "2016", "unstructured": "Spellberg B, Brass EP. The VITAL study: case control studies are hypothesis-generating. Lancet Infect Dis. 2016;16(8):886.", "journal-title": "Lancet Infect Dis"}, {"issue": "10", "key": "34_CR95", "doi-asserted-by": "publisher", "first-page": "1558", "DOI": "10.1093/cid/civ571", "volume": "61", "author": "MH Miceli", "year": "2015", "unstructured": "Miceli MH, Kauffman CA. Isavuconazole: a new broad-spectrum triazole antifungal agent. Clin Infect Dis. 2015;61(10):1558\u201365.", "journal-title": "Clin Infect Dis"}, {"issue": "5", "key": "34_CR96", "doi-asserted-by": "publisher", "first-page": "1581", "DOI": "10.1128/AAC.46.5.1581-1582.2002", "volume": "46", "author": "QN Sun", "year": "2002", "unstructured": "Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother. 2002;46(5):1581\u20132.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "7", "key": "34_CR97", "doi-asserted-by": "publisher", "first-page": "425", "DOI": "10.1038/sj.bmt.1705614", "volume": "39", "author": "SM Trifilio", "year": "2007", "unstructured": "Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J, et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007;39(7):425\u20139.", "journal-title": "Bone Marrow Transplant"}, {"issue": "11", "key": "34_CR98", "doi-asserted-by": "publisher", "first-page": "3647", "DOI": "10.1128/AAC.47.11.3647-3650.2003", "volume": "47", "author": "E Dannaoui", "year": "2003", "unstructured": "Dannaoui E, Meis JF, Loebenberg D, Verweij PE. Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob Agents Chemother. 2003;47(11):3647\u201350.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "1", "key": "34_CR99", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1093/jac/dkg020", "volume": "51", "author": "E Dannaoui", "year": "2003", "unstructured": "Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother. 2003;51(1):45\u201352.", "journal-title": "J Antimicrob Chemother"}, {"issue": "4", "key": "34_CR100", "doi-asserted-by": "publisher", "first-page": "267", "DOI": "10.1159/000238681", "volume": "35", "author": "J Cutsem Van", "year": "1989", "unstructured": "Van Cutsem J, Van Gerven F, Fransen J, Janssen PA. Treatment of experimental zygomycosis in Guinea pigs with azoles and with amphotericin B. Chemotherapy. 1989;35(4):267\u201372.", "journal-title": "Chemotherapy"}, {"issue": "4", "key": "34_CR101", "doi-asserted-by": "publisher", "first-page": "1032", "DOI": "10.1128/AAC.46.4.1032-1037.2002", "volume": "46", "author": "MA Pfaller", "year": "2002", "unstructured": "Pfaller MA, Messer SA, Hollis RJ, Jones RN. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother. 2002;46(4):1032\u20137.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "7", "key": "34_CR102", "doi-asserted-by": "publisher", "first-page": "2587", "DOI": "10.1128/AAC.00452-07", "volume": "51", "author": "NG Almyroudis", "year": "2007", "unstructured": "Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother. 2007;51(7):2587\u201390.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "34_CR103", "doi-asserted-by": "publisher", "first-page": "3637", "DOI": "10.1128/AAC.00662-08", "volume": "52", "author": "C Lass-Florl", "year": "2008", "unstructured": "Lass-Florl C, Mayr A, Perkhofer S, Hinterberger G, Hausdorfer J, Speth C, Fille M. The activities of antifungal agents against yeasts and filamentous fungi: assessment according to EUCAST methodology. Antimicrob Agents Chemother. 2008;52:3637\u201341.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "34_CR104", "first-page": "1", "volume": "12", "author": "S Arikan", "year": "2008", "unstructured": "Arikan S, Sancak B, Alp S, Hascelik G, McNicholas P. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus. Med Mycol. 2008;12:1\u20137.", "journal-title": "Med Mycol"}, {"issue": "2", "key": "34_CR105", "doi-asserted-by": "publisher", "first-page": "658", "DOI": "10.1128/AAC.50.2.658-666.2006", "volume": "50", "author": "AJ Ullmann", "year": "2006", "unstructured": "Ullmann AJ, Cornely OA, Burchardt A, Hachem R, Kontoyiannis DP, Topelt K, et al. Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother. 2006;50(2):658\u201366.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "3", "key": "34_CR106", "doi-asserted-by": "publisher", "first-page": "812", "DOI": "10.1128/AAC.00454-06", "volume": "51", "author": "G Krishna", "year": "2007", "unstructured": "Krishna G, Sansone-Parsons A, Martinho M, Kantesaria B, Pedicone L. Posaconazole plasma concentrations in juvenile patients with invasive fungal infection. Antimicrob Agents Chemother. 2007;51(3):812\u20138.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "12", "key": "34_CR107", "doi-asserted-by": "publisher", "first-page": "1627", "DOI": "10.1592/phco.27.12.1627", "volume": "27", "author": "G Krishna", "year": "2007", "unstructured": "Krishna G, Martinho M, Chandrasekar P, Ullmann AJ, Patino H. Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease. Pharmacotherapy. 2007;27(12):1627\u201336.", "journal-title": "Pharmacotherapy"}, {"issue": "7", "key": "34_CR108", "doi-asserted-by": "publisher", "first-page": "2310", "DOI": "10.1128/AAC.46.7.2310-2312.2002", "volume": "46", "author": "QN Sun", "year": "2002", "unstructured": "Sun QN, Najvar LK, Bocanegra R, Loebenberg D, Graybill JR. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother. 2002;46(7):2310\u20132.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "34_CR109", "doi-asserted-by": "publisher", "first-page": "3786", "DOI": "10.1128/AAC.00628-08", "volume": "52", "author": "MM Rodriguez", "year": "2008", "unstructured": "Rodriguez MM, Serena C, Marine M, Pastor FJ, Guarro J. Posaconazole combined with amphotericin B, an effective therapy for a murine-disseminated infection caused by Rhizopus oryzae. Antimicrob Agents Chemother. 2008;52:3786\u20138.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "2", "key": "34_CR110", "doi-asserted-by": "publisher", "first-page": "772", "DOI": "10.1128/AAC.01124-08", "volume": "53", "author": "A. S. Ibrahim", "year": "2008", "unstructured": "Ibrahim AS, Gebremariam T, Schwartz JA, Edwards JE Jr, Spellberg B. Posaconazole mono- or combination therapy for treatment of murine zygomycosis. Antimocrob Agents Chemother. 2009;53:772\u20135.", "journal-title": "Antimicrobial Agents and Chemotherapy"}, {"issue": "8", "key": "34_CR111", "doi-asserted-by": "publisher", "first-page": "991", "DOI": "10.1016/j.bbmt.2009.04.007", "volume": "15", "author": "LJ Lekakis", "year": "2009", "unstructured": "Lekakis LJ, Lawson A, Prante J, Ribes J, Davis GJ, Monohan G, et al. Fatal rhizopus pneumonia in allogeneic stem cell transplant patients despite posaconazole prophylaxis: two cases and review of the literature. Biol Blood Marrow Transplant. 2009;15(8):991\u20135.", "journal-title": "Biol Blood Marrow Transplant"}, {"issue": "3", "key": "34_CR112", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1111/j.1399-3062.2009.00479.x", "volume": "12", "author": "S Mousset", "year": "2010", "unstructured": "Mousset S, Bug G, Heinz WJ, Tintelnot K, Rickerts V. Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation. Transpl Infect Dis. 2010;12(3):261\u20134.", "journal-title": "Transpl Infect Dis"}, {"issue": "8", "key": "34_CR113", "doi-asserted-by": "publisher", "first-page": "551", "DOI": "10.1038/bmt.2008.199", "volume": "42", "author": "F Schlemmer", "year": "2008", "unstructured": "Schlemmer F, Lagrange-Xelot M, Lacroix C, de La Tour R, Socie G, Molina JM. Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation. Bone Marrow Transplant. 2008;42(8):551\u20132.", "journal-title": "Bone Marrow Transplant"}, {"issue": "7", "key": "34_CR114", "doi-asserted-by": "publisher", "first-page": "e61", "DOI": "10.1086/500212", "volume": "42", "author": "JA Burik van", "year": "2006", "unstructured": "van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis. 2006;42(7):e61\u20135.", "journal-title": "Clin Infect Dis"}, {"issue": "1", "key": "34_CR115", "doi-asserted-by": "publisher", "first-page": "126", "DOI": "10.1128/AAC.50.1.126-133.2006", "volume": "50", "author": "RN Greenberg", "year": "2006", "unstructured": "Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006;50(1):126\u201333.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "34_CR116", "unstructured": "National Diabetes Fact Sheet, 2011. Atlanta: US Centers for Disease Control and Prevention; 2012."}, {"issue": "25", "key": "34_CR117", "doi-asserted-by": "publisher", "first-page": "1906", "DOI": "10.1056/NEJM199912163412507", "volume": "341", "author": "N Joshi", "year": "1999", "unstructured": "Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341(25):1906\u201312.", "journal-title": "N Engl J Med"}, {"issue": "9", "key": "34_CR118", "doi-asserted-by": "publisher", "first-page": "811.e1", "DOI": "10.1016/j.cmi.2016.03.029", "volume": "22", "author": "A Kyvernitakis", "year": "2016", "unstructured": "Kyvernitakis A, Torres HA, Jiang Y, Chamilos G, Lewis RE, Kontoyiannis DP. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis. Clin Microbiol Infect. 2016;22(9):811.e1\u20138.", "journal-title": "Clin Microbiol Infect"}, {"issue": "2", "key": "34_CR119", "doi-asserted-by": "publisher", "first-page": "721", "DOI": "10.1128/AAC.49.2.721-727.2005", "volume": "49", "author": "AS Ibrahim", "year": "2005", "unstructured": "Ibrahim AS, Bowman JC, Avanessian V, Brown K, Spellberg B, Edwards JE Jr, Douglas CM. Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob Agents Chemother. 2005;49(2):721\u20137.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "2", "key": "34_CR120", "doi-asserted-by": "publisher", "first-page": "830", "DOI": "10.1128/AAC.49.2.830-832.2005", "volume": "49", "author": "B Spellberg", "year": "2005", "unstructured": "Spellberg B, Fu Y, Edwards JE Jr, Ibrahim AS. Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice. Antimicrob Agents Chemother. 2005;49(2):830\u20132.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "4", "key": "34_CR121", "doi-asserted-by": "publisher", "first-page": "1556", "DOI": "10.1128/AAC.01458-07", "volume": "52", "author": "AS Ibrahim", "year": "2008", "unstructured": "Ibrahim AS, Gebremariam T, Fu Y, Edwards JE Jr, Spellberg B. Combination echinocandin-polyene treatment of murine mucormycosis. Antimicrob Agents Chemother. 2008;52(4):1556\u20138.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "6", "key": "34_CR122", "doi-asserted-by": "publisher", "first-page": "592", "DOI": "10.1080/13693780802326001", "volume": "47", "author": "AS Ibrahim", "year": "2009", "unstructured": "Ibrahim AS, Bryant R, Edwards JE, Spellberg B. Economic burden of mucormycosis in the United States: can a vaccine be cost-effective? Med Mycol. 2009;47(6):592\u2013600.", "journal-title": "Med Mycol"}, {"issue": "3", "key": "34_CR123", "doi-asserted-by": "publisher", "first-page": "587", "DOI": "10.1111/j.1365-2958.2010.07234.x", "volume": "77", "author": "AS Ibrahim", "year": "2010", "unstructured": "Ibrahim AS, Gebremariam T, Lin L, Luo G, Husseiny MI, Skory CD, et al. The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis. Mol Microbiol. 2010;77(3):587\u2013604.", "journal-title": "Mol Microbiol"}, {"issue": "10", "key": "34_CR124", "doi-asserted-by": "publisher", "first-page": "1843", "DOI": "10.1016/0006-2952(94)90314-X", "volume": "47", "author": "M Locht de", "year": "1994", "unstructured": "de Locht M, Boelaert JR, Schneider YJ. Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus. Biochem Pharmacol. 1994;47(10):1843\u201350.", "journal-title": "Biochem Pharmacol"}, {"key": "34_CR125", "doi-asserted-by": "publisher", "first-page": "1070", "DOI": "10.1093/jac/dkl350", "volume": "58", "author": "AS Ibrahim", "year": "2006", "unstructured": "Ibrahim AS, Edwards JE Jr, Fu Y, Spellberg B. Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother. 2006;58:1070\u20133.", "journal-title": "J Antimicrob Chemother"}, {"issue": "11", "key": "34_CR126", "doi-asserted-by": "publisher", "first-page": "3968", "DOI": "10.1128/AAC.01065-06", "volume": "50", "author": "C Reed", "year": "2006", "unstructured": "Reed C, Ibrahim A, Edwards JE Jr, Walot I, Spellberg B. Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis. Antimicrob Agents Chemother. 2006;50(11):3968\u20139.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "7", "key": "34_CR127", "doi-asserted-by": "publisher", "first-page": "3122", "DOI": "10.1128/AAC.00361-09", "volume": "53", "author": "B Spellberg", "year": "2009", "unstructured": "Spellberg B, Andes D, Perez M, Anglim A, Bonilla H, Mathisen GE, et al. Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis. Antimicrob Agents Chemother. 2009;53(7):3122\u20135.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "3", "key": "34_CR1001", "doi-asserted-by": "publisher", "first-page": "715", "DOI": "10.1093/jac/dkr375", "volume": "67", "author": "Brad Spellberg", "year": "2011", "unstructured": "Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris M, Perfect JR, Fredricks D, Brass EP. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study: A Randomized, Double-Blinded Placebo Controlled Trial. J Antimicrob Chemother. 2012;67:715\u201322.", "journal-title": "Journal of Antimicrobial Chemotherapy"}, {"issue": "1", "key": "34_CR128", "doi-asserted-by": "publisher", "first-page": "484", "DOI": "10.1128/AAC.00956-09", "volume": "54", "author": "R Ben-Ami", "year": "2010", "unstructured": "Ben-Ami R, Lewis RE, Tarrand J, Leventakos K, Kontoyiannis DP. Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection. Antimicrob Agents Chemother. 2010;54(1):484\u201390.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "7", "key": "34_CR129", "doi-asserted-by": "publisher", "first-page": "1180", "DOI": "10.1086/428503", "volume": "191", "author": "C Gil-Lamaignere", "year": "2005", "unstructured": "Gil-Lamaignere C, Simitsopoulou M, Roilides E, Maloukou A, Winn RM, Walsh TJ. Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis. 2005;191(7):1180\u20137.", "journal-title": "J Infect Dis"}, {"issue": "8", "key": "34_CR130", "doi-asserted-by": "publisher", "first-page": "769", "DOI": "10.1097/01.inf.0000134314.65398.bf", "volume": "23", "author": "MJ Abzug", "year": "2004", "unstructured": "Abzug MJ, Walsh TJ. Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children. Pediatr Infect Dis J. 2004;23(8):769\u201373.", "journal-title": "Pediatr Infect Dis J"}, {"issue": "2", "key": "34_CR131", "doi-asserted-by": "publisher", "first-page": "192", "DOI": "10.1093/clinids/24.2.192", "volume": "24", "author": "CE Gonzalez", "year": "1997", "unstructured": "Gonzalez CE, Couriel DR, Walsh TJ. Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Clin Infect Dis. 1997;24(2):192\u20136.", "journal-title": "Clin Infect Dis"}, {"issue": "4\u20135", "key": "34_CR132", "doi-asserted-by": "publisher", "first-page": "478", "DOI": "10.1016/S0923-2494(98)80771-2", "volume": "149", "author": "BJ Kullberg", "year": "1998", "unstructured": "Kullberg BJ, Anaissie EJ. Cytokines as therapy for opportunistic fungal infections. Res Immunol. 1998;149(4\u20135):478\u201388; discussion 515.", "journal-title": "Res Immunol"}, {"issue": "7", "key": "34_CR133", "doi-asserted-by": "publisher", "first-page": "783", "DOI": "10.1007/s00520-005-0910-8", "volume": "14", "author": "L Grigull", "year": "2006", "unstructured": "Grigull L, Beilken A, Schmid H, Kirschner P, Sykora KW, Linderkamp C, et al. Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies. Support Care Cancer. 2006;14(7):783\u20136.", "journal-title": "Support Care Cancer"}, {"issue": "7", "key": "34_CR134", "doi-asserted-by": "publisher", "first-page": "515", "DOI": "10.1111/j.1469-0691.2005.01170.x", "volume": "11", "author": "BV John", "year": "2005", "unstructured": "John BV, Chamilos G, Kontoyiannis DP. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect. 2005;11(7):515\u20137.", "journal-title": "Clin Microbiol Infect"}, {"issue": "3", "key": "34_CR135", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1111/j.1439-0507.2009.01708.x", "volume": "53", "author": "A Busca", "year": "2010", "unstructured": "Busca A, Marmont F, Locatelli F, Limerutti G, Sorrentino MT, Barbui A, et al. Combined antifungal therapy, iron chelation and surgical resection as treatment of hepatic zygomycosis in a patient with haematological malignancy. Mycoses. 2010;53(3):275\u20138.", "journal-title": "Mycoses"}, {"key": "34_CR136", "doi-asserted-by": "publisher", "first-page": "185", "DOI": "10.1007/978-1-4615-0593-8_10", "volume": "509", "author": "H Nick", "year": "2002", "unstructured": "Nick H, Wong A, Acklin P, Faller B, Jin Y, Lattmann R, et al. ICL670A: preclinical profile. Adv Exp Med Biol. 2002;509:185\u2013203.", "journal-title": "Adv Exp Med Biol"}, {"issue": "8", "key": "34_CR137", "doi-asserted-by": "publisher", "first-page": "3569", "DOI": "10.1128/AAC.00456-09", "volume": "53", "author": "MM Rodriguez", "year": "2009", "unstructured": "Rodriguez MM, Calvo E, Marine M, Pastor FJ, Fernandez-Ballart J, Guarro J. Efficacy of liposomal amphotericin B combined with gamma interferon or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice. Antimicrob Agents Chemother. 2009;53(8):3569\u201371.", "journal-title": "Antimicrob Agents Chemother"}], "container-title": ["Principles and Practice of Transplant Infectious Diseases"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4939-9034-4_34", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 13]], "date-time": "2019-06-13T19:15:44Z", "timestamp": 1560453344000}, "score": 38.12899, "issued": {"date-parts": [[2019]]}, "ISBN": ["9781493990320", "9781493990344"], "references-count": 138, "URL": "http://dx.doi.org/10.1007/978-1-4939-9034-4_34", "relation": {"cites": []}, "assertion": [{"value": "14 June 2019", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ChapterHistory", "label": "Chapter History"}}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T22:09:40Z", "timestamp": 1574460580515}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "7", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CLIN INFECT DIS"], "published-print": {"date-parts": [[2010, 10]]}, "DOI": "10.1086/656240", "type": "journal-article", "created": {"date-parts": [[2010, 9, 1]], "date-time": "2010-09-01T20:23:44Z", "timestamp": 1283372624000}, "page": "876-877", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic Resistance, 2nd Edition Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic Resistance, 2nd Edition Edited by Arch\u00a0G.\u00a0 Mainous III and Claire\u00a0 Pomeroy New York, NY: Humana Press, 2010. 399 pp. $179 (hardcover)."], "prefix": "10.1093", "volume": "51", "author": [{"given": "Brad", "family": "Spellberg", "sequence": "additional", "affiliation": []}], "member": "286", "container-title": ["Clinical Infectious Diseases"], "language": "en", "link": [{"URL": "http://academic.oup.com/cid/article-pdf/51/7/876/1017294/51-7-876.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 22]], "date-time": "2017-08-22T23:28:42Z", "timestamp": 1503444522000}, "score": 32.19508, "editor": [{"given": "Arch\u00a0G.", "family": "Mainous", "sequence": "first", "affiliation": []}, {"given": "Claire", "family": "Pomeroy", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[2010, 10]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 10]]}, "issue": "7"}, "alternative-id": ["10.1086/656240"], "URL": "http://dx.doi.org/10.1086/656240", "ISSN": ["1058-4838", "1537-6591"], "issn-type": [{"value": "1058-4838", "type": "print"}, {"value": "1537-6591", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T20:08:43Z", "timestamp": 1575317323448}, "reference-count": 37, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Opinion in Infectious Diseases"], "published-print": {"date-parts": [[2008, 12]]}, "DOI": "10.1097/qco.0b013e3283165fd1", "type": "journal-article", "created": {"date-parts": [[2008, 10, 31]], "date-time": "2008-10-31T07:09:42Z", "timestamp": 1225436982000}, "page": "620-625", "source": "Crossref", "is-referenced-by-count": 90, "title": ["Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment"], "prefix": "10.1097", "volume": "21", "author": [{"given": "Ashraf S", "family": "Ibrahim", "sequence": "first", "affiliation": []}, {"given": "Brad", "family": "Spellberg", "sequence": "additional", "affiliation": []}, {"suffix": "Jr", "given": "John", "family": "Edwards", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Current Opinion in Infectious Diseases"], "language": "en", "deposited": {"date-parts": [[2019, 2, 15]], "date-time": "2019-02-15T07:28:44Z", "timestamp": 1550215724000}, "score": 30.956318, "subtitle": [""], "issued": {"date-parts": [[2008, 12]]}, "references-count": 37, "journal-issue": {"issue": "6"}, "URL": "http://dx.doi.org/10.1097/qco.0b013e3283165fd1", "ISSN": ["0951-7375"], "issn-type": [{"value": "0951-7375", "type": "print"}], "subject": ["Microbiology (medical)", "Infectious Diseases"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T00:53:57Z", "timestamp": 1575161637718}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Microbiology Reviews"], "published-print": {"date-parts": [[2005, 7, 1]]}, "DOI": "10.1128/cmr.18.3.556-569.2005", "type": "journal-article", "created": {"date-parts": [[2005, 7, 14]], "date-time": "2005-07-14T18:48:00Z", "timestamp": 1121366880000}, "page": "556-569", "source": "Crossref", "is-referenced-by-count": 506, "title": ["Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management"], "prefix": "10.1128", "volume": "18", "author": [{"given": "B.", "family": "Spellberg", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Edwards", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Ibrahim", "sequence": "additional", "affiliation": []}], "member": "235", "published-online": {"date-parts": [[2005, 7, 14]]}, "container-title": ["Clinical Microbiology Reviews"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/CMR.18.3.556-569.2005", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T04:48:00Z", "timestamp": 1482468480000}, "score": 28.342207, "issued": {"date-parts": [[2005, 7, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2005, 7, 14]]}, "published-print": {"date-parts": [[2005, 7, 1]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1128/cmr.18.3.556-569.2005", "ISSN": ["0893-8512"], "issn-type": [{"value": "0893-8512", "type": "print"}], "subject": ["Public Health, Environmental and Occupational Health", "Microbiology (medical)", "General Immunology and Microbiology", "Epidemiology", "Infectious Diseases"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T17:23:13Z", "timestamp": 1575307393807}, "reference-count": 51, "publisher": "Oxford University Press (OUP)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Med Mycol"], "published-print": {"date-parts": [[2009, 1]]}, "DOI": "10.1080/13693780802326001", "type": "journal-article", "created": {"date-parts": [[2008, 9, 17]], "date-time": "2008-09-17T00:15:16Z", "timestamp": 1221610516000}, "page": "592-600", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Economic burden of mucormycosis in the United States: can a vaccine be cost-effective?"], "prefix": "10.1093", "volume": "47", "author": [{"given": "Ashraf S.", "family": "Ibrahim", "sequence": "first", "affiliation": []}, {"suffix": "Jr.", "given": "John E.", "family": "Edwards", "sequence": "additional", "affiliation": []}, {"given": "Richard", "family": "Bryant", "sequence": "additional", "affiliation": []}, {"given": "Brad", "family": "Spellberg", "sequence": "additional", "affiliation": []}], "member": "286", "reference": [{"key": "b1", "DOI": "10.1128/CMR.13.2.236-301.2000", "doi-asserted-by": "publisher"}, {"key": "b2", "author": "Ibrahim AS", "first-page": "241", "year": "2003", "volume-title": "Clinical Mycology"}, {"key": "b3", "author": "Spellberg B", "volume": "18", "first-page": "556", "year": "2005", "journal-title": "Clin Microbiol Rev", "DOI": "10.1128/CMR.18.3.556-569.2005", "doi-asserted-by": "crossref"}, {"key": "b4", "DOI": "10.1086/339202", "doi-asserted-by": "publisher"}, {"key": "b5", "DOI": "10.1086/313803", "doi-asserted-by": "publisher"}, {"key": "b6", "DOI": "10.1086/432579", "doi-asserted-by": "publisher"}, {"key": "b7", "DOI": "10.1086/428780", "doi-asserted-by": "publisher"}, {"key": "b8", "author": "Kwon-Chung KJ", "first-page": "524", "year": "1992", "volume-title": "Medical Mycology"}, {"key": "b9", "DOI": "10.1517/14712598.7.12.1785", "doi-asserted-by": "publisher"}, {"key": "b10", "author": "Reed C", "volume": "47", "first-page": "364", "year": "2008", "journal-title": "Clinical Infectious Diseases", "DOI": "10.1086/589857", "doi-asserted-by": "crossref"}, {"key": "b11", "author": "Gold MR", "year": "1996", "volume-title": "Cost-Effectiveness in Health and Medicine"}, {"key": "b12", "author": "Dunger DB", "volume": "89", "first-page": "188", "year": "2004", "journal-title": "Arch Dis Child", "DOI": "10.1136/adc.2003.044875", "doi-asserted-by": "crossref"}, {"key": "b13", "DOI": "10.1097/00000441-200605000-00002", "doi-asserted-by": "publisher"}, {"key": "b14", "author": "Heyland DK", "volume": "28", "first-page": "3599", "year": "2000", "journal-title": "Crit Care Med", "DOI": "10.1097/00003246-200011000-00006", "doi-asserted-by": "crossref"}, {"key": "b15", "author": "Quartin AA", "volume": "277", "first-page": "1058", "year": "1997", "journal-title": "JAMA", "DOI": "10.1001/jama.277.13.1058", "doi-asserted-by": "crossref"}, {"key": "b16", "DOI": "10.1056/NEJMsa020969", "doi-asserted-by": "publisher"}, {"key": "b17", "author": "Davidson TA", "volume": "281", "first-page": "354", "year": "1999", "journal-title": "JAMA", "DOI": "10.1001/jama.281.4.354", "doi-asserted-by": "crossref"}, {"key": "b18", "DOI": "10.1080/10428190310001653691", "doi-asserted-by": "publisher"}, {"key": "b21", "author": "Obraztsova IN", "volume": "41", "first-page": "168", "year": "2004", "journal-title": "Fungal Genet Biol", "DOI": "10.1016/j.fgb.2003.09.007", "doi-asserted-by": "crossref"}, {"key": "b22", "author": "Alaghehbandan R", "volume": "74", "first-page": "82", "year": "2006", "journal-title": "Diabetes Res Clin Pract", "DOI": "10.1016/j.diabres.2006.03.001", "doi-asserted-by": "crossref"}, {"key": "b23", "DOI": "10.1016/j.diabres.2006.07.024", "doi-asserted-by": "publisher"}, {"key": "b24", "DOI": "10.1002/cncr.20983", "doi-asserted-by": "publisher"}, {"key": "b25", "author": "Loberiza FR", "volume": "31", "first-page": "417", "year": "2003", "journal-title": "Bone Marrow Transplant", "DOI": "10.1038/sj.bmt.1703873", "doi-asserted-by": "crossref"}, {"key": "b26", "year": "2008", "volume-title": "Fast Facts About Transplant, January 1, 2006-December 31, 2007"}, {"key": "b27", "author": "Ellis RW", "volume": "19", "first-page": "1559", "year": "2001", "journal-title": "Vaccine", "DOI": "10.1016/S0264-410X(00)00352-2", "doi-asserted-by": "crossref"}, {"key": "b28", "author": "Rees JR", "volume": "27", "first-page": "1138", "year": "1998", "journal-title": "Clinical Infectious Diseases", "DOI": "10.1086/514975", "doi-asserted-by": "crossref"}, {"key": "b29", "author": "Maertens J", "volume": "24", "first-page": "307", "year": "1999", "journal-title": "Bone Marrow Transplantation", "DOI": "10.1038/sj.bmt.1701885", "doi-asserted-by": "crossref"}, {"key": "b30", "DOI": "10.1056/NEJM200402263500923", "doi-asserted-by": "publisher"}, {"key": "b31", "DOI": "10.1097/00001432-200412000-00003", "doi-asserted-by": "publisher"}, {"key": "b32", "author": "Angus DC", "volume": "163", "first-page": "1389", "year": "2001", "journal-title": "Am J Respir Crit Care Med", "DOI": "10.1164/ajrccm.163.6.2005123", "doi-asserted-by": "crossref"}, {"key": "b33", "author": "Evans C", "volume": "7", "first-page": "43", "year": "2004", "journal-title": "Health Care Manag Sci", "DOI": "10.1023/B:HCMS.0000005397.93173.bb", "doi-asserted-by": "crossref"}, {"key": "b34", "DOI": "10.1086/524041", "doi-asserted-by": "publisher"}, {"key": "b35", "DOI": "10.1385/MO:19:2:71", "doi-asserted-by": "publisher"}, {"key": "b36", "DOI": "10.1111/j.1600-0609.2004.00216.x", "doi-asserted-by": "publisher"}, {"key": "b37", "author": "Somjee S", "volume": "26", "first-page": "989", "year": "2002", "journal-title": "Leuk Res", "DOI": "10.1016/S0145-2126(02)00044-9", "doi-asserted-by": "crossref"}, {"key": "b38", "author": "Feldman S", "volume": "161", "first-page": "926", "year": "1990", "journal-title": "J Infect Dis", "DOI": "10.1093/infdis/161.5.926", "doi-asserted-by": "crossref"}, {"key": "b39", "DOI": "10.1080/1042819021000015916", "doi-asserted-by": "publisher"}, {"key": "b40", "author": "King JC", "volume": "15", "first-page": "192", "year": "1996", "journal-title": "Pediatr Infect Dis J", "DOI": "10.1097/00006454-199603000-00003", "doi-asserted-by": "crossref"}, {"key": "b41", "DOI": "10.1016/S0264-410X(99)00167-X", "doi-asserted-by": "publisher"}, {"key": "b42", "DOI": "10.1089/088922204323087732", "doi-asserted-by": "publisher"}, {"key": "b43", "author": "Rutstein RM", "volume": "150", "first-page": "838", "year": "1996", "journal-title": "Arch Pediatr Adolesc Med", "DOI": "10.1001/archpedi.1996.02170330064011", "doi-asserted-by": "crossref"}, {"key": "b44", "author": "Chokephaibulkit K", "volume": "22", "first-page": "2018", "year": "2004", "journal-title": "Vaccine", "DOI": "10.1016/j.vaccine.2003.10.033", "doi-asserted-by": "crossref"}, {"key": "b45", "DOI": "10.1016/S0264-410X(99)00089-4", "doi-asserted-by": "publisher"}, {"key": "b46", "DOI": "10.1067/mpd.2001.115972", "doi-asserted-by": "publisher"}, {"key": "b47", "DOI": "10.1086/420740", "doi-asserted-by": "publisher"}, {"key": "b48", "DOI": "10.1086/374562", "doi-asserted-by": "publisher"}, {"key": "b49", "author": "Madhi SA", "volume": "21", "first-page": "315", "year": "2002", "journal-title": "Pediatr Infect Dis J", "DOI": "10.1097/00006454-200204000-00011", "doi-asserted-by": "crossref"}, {"key": "b50", "DOI": "10.1056/NEJMoa035060", "doi-asserted-by": "publisher"}, {"key": "b51", "author": "Guerrero M", "volume": "13", "first-page": "1971", "year": "1999", "journal-title": "Aids", "DOI": "10.1097/00002030-199910010-00021", "doi-asserted-by": "crossref"}, {"key": "b52", "author": "Greenwood B", "volume": "40", "first-page": "1519", "year": "2005", "journal-title": "Clin Infect Dis", "DOI": "10.1086/429833", "doi-asserted-by": "crossref"}, {"key": "b53", "DOI": "10.1086/429828", "doi-asserted-by": "publisher"}], "container-title": ["Medical Mycology"], "language": "en", "link": [{"URL": "http://academic.oup.com/mmy/article-pdf/47/6/592/2910385/47-6-592.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 14]], "date-time": "2019-05-14T01:38:59Z", "timestamp": 1557797939000}, "score": 27.851116, "issued": {"date-parts": [[2009, 1]]}, "references-count": 51, "journal-issue": {"published-print": {"date-parts": [[2009, 1]]}, "issue": "6"}, "alternative-id": ["10.1080/13693780802326001"], "URL": "http://dx.doi.org/10.1080/13693780802326001", "relation": {"cites": []}, "ISSN": ["1369-3786", "1460-2709"], "issn-type": [{"value": "1369-3786", "type": "print"}, {"value": "1460-2709", "type": "electronic"}], "subject": ["Infectious Diseases", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T08:26:22Z", "timestamp": 1574497582005}, "reference-count": 21, "publisher": "Informa UK Limited", "issue": "10", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Human Vaccines"], "published-print": {"date-parts": [[2010, 10]]}, "DOI": "10.4161/hv.6.10.12469", "type": "journal-article", "created": {"date-parts": [[2011, 3, 3]], "date-time": "2011-03-03T16:10:55Z", "timestamp": 1299168655000}, "page": "857-859", "source": "Crossref", "is-referenced-by-count": 12, "title": ["A new view on development of aStaphylococcus aureusvaccine"], "prefix": "10.1080", "volume": "6", "author": [{"given": "Brad", "family": "Spellberg", "sequence": "first", "affiliation": []}, {"given": "Robert S.", "family": "Daum", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2014, 11, 4]]}, "reference": [{"key": "R1", "author": "Plotkin SA", "volume": "7", "first-page": "401", "year": "2008", "journal-title": "Clin Infect Dis", "DOI": "10.1086/589862", "doi-asserted-by": "crossref"}, {"key": "R2", "author": "Rich RR", "year": "2001", "edition": "2", "volume-title": "Clinical Immunology: Principles and Practice"}, {"key": "R3", "author": "Robbins JB", "volume": "47", "first-page": "593", "year": "2004", "journal-title": "Am Heart J", "DOI": "10.1016/j.ahj.2004.01.012", "doi-asserted-by": "crossref"}, {"key": "R4", "author": "Fattom AI", "volume": "2", "first-page": "880", "year": "2004", "journal-title": "Vaccine", "DOI": "10.1016/j.vaccine.2003.11.034", "doi-asserted-by": "crossref"}, {"key": "R5", "author": "Shinefield H", "volume": "46", "first-page": "491", "year": "2002", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJMoa011297", "doi-asserted-by": "crossref"}, {"key": "R6", "author": "Fattom A", "volume": "3", "first-page": "656", "year": "2004", "journal-title": "Vaccine", "DOI": "10.1016/j.vaccine.2004.06.043", "doi-asserted-by": "crossref"}, {"key": "R8", "author": "Montgomery CP", "volume": "98", "first-page": "561", "year": "2008", "journal-title": "J Infect Dis", "DOI": "10.1086/590157", "doi-asserted-by": "crossref"}, {"key": "R11", "author": "Spellberg B", "volume": "6", "first-page": "4574", "year": "2008", "journal-title": "Infect Immun", "DOI": "10.1128/IAI.00700-08", "doi-asserted-by": "crossref"}, {"key": "R12", "author": "Miller LG", "volume": "4", "first-page": "471", "year": "2007", "journal-title": "Clin Infect Dis", "DOI": "10.1086/511033", "doi-asserted-by": "crossref"}, {"key": "R13", "author": "Klevens RM", "volume": "98", "first-page": "1763", "year": "2007", "journal-title": "Jama", "DOI": "10.1001/jama.298.15.1763", "doi-asserted-by": "crossref"}, {"key": "R14", "author": "Moran GJ", "volume": "55", "first-page": "666", "year": "2006", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJMoa055356", "doi-asserted-by": "crossref"}, {"key": "R15", "author": "Fridkin SK", "volume": "52", "first-page": "1436", "year": "2005", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJMoa043252", "doi-asserted-by": "crossref"}, {"key": "R16", "author": "Moreillon P", "first-page": "2321", "year": "2005", "edition": "6", "volume-title": "Principles and Practice of Infectious Diseases"}, {"key": "R17", "author": "Laupland KB", "volume": "87", "first-page": "1452", "year": "2003", "journal-title": "J Infect Dis", "DOI": "10.1086/374621", "doi-asserted-by": "crossref"}, {"key": "R18", "author": "Jensen AG", "volume": "59", "first-page": "1437", "year": "1999", "journal-title": "Arch Intern Med", "DOI": "10.1001/archinte.159.13.1437", "doi-asserted-by": "crossref"}, {"key": "R19", "author": "Lin L", "first-page": "1000703", "year": "2009", "journal-title": "PLoS Pathog", "DOI": "10.1371/journal.ppat.1000703", "doi-asserted-by": "crossref"}, {"key": "R20", "author": "Ishigame H", "first-page": "108", "year": "2009", "journal-title": "Immunity", "DOI": "10.1016/j.immuni.2008.11.009", "doi-asserted-by": "crossref"}, {"key": "R21", "author": "Lin L", "volume": "80", "first-page": "259", "year": "2009", "journal-title": "FEMS Immunol Med Microbiol"}, {"key": "R22", "author": "Pachl J", "volume": "2", "first-page": "1404", "year": "2006", "journal-title": "Clin Infect Dis", "DOI": "10.1086/503428", "doi-asserted-by": "crossref"}, {"key": "R23", "author": "Torosantucci A", "volume": "02", "first-page": "597", "year": "2005", "journal-title": "J Exp Med", "DOI": "10.1084/jem.20050749", "doi-asserted-by": "crossref"}, {"key": "R24", "author": "Torosantucci A", "first-page": "5392", "year": "2009", "journal-title": "PLoS ONE", "DOI": "10.1371/journal.pone.0005392", "doi-asserted-by": "crossref"}], "container-title": ["Human Vaccines"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.4161/hv.6.10.12469", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 19]], "date-time": "2017-06-19T20:27:57Z", "timestamp": 1497904077000}, "score": 26.714819, "subtitle": ["Insights from mice and men"], "issued": {"date-parts": [[2010, 10]]}, "references-count": 21, "journal-issue": {"published-online": {"date-parts": [[2014, 11, 4]]}, "published-print": {"date-parts": [[2010, 10]]}, "issue": "10"}, "alternative-id": ["10.4161/hv.6.10.12469"], "URL": "http://dx.doi.org/10.4161/hv.6.10.12469", "relation": {"cites": []}, "ISSN": ["1554-8600", "1554-8619"], "issn-type": [{"value": "1554-8600", "type": "print"}, {"value": "1554-8619", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T18:52:18Z", "timestamp": 1575226338958}, "reference-count": 0, "publisher": "American Thoracic Society", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 5]]}, "DOI": "10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6106", "type": "proceedings-article", "created": {"date-parts": [[2013, 5, 23]], "date-time": "2013-05-23T13:08:32Z", "timestamp": 1369314512000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["A Case Report Of Disseminated Mucormycosis With Lung Cavitation Treated With A Combination Of Parenteral, Nebulized, And Direct Instillation Via Chest Thoracostomy Of Lipid-Based Amphotericin B"], "prefix": "10.1164", "author": [{"given": "Hassan K.", "family": "Bencheqroun", "sequence": "first", "affiliation": []}, {"given": "Farzana", "family": "Qureshi", "sequence": "additional", "affiliation": []}, {"given": "Ryan", "family": "Yalung", "sequence": "additional", "affiliation": []}, {"given": "Brad", "family": "Spellberg", "sequence": "additional", "affiliation": []}], "member": "19", "event": {"name": "American Thoracic Society 2012 International Conference, May 18-23, 2012 \u2022 San Francisco, California"}, "container-title": ["D65. CASE REPORTS OF UNUSUAL PULMONARY INFECTIONS"], "deposited": {"date-parts": [[2013, 5, 23]], "date-time": "2013-05-23T13:08:34Z", "timestamp": 1369314514000}, "score": 25.869123, "issued": {"date-parts": [[2012, 5]]}, "references-count": 0, "alternative-id": ["10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A6106", "10.1164/ajrccm-conference.2012.D065"], "URL": "http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6106"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T17:37:06Z", "timestamp": 1574444226613}, "reference-count": 62, "publisher": "Oxford University Press (OUP)", "issue": "suppl_1", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 2, 1]]}, "DOI": "10.1093/cid/cir865", "type": "journal-article", "created": {"date-parts": [[2012, 1, 13]], "date-time": "2012-01-13T18:56:48Z", "timestamp": 1326481008000}, "page": "S16-S22", "source": "Crossref", "is-referenced-by-count": 149, "title": ["Pathogenesis of Mucormycosis"], "prefix": "10.1093", "volume": "54", "author": [{"given": "Ashraf S.", "family": "Ibrahim", "sequence": "first", "affiliation": []}, {"given": "Brad", "family": "Spellberg", "sequence": "additional", "affiliation": []}, {"given": "Thomas J.", "family": "Walsh", "sequence": "additional", "affiliation": []}, {"given": "Dimitrios P.", "family": "Kontoyiannis", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2012, 2, 1]]}, "reference": [{"key": "key\n\t\t\t\t20171014004519_bib1", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1016/j.mycres.2007.03.004", "article-title": "A higher-level phylogenetic classification of the Fungi", "volume": "111", "author": "Hibbett", "year": "2007", "journal-title": "Mycol Res"}, {"key": "key\n\t\t\t\t20171014004519_bib2", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.1128/CMR.13.2.236-301.2000", "article-title": "Zygomycetes in human disease", "volume": "13", "author": "Ribes", "year": "2000", "journal-title": "Clin Microbiol Rev"}, {"key": "key\n\t\t\t\t20171014004519_bib3", "doi-asserted-by": "crossref", "first-page": "556", "DOI": "10.1128/CMR.18.3.556-569.2005", "article-title": "Novel perspectives on mucormycosis: pathophysiology, presentation, and management", "volume": "18", "author": "Spellberg", "year": "2005", "journal-title": "Clin Microbiol Rev"}, {"key": "key\n\t\t\t\t20171014004519_bib4", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1086/432579", "article-title": "Epidemiology and outcome of zygomycosis: a review of 929 reported cases", "volume": "41", "author": "Roden", "year": "2005", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171014004519_bib5", "first-page": "2979", "article-title": "Agents of mucormycosis and related species", "volume-title": "Principles and practice of infectious diseases", "author": "Sugar", "year": "2005", "edition": "6th ed"}, {"key": "key\n\t\t\t\t20171014004519_bib6", "author": "Ibrahim", "first-page": "241", "year": "2003", "article-title": "Zygomycosis", "volume-title": "Clinical mycology"}, {"key": "key\n\t\t\t\t20171014004519_bib7", "doi-asserted-by": "crossref", "first-page": "909", "DOI": "10.1086/339202", "article-title": "Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients", "volume": "34", "author": "Marr", "year": "2002", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171014004519_bib8", "doi-asserted-by": "crossref", "first-page": "1351", "DOI": "10.1080/10428190310001653691", "article-title": "Improved outcome of zygomycosis in patients with hematological diseases?", "volume": "45", "author": "Gleissner", "year": "2004", "journal-title": "Leuk Lymphoma"}, {"key": "key\n\t\t\t\t20171014004519_bib9", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1172/JCI111395", "article-title": "Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus", "volume": "74", "author": "Waldorf", "year": "1984", "journal-title": "J Clin Invest"}, {"key": "key\n\t\t\t\t20171014004519_bib10", "first-page": "243", "article-title": "Pulmonary defense mechanisms against opportunistic fungal pathogens", "volume": "47", "author": "Waldorf", "year": "1989", "journal-title": "Immunol Ser"}, {"key": "key\n\t\t\t\t20171014004519_bib11", "first-page": "292", "article-title": "Monocyte-mediated damage to Rhizopus oryzae hyphae in vitro", "volume": "38", "author": "Diamond", "year": "1982", "journal-title": "Infect Immun"}, {"key": "key\n\t\t\t\t20171014004519_bib12", "doi-asserted-by": "crossref", "first-page": "722", "DOI": "10.1128/AAC.01136-07", "article-title": "Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage", "volume": "52", "author": "Chamilos", "year": "2008", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171014004519_bib13", "first-page": "1123", "article-title": "Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis", "volume": "38", "author": "Chinn", "year": "1982", "journal-title": "Infect Immun"}, {"key": "key\n\t\t\t\t20171014004519_bib14", "doi-asserted-by": "crossref", "first-page": "1399", "DOI": "10.1086/597615", "article-title": "Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis", "volume": "199", "author": "Lamaris", "year": "2009", "journal-title": "J Infect Dis"}, {"key": "key\n\t\t\t\t20171014004519_bib15", "author": "Kwon-Chung", "first-page": "524", "year": "1992", "article-title": "Mucormycosis", "volume-title": "Medical mycology"}, {"key": "key\n\t\t\t\t20171014004519_bib16", "doi-asserted-by": "crossref", "first-page": "1115", "DOI": "10.1056/NEJM197811162992007", "article-title": "Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment", "volume": "299", "author": "Gartenberg", "year": "1978", "journal-title": "New Engl J Med"}, {"key": "key\n\t\t\t\t20171014004519_bib17", "doi-asserted-by": "crossref", "first-page": "272", "DOI": "10.1001/jama.1979.03300030044022", "article-title": "Cutaneous Rhizopus infection. Occurrence as a postoperative complication associated with an elasticized adhesive dressing", "volume": "242", "author": "Mead", "year": "1979", "journal-title": "JAMA"}, {"key": "key\n\t\t\t\t20171014004519_bib18", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1016/S0140-6736(96)05059-3", "article-title": "Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors [see comments]", "volume": "348", "author": "Mitchell", "year": "1996", "journal-title": "Lancet"}, {"key": "key\n\t\t\t\t20171014004519_bib19", "first-page": "2422", "article-title": "Wooden sticks as the source of a pseudoepidemic of infection with Rhizopus microsporus var. rhizopodiformis among immunocompromised patients", "volume": "35", "author": "Verweij", "year": "1997", "journal-title": "J Clin Microbiol"}, {"key": "key\n\t\t\t\t20171014004519_bib20", "doi-asserted-by": "crossref", "first-page": "394", "DOI": "10.1128/CMR.12.3.394", "article-title": "Acquisition, transport, and storage of iron by pathogenic fungi", "volume": "12", "author": "Howard", "year": "1999", "journal-title": "Clin Microbiol Rev"}, {"key": "key\n\t\t\t\t20171014004519_bib21", "doi-asserted-by": "crossref", "first-page": "1109", "DOI": "10.2337/diacare.31.12.1109", "article-title": "A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability", "volume": "31", "author": "Artis", "year": "1982", "journal-title": "Diabetes"}, {"key": "key\n\t\t\t\t20171014004519_bib22", "doi-asserted-by": "crossref", "first-page": "1979", "DOI": "10.1172/JCI116419", "article-title": "Mucormycosis during deferoxamine therapy is a siderophore-mediated infection: in vitro and in vivo animal studies", "volume": "91", "author": "Boelaert", "year": "1993", "journal-title": "J Clin Invest"}, {"key": "key\n\t\t\t\t20171014004519_bib23", "doi-asserted-by": "crossref", "first-page": "620", "DOI": "10.1097/QCO.0b013e3283165fd1", "article-title": "Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment", "volume": "21", "author": "Ibrahim", "year": "2008", "journal-title": "Curr Opin Infect Dis"}, {"key": "key\n\t\t\t\t20171014004519_bib24", "doi-asserted-by": "crossref", "first-page": "1070", "DOI": "10.1093/jac/dkl350", "article-title": "Deferiprone iron chelation as a novel therapy for experimental mucormycosis", "volume": "58", "author": "Ibrahim", "year": "2006", "journal-title": "J Antimicrob Chemother"}, {"key": "key\n\t\t\t\t20171014004519_bib25", "doi-asserted-by": "crossref", "first-page": "2649", "DOI": "10.1172/JCI32338", "article-title": "The iron chelator deferasirox protects mice from mucormycosis through iron starvation", "volume": "117", "author": "Ibrahim", "year": "2007", "journal-title": "J Clin Invest"}, {"key": "key\n\t\t\t\t20171014004519_bib26", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1128/AAC.00792-10", "article-title": "Activity of deferasirox in Mucorales: influences of species and exogenous iron", "volume": "55", "author": "Lewis", "year": "2011", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171014004519_bib27", "doi-asserted-by": "crossref", "first-page": "660", "DOI": "10.1016/S0272-6386(12)80606-8", "article-title": "Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry", "volume": "18", "author": "Boelaert", "year": "1991", "journal-title": "Am J Kidney Dis"}, {"key": "key\n\t\t\t\t20171014004519_bib28", "doi-asserted-by": "crossref", "first-page": "914", "DOI": "10.1093/infdis/160.5.914", "article-title": "Registry on mucormycosis in dialysis patients", "volume": "160", "author": "Boelaert", "year": "1989", "journal-title": "J Infect Dis"}, {"key": "key\n\t\t\t\t20171014004519_bib29", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1056/NEJM198907203210313", "article-title": "Mucormycosis among patients on dialysis", "volume": "321", "author": "Boelaert", "year": "1989", "journal-title": "New Engl J Med"}, {"key": "key\n\t\t\t\t20171014004519_bib30", "first-page": "261", "article-title": "The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature", "volume": "29", "author": "Boelaert", "year": "1988", "journal-title": "Clin Nephrol"}, {"key": "key\n\t\t\t\t20171014004519_bib31", "doi-asserted-by": "crossref", "first-page": "1843", "DOI": "10.1016/0006-2952(94)90314-X", "article-title": "Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus", "volume": "47", "author": "de Locht", "year": "1994", "journal-title": "Biochem Pharmacol"}, {"key": "key\n\t\t\t\t20171014004519_bib32", "doi-asserted-by": "crossref", "first-page": "667", "DOI": "10.1038/ki.1994.89", "article-title": "Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect", "volume": "45", "author": "Boelaert", "year": "1994", "journal-title": "Kidney Int"}, {"key": "key\n\t\t\t\t20171014004519_bib33", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1038/sj.bmt.1701885", "article-title": "Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis", "volume": "24", "author": "Maertens", "year": "1999", "journal-title": "Bone Marrow Transplant"}, {"key": "key\n\t\t\t\t20171014004519_bib34", "doi-asserted-by": "crossref", "first-page": "1552", "DOI": "10.1126/science.271.5255.1552", "article-title": "A permease-oxidase complex involved in high-affinity iron uptake in yeast", "volume": "271", "author": "Stearman", "year": "1996", "journal-title": "Science"}, {"key": "key\n\t\t\t\t20171014004519_bib35", "doi-asserted-by": "crossref", "first-page": "5482", "DOI": "10.1128/IAI.73.9.5482-5492.2005", "article-title": "Iron acquisition from transferrin by Candida albicans depends on the reductive pathway", "volume": "73", "author": "Knight", "year": "2005", "journal-title": "Infect Immun"}, {"key": "key\n\t\t\t\t20171014004519_bib36", "doi-asserted-by": "crossref", "first-page": "e45", "DOI": "10.1371/journal.ppat.0040045", "article-title": "Iron source preference and regulation of iron uptake in Cryptococcus neoformans", "volume": "4", "author": "Jung", "year": "2008", "journal-title": "PLoS Pathog"}, {"key": "key\n\t\t\t\t20171014004519_bib37", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1111/j.1365-2958.2010.07234.x", "article-title": "The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis", "volume": "77", "author": "Ibrahim", "year": "2010", "journal-title": "Mol Microbiol"}, {"key": "key\n\t\t\t\t20171014004519_bib38", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1111/j.1574-6968.1992.tb05285.x", "article-title": "Rhizoferrin: a complexone type siderophore of the Mucorales and entomophthorales (Zygomycetes)", "volume": "73", "author": "Thieken", "year": "1992", "journal-title": "FEMS Microbiol Lett"}, {"key": "key\n\t\t\t\t20171014004519_bib39", "doi-asserted-by": "crossref", "first-page": "579", "DOI": "10.1099/mic.0.26108-0", "article-title": "Haemin uptake and use as an iron source by Candida albicans: role of CaHMX1-encoded haem oxygenase", "volume": "149", "author": "Santos", "year": "2003", "journal-title": "Microbiology"}, {"key": "key\n\t\t\t\t20171014004519_bib40", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1080/02681218880000211", "article-title": "Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores", "volume": "26", "author": "Worsham", "year": "1988", "journal-title": "J Med Vet Mycol"}, {"key": "key\n\t\t\t\t20171014004519_bib41", "doi-asserted-by": "crossref", "first-page": "e1000549", "DOI": "10.1371/journal.pgen.1000549", "article-title": "Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication", "volume": "5", "author": "Ma", "year": "2009", "journal-title": "PLoS Genet"}, {"key": "key\n\t\t\t\t20171014004519_bib42", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1111/j.1365-2958.2008.06376.x", "article-title": "SreA-mediated iron regulation in Aspergillus fumigatus", "volume": "70", "author": "Schrettl", "year": "2008", "journal-title": "Mol Microbiol"}, {"key": "key\n\t\t\t\t20171014004519_bib43", "doi-asserted-by": "crossref", "first-page": "134", "DOI": "10.1016/j.jinf.2009.06.002", "article-title": "A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response", "volume": "59", "author": "Ben-Ami", "year": "2009", "journal-title": "J Infect"}, {"key": "key\n\t\t\t\t20171014004519_bib44", "first-page": "76", "article-title": "Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components", "volume": "70", "author": "Bouchara", "year": "1996", "journal-title": "Eur J Cell Biol"}, {"key": "key\n\t\t\t\t20171014004519_bib45", "doi-asserted-by": "crossref", "first-page": "778", "DOI": "10.1128/IAI.73.2.778-783.2005", "article-title": "Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro", "volume": "73", "author": "Ibrahim", "year": "2005", "journal-title": "Infect Immun"}, {"key": "key\n\t\t\t\t20171014004519_bib46", "doi-asserted-by": "crossref", "first-page": "1914", "DOI": "10.1172/JCI42164", "article-title": "The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice", "volume": "120", "author": "Liu", "year": "2010", "journal-title": "J Clin Invest"}, {"key": "key\n\t\t\t\t20171014004519_bib47", "doi-asserted-by": "crossref", "first-page": "3496", "DOI": "10.1158/0008-5472.CAN-07-0325", "article-title": "GRP78 induction in cancer: therapeutic and prognostic implications", "volume": "67", "author": "Lee", "year": "2007", "journal-title": "Cancer Res"}, {"key": "key\n\t\t\t\t20171014004519_bib48", "doi-asserted-by": "crossref", "first-page": "3641", "DOI": "10.1016/j.febslet.2007.04.045", "article-title": "ER chaperones in mammalian development and human diseases", "volume": "581", "author": "Ni", "year": "2007", "journal-title": "FEBS Lett"}, {"key": "key\n\t\t\t\t20171014004519_bib49", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.2174/156652406775574523", "article-title": "Stress induction of GRP78/BiP and its role in cancer", "volume": "6", "author": "Li", "year": "2006", "journal-title": "Curr Mol Med"}, {"key": "key\n\t\t\t\t20171014004519_bib50", "doi-asserted-by": "crossref", "first-page": "2307", "DOI": "10.1089/ars.2009.2485", "article-title": "Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders", "volume": "11", "author": "Wang", "year": "2009", "journal-title": "Antioxid Redox Signal"}, {"key": "key\n\t\t\t\t20171014004519_bib51", "doi-asserted-by": "crossref", "first-page": "9367", "DOI": "10.1073/pnas.0709578105", "article-title": "Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis", "volume": "105", "author": "Chamilos", "year": "2008", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "key\n\t\t\t\t20171014004519_bib52", "doi-asserted-by": "crossref", "first-page": "1833", "DOI": "10.1021/jf048147n", "article-title": "Secondary metabolite and mycotoxin production by the Rhizopus microsporus group", "volume": "53", "author": "Jennessen", "year": "2005", "journal-title": "J Agric Food Chem"}, {"key": "key\n\t\t\t\t20171014004519_bib53", "doi-asserted-by": "crossref", "first-page": "7750", "DOI": "10.1021/jo020537q", "article-title": "Total synthesis of rhizoxin D, a potent antimitotic agent from the fungus Rhizopus chinensis", "volume": "67", "author": "White", "year": "2002", "journal-title": "J Org Chem"}, {"key": "key\n\t\t\t\t20171014004519_bib54", "doi-asserted-by": "crossref", "first-page": "884", "DOI": "10.1038/nature03997", "article-title": "Pathogenic fungus harbours endosymbiotic bacteria for toxin production", "volume": "437", "author": "Partida-Martinez", "year": "2005", "journal-title": "Nature"}, {"key": "key\n\t\t\t\t20171014004519_bib55", "doi-asserted-by": "crossref", "first-page": "1083", "DOI": "10.1086/591461", "article-title": "Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis", "volume": "198", "author": "Ibrahim", "year": "2008", "journal-title": "J Infect Dis"}, {"key": "key\n\t\t\t\t20171014004519_bib56", "doi-asserted-by": "crossref", "first-page": "2355", "DOI": "10.1099/00221287-144-8-2355", "article-title": "The Rhizopus oryzae secreted aspartic proteinase gene family: an analysis of gene expression", "volume": "144", "author": "Farley", "year": "1998", "journal-title": "Microbiology"}, {"key": "key\n\t\t\t\t20171014004519_bib57", "doi-asserted-by": "crossref", "first-page": "656", "DOI": "10.1288/00005537-199206000-00011", "article-title": "Intracranial complications of mucormycosis: an experimental model and clinical review", "volume": "102", "author": "Anand", "year": "1992", "journal-title": "Laryngoscope"}, {"key": "key\n\t\t\t\t20171014004519_bib58", "doi-asserted-by": "crossref", "first-page": "743", "DOI": "10.1086/423274", "article-title": "Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole", "volume": "39", "author": "Imhof", "year": "2004", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171014004519_bib59", "doi-asserted-by": "crossref", "first-page": "1350", "DOI": "10.1086/428780", "article-title": "Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases", "volume": "191", "author": "Kontoyiannis", "year": "2005", "journal-title": "J Infect Dis"}, {"key": "key\n\t\t\t\t20171014004519_bib60", "doi-asserted-by": "crossref", "first-page": "950", "DOI": "10.1056/NEJM200402263500923", "article-title": "Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants", "volume": "350", "author": "Marty", "year": "2004", "journal-title": "N Engl J Med"}, {"key": "key\n\t\t\t\t20171014004519_bib61", "doi-asserted-by": "crossref", "first-page": "770", "DOI": "10.1086/427759", "article-title": "Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia", "volume": "40", "author": "Oren", "year": "2005", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171014004519_bib62", "doi-asserted-by": "crossref", "first-page": "584", "DOI": "10.1086/422723", "article-title": "Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis", "volume": "39", "author": "Siwek", "year": "2004", "journal-title": "Clin Infect Dis"}], "container-title": ["Clinical Infectious Diseases"], "language": "en", "link": [{"URL": "http://academic.oup.com/cid/article-pdf/54/suppl_1/S16/20910688/cir865.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 22]], "date-time": "2019-06-22T11:59:04Z", "timestamp": 1561204744000}, "score": 25.5786, "issued": {"date-parts": [[2012, 2, 1]]}, "references-count": 62, "journal-issue": {"published-online": {"date-parts": [[2012, 2, 1]]}, "published-print": {"date-parts": [[2012, 2, 1]]}, "issue": "suppl_1"}, "URL": "http://dx.doi.org/10.1093/cid/cir865", "relation": {"cites": []}, "ISSN": ["1537-6591", "1058-4838"], "issn-type": [{"value": "1058-4838", "type": "print"}, {"value": "1537-6591", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:53:27Z", "timestamp": 1574488407026}, "publisher-location": "New York, NY", "reference-count": 186, "publisher": "Springer New York", "isbn-type": [{"value": "9781441966391", "type": "print"}, {"value": "9781441966407", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011]]}, "DOI": "10.1007/978-1-4419-6640-7_15", "type": "book-chapter", "created": {"date-parts": [[2011, 1, 11]], "date-time": "2011-01-11T21:36:17Z", "timestamp": 1294781777000}, "page": "265-280", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Mucormycosis and Entomophthoramycosis (Zygomycosis)"], "prefix": "10.1007", "author": [{"given": "Ashraf S.", "family": "Ibrahim", "sequence": "first", "affiliation": []}, {"given": "John E.", "family": "Edwards", "sequence": "additional", "affiliation": []}, {"given": "Scott G.", "family": "Filler", "sequence": "additional", "affiliation": []}, {"given": "Brad", "family": "Spellberg", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 11, 27]]}, "reference": [{"key": "15_CR1_15", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1016/j.mycres.2007.03.004", "volume": "111", "author": "DS Hibbett", "year": "2007", "unstructured": "Hibbett DS, Binder M, Bischoff JF, et al. A higher-level phylogenetic classification of the Fungi. Mycol Res. 2007;111:509\u201347.", "journal-title": "Mycol Res"}, {"key": "15_CR2_15", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.1128/CMR.13.2.236", "volume": "13", "author": "JA Ribes", "year": "2000", "unstructured": "Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236\u2013301.", "journal-title": "Clin Microbiol Rev"}, {"key": "15_CR3_15", "author": "AM Sugar", "year": "2005", "edition": "6", "unstructured": "Sugar AM. Agents of Mucormycosis and Related Species. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier; 2005. 2979.", "volume-title": "Principles and practice of infectious diseases"}, {"key": "15_CR4_15", "doi-asserted-by": "crossref", "first-page": "556", "DOI": "10.1128/CMR.18.3.556-569.2005", "volume": "18", "author": "B Spellberg", "year": "2005", "unstructured": "Spellberg B, Edwards Jr J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18:556\u201369.", "journal-title": "Clin Microbiol Rev"}, {"key": "15_CR5_15", "author": "KJ Kwon-Chung", "first-page": "524", "year": "1992", "unstructured": "Kwon-Chung KJ, Bennett JE. Mucormycosis. In: Medical mycology. Philadelphia: Lea & Febiger; 1992. p. 524\u201359.", "volume-title": "Medical mycology"}, {"key": "15_CR6_15", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1093/clinids/17.2.173", "volume": "17", "author": "A Cohen-Abbo", "year": "1993", "unstructured": "Cohen-Abbo A, Bozeman PM, Patrick CC. Cunninghamella infections: review and report of two cases of Cunninghamella pneumonia in immunocompromised children. Clin Infect Dis. 1993;17:173\u20137.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR7_15", "doi-asserted-by": "crossref", "first-page": "925", "DOI": "10.1093/clinids/18.6.925", "volume": "18", "author": "DP Kontoyianis", "year": "1994", "unstructured": "Kontoyianis DP, Vartivarian S, Anaissie EJ, Samonis G, Bodey GP, Rinaldi M. Infections due to Cunninghamella bertholletiae in patients with cancer: report of three cases and review. Clin Infect Dis. 1994;18:925\u20138.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR8_15", "doi-asserted-by": "crossref", "first-page": "544", "DOI": "10.1093/ajcp/64.4.544", "volume": "64", "author": "KJ Kwon-Chung", "year": "1975", "unstructured": "Kwon-Chung KJ, Young RC, Orlando M. Pulmonary mucormycosis caused by Cunninghamella elegans in a patient with chronic myelogenous leukemia. Am J Clin Pathol. 1975;64:544\u20138.", "journal-title": "Am J Clin Pathol"}, {"key": "15_CR9_15", "doi-asserted-by": "crossref", "first-page": "447", "DOI": "10.1002/ajh.21289", "volume": "84", "author": "K Motohashi", "year": "2009", "unstructured": "Motohashi K, Ito S, Hagihara M, Maruta A, Ishigatsubo Y, Kanamori H. Cutaneous zygomycosis caused by Cunninghamella bertholletiae in a patient with chronic myelogenous leukemia in blast crisis. Am J Hematol. 2009;84:447\u20138.", "journal-title": "Am J Hematol"}, {"key": "15_CR10_15", "first-page": "1823", "volume": "32", "author": "EA Bearer", "year": "1994", "unstructured": "Bearer EA, Nelson PR, Chowers MY, Davis CE. Cutaneous zygomycosis caused by Saksenaea vasiformis in a diabetic patient. J Clin Microbiol. 1994;32:1823\u20134.", "journal-title": "J Clin Microbiol"}, {"key": "15_CR11_15", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1080/00313029600169364", "volume": "28", "author": "GR Lye", "year": "1996", "unstructured": "Lye GR, Wood G, Nimmo G. Subcutaneous zygomycosis due to Saksenaea vasiformis: rapid isolate identification using a modified sporulation technique. Pathology. 1996;28:364\u20135.", "journal-title": "Pathology"}, {"key": "15_CR12_15", "first-page": "630", "volume": "145", "author": "RC Pritchard", "year": "1986", "unstructured": "Pritchard RC, Muir DB, Archer KH, Beith JM. Subcutaneous zygomycosis due to Saksenaea vasiformis in an infant. Med J Australia. 1986;145:630\u20131.", "journal-title": "Med J Australia"}, {"key": "15_CR13_15", "doi-asserted-by": "crossref", "first-page": "714", "DOI": "10.1097/00006454-199707000-00017", "volume": "16", "author": "G Gonis", "year": "1997", "unstructured": "Gonis G, Starr M. Fatal rhinoorbital mucormycosis caused by Saksenaea vasiformis in an immunocompromised child. Pediatr Infect Dis J. 1997;16:714\u20136.", "journal-title": "Pediatr Infect Dis J"}, {"key": "15_CR14_15", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.1016/S0163-4453(83)90695-3", "volume": "7", "author": "RJ Hay", "year": "1983", "unstructured": "Hay RJ, Campbell CK, Marshall WM, Rees BI, Pincott J. Disseminated zygomycosis (mucormycosis) caused by Saksenaea vasiformis. J Infect. 1983;7:162\u20135.", "journal-title": "J Infect"}, {"key": "15_CR15_15", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1093/ajcp/76.1.116", "volume": "76", "author": "J Torell", "year": "1981", "unstructured": "Torell J, Cooper BH, Helgeson NG. Disseminated Saksenaea vasiformis infection. Am J Clin Pathol. 1981;76:116\u201321.", "journal-title": "Am J Clin Pathol"}, {"key": "15_CR16_15", "first-page": "843", "volume": "32", "author": "ME Kemna", "year": "1994", "unstructured": "Kemna ME, Neri RC, Ali R, Salkin IF. Cokeromyces recurvatus, a mucoraceous zygomycete rarely isolated in clinical laboratories. J Clin Microbiol. 1994;32:843\u20135.", "journal-title": "J Clin Microbiol"}, {"key": "15_CR17_15", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1080/00362178085380051", "volume": "18", "author": "A Kamalam", "year": "1980", "unstructured": "Kamalam A, Thambiah AS. Cutaneous infection by Syncephalastrum. Sabouraudia. 1980;18:19\u201320.", "journal-title": "Sabouraudia"}, {"key": "15_CR18_15", "first-page": "2422", "volume": "35", "author": "PE Verweij", "year": "1997", "unstructured": "Verweij PE, Voss A, Donnelly JP, de Pauw BE, Meis JF. Wooden sticks as the source of a pseudoepidemic of infection with Rhizopus microsporus var. rhizopodiformis among immunocompromised patients. J Clin Microbiol. 1997;35:2422\u20133.", "journal-title": "J Clin Microbiol"}, {"key": "15_CR19_15", "first-page": "606", "volume": "91", "author": "RH Al-Asiri", "year": "1996", "unstructured": "Al-Asiri RH, Van Dijken PJ, Mahmood MA, Al-Shahed MS, Rossi ML, Osoba AO. Isolated hepatic mucormycosis in an immunocompetent child. Am J Gastroenterol. 1996;91:606\u20137.", "journal-title": "Am J Gastroenterol"}, {"key": "15_CR20_15", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1017/S0022215100134012", "volume": "110", "author": "A Valle Zapico Del", "year": "1996", "unstructured": "Del Valle Zapico A, Rubio Su\u00e1rez A, Mellado Encinas P, Morales Angulo C, Cabrera Pozuelo E. Mucormycosis of the sphenoid sinus in an otherwise healthy patient. Case report and literature review. J Laryngol Otol. 1996;110:471\u20133.", "journal-title": "J Laryngol Otol"}, {"key": "15_CR21_15", "doi-asserted-by": "crossref", "first-page": "753", "DOI": "10.1007/s10096-003-1035-y", "volume": "22", "author": "G Petrikkos", "year": "2003", "unstructured": "Petrikkos G, Skiada A, Sambatakou H, et al. Mucormycosis: ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis. 2003;22:753\u20136.", "journal-title": "Eur J Clin Microbiol Infect Dis"}, {"key": "15_CR22_15", "doi-asserted-by": "crossref", "first-page": "779", "DOI": "10.1016/S0091-6749(95)70188-5", "volume": "95", "author": "MA O\u2019Connell", "year": "1995", "unstructured": "O\u2019Connell MA, Pluss JL, Schkade P, Henry AR, Goodman DL. Rhizopus-induced hypersensitivity pneumonitis in a tractor driver. J Allergy Clin Immunol. 1995;95:779\u201380.", "journal-title": "J Allergy Clin Immunol"}, {"key": "15_CR23_15", "first-page": "163", "volume": "107", "author": "K Wimander", "year": "1980", "unstructured": "Wimander K, Belin L. Recognition of allergic alveolitis in the trimming department of a Swedish sawmill. Eur J Respir Dis Suppl. 1980;107:163\u20137.", "journal-title": "Eur J Respir Dis Suppl"}, {"key": "15_CR24_15", "doi-asserted-by": "crossref", "first-page": "909", "DOI": "10.1086/339202", "volume": "34", "author": "KA Marr", "year": "2002", "unstructured": "Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34:909\u201317.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR25_15", "doi-asserted-by": "crossref", "first-page": "851", "DOI": "10.1086/313803", "volume": "30", "author": "DP Kontoyiannis", "year": "2000", "unstructured": "Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis. 2000;30:851\u20136.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR26_15", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1038/sj.bmt.1701885", "volume": "24", "author": "J Maertens", "year": "1999", "unstructured": "Maertens J, Demuynck H, Verbeken EK, et al. Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant. 1999;24:307\u201312.", "journal-title": "Bone Marrow Transplant"}, {"key": "15_CR27_15", "doi-asserted-by": "crossref", "first-page": "950", "DOI": "10.1056/NEJM200402263500923", "volume": "350", "author": "FM Marty", "year": "2004", "unstructured": "Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med. 2004;350:950\u20132.", "journal-title": "N Engl J Med"}, {"key": "15_CR28_15", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1097/00001432-200412000-00003", "volume": "17", "author": "RN Greenberg", "year": "2004", "unstructured": "Greenberg RN, Scott LJ, Vaughn HH, Ribes JA. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis. 2004;17:517\u201325.", "journal-title": "Curr Opin Infect Dis"}, {"key": "15_CR29_15", "first-page": "366", "volume": "25", "author": "EA Lueg", "year": "1996", "unstructured": "Lueg EA, Ballagh RH, Forte V. Analysis of the recent cluster of invasive fungal sinusitis at the Toronto Hospital for Sick Children. J Otolaryngol. 1996;25:366\u201370.", "journal-title": "J Otolaryngol"}, {"key": "15_CR30_15", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1172/JCI111395", "volume": "74", "author": "AR Waldorf", "year": "1984", "unstructured": "Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest. 1984;74:150\u201360.", "journal-title": "J Clin Invest"}, {"key": "15_CR31_15", "doi-asserted-by": "crossref", "first-page": "1399", "DOI": "10.1086/597615", "volume": "199", "author": "GA Lamaris", "year": "2009", "unstructured": "Lamaris GA, Ben-Ami R, Lewis RE, Chamilos G, Samonis G, Kontoyiannis DP. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis. J Infect Dis. 2009;199:1399\u2013406.", "journal-title": "J Infect Dis"}, {"key": "15_CR32_15", "first-page": "313", "volume": "91", "author": "RD Diamond", "year": "1978", "unstructured": "Diamond RD, Krzesicki R, Epstein B, Jao W. Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis. Am J Pathol. 1978;91:313\u201328.", "journal-title": "Am J Pathol"}, {"key": "15_CR33_15", "first-page": "1217", "volume": "38", "author": "RS Marx", "year": "1982", "unstructured": "Marx RS, Forsyth KR, Hentz SK. Mucorales species activation of a serum leukotactic factor. Infect Immun. 1982;38:1217\u201322.", "journal-title": "Infect Immun"}, {"key": "15_CR34_15", "first-page": "243", "volume": "47", "author": "AR Waldorf", "year": "1989", "unstructured": "Waldorf AR. Pulmonary defense mechanisms against opportunistic fungal pathogens. Immunol Ser. 1989;47:243\u201371.", "journal-title": "Immunol Ser"}, {"key": "15_CR35_15", "first-page": "292", "volume": "38", "author": "RD Diamond", "year": "1982", "unstructured": "Diamond RD, Haudenschild CC, Erickson NF. Monocyte-mediated damage to Rhizopus oryzae hyphae in vitro. Infect Immun. 1982;38:292\u20137.", "journal-title": "Infect Immun"}, {"key": "15_CR36_15", "first-page": "1123", "volume": "38", "author": "RY Chinn", "year": "1982", "unstructured": "Chinn RY, Diamond RD. Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis. Infect Immun. 1982;38:1123\u20139.", "journal-title": "Infect Immun"}, {"key": "15_CR37_15", "doi-asserted-by": "crossref", "first-page": "1109", "DOI": "10.2337/diacare.31.12.1109", "volume": "31", "author": "WM Artis", "year": "1982", "unstructured": "Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes. 1982;31:1109\u201314.", "journal-title": "Diabetes"}, {"key": "15_CR38_15", "doi-asserted-by": "crossref", "first-page": "1979", "DOI": "10.1172/JCI116419", "volume": "91", "author": "JR Boelaert", "year": "1993", "unstructured": "Boelaert JR, de Locht M, Van Cutsem J, et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest. 1993;91:1979\u201386.", "journal-title": "J Clin Invest"}, {"key": "15_CR39_15", "doi-asserted-by": "crossref", "first-page": "394", "DOI": "10.1128/CMR.12.3.394", "volume": "12", "author": "DH Howard", "year": "1999", "unstructured": "Howard DH. Acquisition, transport, and storage of iron by pathogenic fungi. Clin Microbiol Rev. 1999;12:394\u2013404.", "journal-title": "Clin Microbiol Rev"}, {"key": "15_CR40_15", "doi-asserted-by": "crossref", "first-page": "1843", "DOI": "10.1016/0006-2952(94)90314-X", "volume": "47", "author": "M Locht de", "year": "1994", "unstructured": "de Locht M, Boelaert JR, Schneider YJ. Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus. Biochem Pharmacol. 1994;47:1843\u201350.", "journal-title": "Biochem Pharmacol"}, {"key": "15_CR41_15", "doi-asserted-by": "crossref", "first-page": "667", "DOI": "10.1038/ki.1994.89", "volume": "45", "author": "JR Boelaert", "year": "1994", "unstructured": "Boelaert JR, Van Cutsem J, de Locht M, Schneider YJ, Crichton RR. Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney Int. 1994;45:667\u201371.", "journal-title": "Kidney Int"}, {"key": "15_CR42_15", "doi-asserted-by": "crossref", "first-page": "620", "DOI": "10.1097/QCO.0b013e3283165fd1", "volume": "21", "author": "AS Ibrahim", "year": "2008", "unstructured": "Ibrahim AS, Spellberg B, Edwards Jr J. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis. 2008;21:620\u20135.", "journal-title": "Curr Opin Infect Dis"}, {"key": "15_CR43_15", "doi-asserted-by": "crossref", "first-page": "1070", "DOI": "10.1093/jac/dkl350", "volume": "58", "author": "AS Ibrahim", "year": "2006", "unstructured": "Ibrahim AS, Edwards JE, Jr, Fu Y, Spellberg B. Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother. 2006;58:1070\u20133.", "journal-title": "J Antimicrob Chemother"}, {"key": "15_CR44_15", "doi-asserted-by": "crossref", "first-page": "2649", "DOI": "10.1172/JCI32338", "volume": "117", "author": "AS Ibrahim", "year": "2007", "unstructured": "Ibrahim AS, Gebermariam T, Fu Y, et al. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest. 2007;117:2649\u201357.", "journal-title": "J Clin Invest"}, {"key": "15_CR45_15", "doi-asserted-by": "crossref", "first-page": "1552", "DOI": "10.1126/science.271.5255.1552", "volume": "271", "author": "R Stearman", "year": "1996", "unstructured": "Stearman R, Yuan DS, Yamaguchi-Iwai Y, Klausner RD, Dancis A. A permease-oxidase complex involved in high-affinity iron uptake in yeast. Science. 1996;271:1552\u20137.", "journal-title": "Science"}, {"key": "15_CR46_15", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1111/j.1365-2958.2010.07234.x", "volume": "77", "author": "AS Ibrahim", "year": "2010", "unstructured": "Ibrahim AS, Gebermariam T, Lin L, Luo G, Husseiny MI, Skory CD, Fu Y, French SW, Edwards JE, Jr, Spellberg B. The high affinity iron permeasc is a key virulence factor required for Rhizopus oryzae pathogenesis. Mol Microbiol. 2010;77:587\u2013604.", "journal-title": "Mol Microbiol"}, {"key": "15_CR47_15", "doi-asserted-by": "crossref", "first-page": "579", "DOI": "10.1099/mic.0.26108-0", "volume": "149", "author": "R Santos", "year": "2003", "unstructured": "Santos R, Buisson N, Knight S, Dancis A, Camadro JM, Lesuisse E. Haemin uptake and use as an iron source by Candida albicans: role of CaHMX1-encoded haem oxygenase. Microbiology. 2003;149:579\u201388.", "journal-title": "Microbiology"}, {"key": "15_CR48_15", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1080/02681218880000211", "volume": "26", "author": "PL Worsham", "year": "1988", "unstructured": "Worsham PL, Goldman WE. Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores. J Med Vet Mycol. 1988;26:137\u201343.", "journal-title": "J Med Vet Mycol"}, {"key": "15_CR49_15", "doi-asserted-by": "crossref", "first-page": "e1000549", "DOI": "10.1371/journal.pgen.1000549", "volume": "5", "author": "LJ Ma", "year": "2009", "unstructured": "Ma LJ, Ibrahim AS, Skory C, et al. Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication. PLoS Genet. 2009;5:e1000549.", "journal-title": "PLoS Genet"}, {"key": "15_CR50_15", "author": "AS Ibrahim", "first-page": "241", "year": "2003", "unstructured": "Ibrahim AS, Edwards JE, Jr, Filler SG. Zygomycosis. In: Dismukes WE, Pappas PG, Sobel JD, editors. Clinical mycology. New York: Oxford University Press; 2003. p. 241\u201351.", "volume-title": "Clinical mycology"}, {"key": "15_CR51_15", "first-page": "76", "volume": "70", "author": "JP Bouchara", "year": "1996", "unstructured": "Bouchara JP, Oumeziane NA, Lissitzky JC, Larcher G, Tronchin G, Chabasse D. Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components. Eur J Cell Biol. 1996;70:76\u201383.", "journal-title": "Eur J Cell Biol"}, {"key": "15_CR52_15", "doi-asserted-by": "crossref", "first-page": "778", "DOI": "10.1128/IAI.73.2.778-783.2005", "volume": "73", "author": "AS Ibrahim", "year": "2005", "unstructured": "Ibrahim AS, Spellberg B, Avanessian V, Fu Y, Edwards JE, Jr. Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro. Infect Immun. 2005;73:778\u201383.", "journal-title": "Infect Immun"}, {"key": "15_CR53_15", "doi-asserted-by": "crossref", "first-page": "2307", "DOI": "10.1089/ars.2009.2485", "volume": "11", "author": "M Wang", "year": "2009", "unstructured": "Wang M, Wey S, Zhang Y, Ye R, Lee AS. Role of the unfolded protein response regulator GRP78/BiP in development, cancer and neurological disorders. Antioxidants Redox Signal. 2009;11:2307\u201316.", "journal-title": "Antioxidants Redox Signal"}, {"key": "15_CR54_15", "doi-asserted-by": "crossref", "first-page": "3641", "DOI": "10.1016/j.febslet.2007.04.045", "volume": "581", "author": "M Ni", "year": "2007", "unstructured": "Ni M, Lee AS. ER chaperones in mammalian development and human diseases. FEBS Lett. 2007;581:3641\u201351.", "journal-title": "FEBS Lett"}, {"key": "15_CR55_15", "doi-asserted-by": "crossref", "first-page": "1914", "DOI": "10.1172/JCI42164", "volume": "120", "author": "M Liu", "year": "2010", "unstructured": "Liu M, Spellberg B, Phan QT, Fu Y, Lec AS, Edwards JE Jr. Filler SG, Ibrahim AS. The endothelial cell receptor GRP78 is required for macormycosis pathogenesis in diabetic mice. J Clin Invest; 2010;120:1914\u20131924.", "journal-title": "J Clin Invest"}, {"key": "15_CR56_15", "doi-asserted-by": "crossref", "first-page": "1833", "DOI": "10.1021/jf048147n", "volume": "53", "author": "J Jennessen", "year": "2005", "unstructured": "Jennessen J, Nielsen KF, Houbraken J, et al. Secondary metabolite and mycotoxin production by the Rhizopus microsporus group. J Agric Food Chem. 2005;53:1833\u201340.", "journal-title": "J Agric Food Chem"}, {"key": "15_CR57_15", "doi-asserted-by": "crossref", "first-page": "884", "DOI": "10.1038/nature03997", "volume": "437", "author": "LP Partida-Martinez", "year": "2005", "unstructured": "Partida-Martinez LP, Hertweck C. Pathogenic fungus harbours endosymbiotic bacteria for toxin production. Nature. 2005;437:884\u20138.", "journal-title": "Nature"}, {"key": "15_CR58_15", "doi-asserted-by": "crossref", "first-page": "1083", "DOI": "10.1086/591461", "volume": "198", "author": "AS Ibrahim", "year": "2008", "unstructured": "Ibrahim AS, Gebremariam T, Liu M, et al. Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis. J Infect Dis. 2008;198:1083\u201390.", "journal-title": "J Infect Dis"}, {"issue": "Pt 8", "key": "15_CR59_15", "doi-asserted-by": "crossref", "first-page": "2355", "DOI": "10.1099/00221287-144-8-2355", "volume": "144", "author": "PC Farley", "year": "1998", "unstructured": "Farley PC, Sullivan PA. The Rhizopus oryzae secreted aspartic proteinase gene family: an analysis of gene expression. Microbiology. 1998;144(Pt 8):2355\u201366.", "journal-title": "Microbiology"}, {"key": "15_CR60_15", "doi-asserted-by": "crossref", "first-page": "656", "DOI": "10.1288/00005537-199206000-00011", "volume": "102", "author": "VK Anand", "year": "1992", "unstructured": "Anand VK, Alemar G, Griswold Jr JA. Intracranial complications of mucormycosis: an experimental model and clinical review. Laryngoscope. 1992;102:656\u201362.", "journal-title": "Laryngoscope"}, {"key": "15_CR61_15", "doi-asserted-by": "crossref", "first-page": "600", "DOI": "10.1001/archotol.1977.00780270068011", "volume": "103", "author": "HC Pillsbury", "year": "1977", "unstructured": "Pillsbury HC, Fischer ND. Rhinocerebral mucormycosis. Arch Otolaryngol. 1977;103:600\u20134.", "journal-title": "Arch Otolaryngol"}, {"key": "15_CR62_15", "doi-asserted-by": "crossref", "first-page": "1140", "DOI": "10.1288/00005537-198210000-00007", "volume": "92", "author": "JS McNulty", "year": "1982", "unstructured": "McNulty JS. Rhinocerebral mucormycosis: predisposing factors. Laryngoscope. 1982;92:1140\u20133.", "journal-title": "Laryngoscope"}, {"key": "15_CR63_15", "doi-asserted-by": "crossref", "first-page": "855", "DOI": "10.1097/00005537-199707000-00004", "volume": "107", "author": "KL Peterson", "year": "1997", "unstructured": "Peterson KL, Wang M, Canalis RF, Abemayor E. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope. 1997;107:855\u201362.", "journal-title": "Laryngoscope"}, {"key": "15_CR64_15", "doi-asserted-by": "crossref", "first-page": "1319", "DOI": "10.1288/00005537-197708000-00012", "volume": "87", "author": "E Yanagisawa", "year": "1977", "unstructured": "Yanagisawa E, Friedman S, Kundargi RS, Smith HW. Rhinocerebral phycomycosis. Laryngoscope. 1977;87:1319\u201335.", "journal-title": "Laryngoscope"}, {"key": "15_CR65_15", "first-page": "1060", "volume": "94", "author": "E Abedi", "year": "1984", "unstructured": "Abedi E, Sismanis A, Choi K, Pastore P. Twenty-five years\u2019 experience treating cerebro-rhino-orbital mucormycosis. Laryngoscope. 1984;94:1060\u20132.", "journal-title": "Laryngoscope"}, {"key": "15_CR66_15", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1001/archotol.1975.00780310022006", "volume": "101", "author": "JT Lowe Jr", "year": "1975", "unstructured": "Lowe Jr JT, Hudson WR. Rhincerebral phycomycosis and internal carotid artery thrombosis. Arch Otolaryngol. 1975;101:100\u20133.", "journal-title": "Arch Otolaryngol"}, {"key": "15_CR67_15", "first-page": "673", "volume": "23", "author": "PM LeCompte", "year": "1947", "unstructured": "LeCompte PM, Miessner WA. Mucormycosis of the central nervous system associated with hemochromatosis. Am J Pathol. 1947;23:673\u20136.", "journal-title": "Am J Pathol"}, {"key": "15_CR68_15", "doi-asserted-by": "crossref", "first-page": "811", "DOI": "10.1016/0002-9394(74)90305-5", "volume": "78", "author": "JD Bullock", "year": "1974", "unstructured": "Bullock JD, Jampol LM, Fezza AJ. Two cases of orbital phycomycosis with recovery. Am J Ophthalmol. 1974;78:811\u20135.", "journal-title": "Am J Ophthalmol"}, {"key": "15_CR69_15", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1097/00005792-198603000-00004", "volume": "65", "author": "NA Parfrey", "year": "1986", "unstructured": "Parfrey NA. Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases. Medicine. 1986;65:113\u201323.", "journal-title": "Medicine"}, {"key": "15_CR70_15", "doi-asserted-by": "crossref", "first-page": "635", "DOI": "10.1288/00005537-198004000-00010", "volume": "90", "author": "A Blitzer", "year": "1980", "unstructured": "Blitzer A, Lawson W, Meyers BR, Biller HF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope. 1980;90:635\u201348.", "journal-title": "Laryngoscope"}, {"key": "15_CR71_15", "first-page": "383", "volume": "11", "author": "VA Morrison", "year": "1993", "unstructured": "Morrison VA, McGlave PB. Mucormycosis in the BMT population. Bone Marrow Transplant. 1993;11:383\u20138.", "journal-title": "Bone Marrow Transplant"}, {"key": "15_CR72_15", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1080/02681218680000591", "volume": "24", "author": "RD Rothstein", "year": "1986", "unstructured": "Rothstein RD, Simon GL. Subacute pulmonary mucormycosis. J Med Vet Mycol. 1986;24:391\u20134.", "journal-title": "J Med Vet Mycol"}, {"key": "15_CR73_15", "doi-asserted-by": "crossref", "first-page": "1044", "DOI": "10.1016/0003-4975(94)90243-7", "volume": "57", "author": "M Tedder", "year": "1994", "unstructured": "Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994;57:1044\u201350.", "journal-title": "Ann Thorac Surg"}, {"key": "15_CR74_15", "first-page": "49", "volume": "42", "author": "M Harada", "year": "1992", "unstructured": "Harada M, Manabe T, Yamashita K, Okamoto N. Pulmonary mucormycosis with fatal massive hemoptysis. Acta Pathol Jpn. 1992;42:49\u201355.", "journal-title": "Acta Pathol Jpn"}, {"key": "15_CR75_15", "doi-asserted-by": "crossref", "first-page": "1029", "DOI": "10.1001/archinte.1983.00350050193037", "volume": "143", "author": "WJ Watts", "year": "1983", "unstructured": "Watts WJ. Bronchopleural fistula followed by massive fatal hemoptysis in a patient with pulmonary mucormycosis. A case report. Arch Intern Med. 1983;143:1029\u201330.", "journal-title": "Arch Intern Med"}, {"key": "15_CR76_15", "doi-asserted-by": "crossref", "first-page": "1351", "DOI": "10.1080/10428190310001653691", "volume": "45", "author": "B Gleissner", "year": "2004", "unstructured": "Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma. 2004;45:1351\u201360.", "journal-title": "Leuk Lymphoma"}, {"key": "15_CR77_15", "doi-asserted-by": "crossref", "first-page": "1212", "DOI": "10.1111/j.1365-2133.2004.05826.x", "volume": "150", "author": "OA Kerr", "year": "2004", "unstructured": "Kerr OA, Bong C, Wallis C, Tidman MJ. Primary cutaneous mucormycosis masquerading as pyoderma gangrenosum. Br J Dermatol. 2004;150:1212\u20133.", "journal-title": "Br J Dermatol"}, {"key": "15_CR78_15", "doi-asserted-by": "crossref", "first-page": "1115", "DOI": "10.1056/NEJM197811162992007", "volume": "299", "author": "G Gartenberg", "year": "1978", "unstructured": "Gartenberg G, Bottone EJ, Keusch GT, Weitzman I. Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment. N Engl J Med. 1978;299:1115\u20138.", "journal-title": "N Engl J Med"}, {"key": "15_CR79_15", "doi-asserted-by": "crossref", "first-page": "272", "DOI": "10.1001/jama.1979.03300030044022", "volume": "242", "author": "JH Mead", "year": "1979", "unstructured": "Mead JH, Lupton GP, Dillavou CL, Odom RB. Cutaneous Rhizopus infection. Occurrence as a postoperative complication associated with an elasticized adhesive dressing. J Am Med Assoc. 1979;242:272\u20134.", "journal-title": "J Am Med Assoc"}, {"key": "15_CR80_15", "doi-asserted-by": "crossref", "first-page": "286", "DOI": "10.1097/BCR.0b013e31816673b1", "volume": "29", "author": "JP Ledgard", "year": "2008", "unstructured": "Ledgard JP, van Hal S, Greenwood JE. Primary cutaneous zygomycosis in a burns patient: a review. J Burn Care Res. 2008;29:286\u201390.", "journal-title": "J Burn Care Res"}, {"key": "15_CR81_15", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1046/j.1525-1470.2003.20508.x", "volume": "20", "author": "AS Boyd", "year": "2003", "unstructured": "Boyd AS, Wiser B, Sams HH, King LE. Gangrenous cutaneous mucormycosis in a child with a solid organ transplant: a case report and review of the literature. Pediatr Dermatol. 2003;20:411\u20135.", "journal-title": "Pediatr Dermatol"}, {"key": "15_CR82_15", "doi-asserted-by": "crossref", "first-page": "877", "DOI": "10.1097/01.inf.0000136870.17071.fd", "volume": "23", "author": "FN Kordy", "year": "2004", "unstructured": "Kordy FN, Al-Mohsen IZ, Hashem F, Almodovar E, Al Hajjar S, Walsh TJ. Successful treatment of a child with posttraumatic necrotizing fasciitis caused by Apophysomyces elegans: case report and review of literature. Pediatr Infect Dis J. 2004;23:877\u20139.", "journal-title": "Pediatr Infect Dis J"}, {"key": "15_CR83_15", "first-page": "187", "volume": "49", "author": "RM Prasad", "year": "2003", "unstructured": "Prasad RM, Bose SM, Vaiphei K, Verma GR. Post operative abdominal wall mucormycosis mimicking as bacterial necrotising fasciitis. J Postgrad Med. 2003;49:187\u20138.", "journal-title": "J Postgrad Med"}, {"key": "15_CR84_15", "doi-asserted-by": "crossref", "first-page": "990", "DOI": "10.1086/513940", "volume": "26", "author": "SB Amin", "year": "1998", "unstructured": "Amin SB, Ryan RM, Metlay LA, Watson WJ. Absidia corymbifera infections in neonates. Clin Infect Dis. 1998;26:990\u20132.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR85_15", "first-page": "131", "volume": "17", "author": "MC Sharma", "year": "1998", "unstructured": "Sharma MC, Gill SS, Kashyap S, et al. Gastrointestinal mucormycosis\u2013an uncommon isolated mucormycosis. Indian J Gastroenterol. 1998;17:131\u20133.", "journal-title": "Indian J Gastroenterol"}, {"key": "15_CR86_15", "first-page": "963", "volume": "11", "author": "BR Straatsma", "year": "1962", "unstructured": "Straatsma BR, Zimmerman LE, Gass JDM. Phycomycosis: a clinicopathologic study of fifty-one cases. Lab Invest. 1962;11:963\u201385.", "journal-title": "Lab Invest"}, {"key": "15_CR87_15", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1016/0002-9343(86)90062-8", "volume": "80", "author": "KF Woods", "year": "1986", "unstructured": "Woods KF, Hanna BJ. Brain stem mucormycosis in a narcotic addict with eventual recovery. Am J Med. 1986;80:126\u20138.", "journal-title": "Am J Med"}, {"key": "15_CR88_15", "doi-asserted-by": "crossref", "first-page": "42", "DOI": "10.1093/ajcp/78.1.42", "volume": "78", "author": "R Virmani", "year": "1982", "unstructured": "Virmani R, Connor DH, McAllister HA. Cardiac mucormycosis. A report of five patients and review of 14 previously reported cases. Am J Clin Pathol. 1982;78:42\u20137.", "journal-title": "Am J Clin Pathol"}, {"key": "15_CR89_15", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1007/BF00431474", "volume": "89", "author": "RM Tuder", "year": "1985", "unstructured": "Tuder RM. Myocardial infarct in disseminated mucormycosis: case report with special emphasis on the pathogenic mechanisms. Mycopathologia. 1985;89:81\u20138.", "journal-title": "Mycopathologia"}, {"key": "15_CR90_15", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1007/BF02033068", "volume": "20", "author": "J Vesa", "year": "1992", "unstructured": "Vesa J, Bielsa O, Arango O, Llad\u00f3 C, Gelabert A. Massive renal infarction due to mucormycosis in an AIDS patient. Infection. 1992;20:234\u20136.", "journal-title": "Infection"}, {"key": "15_CR91_15", "doi-asserted-by": "crossref", "first-page": "479", "DOI": "10.1097/00000372-198410000-00011", "volume": "6", "author": "N Maliwan", "year": "1984", "unstructured": "Maliwan N, Reyes CV, Rippon JW. Osteomyelitis secondary to cutaneous mucormycosis. Report of a case and a review of the literature. Am J Dermatopathol. 1984;6:479\u201381.", "journal-title": "Am J Dermatopathol"}, {"key": "15_CR92_15", "first-page": "933", "volume": "25", "author": "PF Pierce", "year": "1987", "unstructured": "Pierce PF, Wood MB, Roberts GD, Fitzgerald Jr RH, Robertson C, Edson RS. Saksenaea vasiformis osteomyelitis. J Clin Microbiol. 1987;25:933\u20135.", "journal-title": "J Clin Microbiol"}, {"key": "15_CR93_15", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1093/ajcp/70.1.103", "volume": "70", "author": "ASY Leong", "year": "1978", "unstructured": "Leong ASY. Granulomatous mediastinitis due to Rhizopus species. Am J Clin Pathol. 1978;70:103\u20137.", "journal-title": "Am J Clin Pathol"}, {"key": "15_CR94_15", "doi-asserted-by": "crossref", "first-page": "524", "DOI": "10.1378/chest.75.4.524", "volume": "75", "author": "BA Connor", "year": "1979", "unstructured": "Connor BA, Anderson RJ, Smith JW. Mucor mediastinitis. Chest. 1979;75:524\u20136.", "journal-title": "Chest"}, {"key": "15_CR95_15", "doi-asserted-by": "crossref", "first-page": "230", "DOI": "10.1016/S0003-4975(96)00817-X", "volume": "63", "author": "DR Andrews", "year": "1997", "unstructured": "Andrews DR, Allan A, Larbalestier RI. Tracheal mucormycosis. Ann Thorac Surg. 1997;63:230\u20132.", "journal-title": "Ann Thorac Surg"}, {"key": "15_CR96_15", "doi-asserted-by": "crossref", "first-page": "108", "DOI": "10.1136/bmj.282.6258.108-a", "volume": "282", "author": "G Helenglass", "year": "1981", "unstructured": "Helenglass G, Elliott JA, Lucie NP. An unusual presentation of opportunistic mucormycosis. Br Med J (Clin Res ed). 1981;282:108\u20139.", "journal-title": "Br Med J (Clin Res ed)"}, {"key": "15_CR97_15", "first-page": "458", "volume": "29", "author": "EO Ogunlana", "year": "1975", "unstructured": "Ogunlana EO. Fungal air spora at Ibadan, Nigeria. Appl Microbiol. 1975;29:458\u201363.", "journal-title": "Appl Microbiol"}, {"key": "15_CR98_15", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.3314/jjmm.44.163", "volume": "44", "author": "T Mori", "year": "2003", "unstructured": "Mori T, Egashira M, Kawamata N, et al. Zygomycosis: two case reports and review of reported cases in the literature in Japan. Nippon Ishinkin Gakkai Zasshi. 2003;44:163\u201379.", "journal-title": "Nippon Ishinkin Gakkai Zasshi"}, {"issue": "Suppl 2", "key": "15_CR99_15", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1111/j.1439-0507.1998.tb00609.x", "volume": "41", "author": "HJ Tietz", "year": "1998", "unstructured": "Tietz HJ, Brehmer D, J\u00e4nisch W, Martin H. Incidence of endomycoses in the autopsy material of the Berlin Charit\u00e9 Hospital. Mycoses. 1998;41 Suppl 2:81\u20135.", "journal-title": "Mycoses"}, {"key": "15_CR100_15", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1086/589857", "volume": "47", "author": "C Reed", "year": "2008", "unstructured": "Reed C, Bryant R, Ibrahim AS, et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008;47:364\u201371.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR101_15", "doi-asserted-by": "crossref", "first-page": "60", "DOI": "10.1086/430710", "volume": "41", "author": "G Chamilos", "year": "2005", "unstructured": "Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis. 2005;41:60\u20136.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR102_15", "doi-asserted-by": "crossref", "first-page": "1733", "DOI": "10.1086/587991", "volume": "46", "author": "H Wahba", "year": "2008", "unstructured": "Wahba H, Truong MT, Lei X, Kontoyiannis DP, Marom EM. Reversed halo sign in invasive pulmonary fungal infections. Clin Infect Dis. 2008;46:1733\u20137.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR103_15", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.1086/590004", "volume": "47", "author": "G Chamilos", "year": "2008", "unstructured": "Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47:503\u20139.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR104_15", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1086/432579", "volume": "41", "author": "MM Roden", "year": "2005", "unstructured": "Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634\u201353.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR105_15", "doi-asserted-by": "crossref", "first-page": "764", "DOI": "10.1056/NEJM199903113401004", "volume": "340", "author": "TJ Walsh", "year": "1999", "unstructured": "Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med. 1999;340:764\u201371.", "journal-title": "N Engl J Med"}, {"key": "15_CR106_15", "doi-asserted-by": "crossref", "first-page": "1383", "DOI": "10.1086/516353", "volume": "26", "author": "TJ Walsh", "year": "1998", "unstructured": "Walsh TJ, Hiemenz JW, Seibel NL, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis. 1998;26:1383\u201396.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR107_15", "doi-asserted-by": "crossref", "first-page": "3343", "DOI": "10.1128/AAC.47.10.3343-3344.2003", "volume": "47", "author": "AS Ibrahim", "year": "2003", "unstructured": "Ibrahim AS, Avanessian V, Spellberg B, Edwards Jr JE. Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae. Antimicrob Agents Chemother. 2003;47:3343\u20134.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR108_15", "doi-asserted-by": "crossref", "first-page": "274", "DOI": "10.1086/315643", "volume": "182", "author": "AH Groll", "year": "2000", "unstructured": "Groll AH, Giri N, Petraitis V, et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis. 2000;182:274\u201382.", "journal-title": "J Infect Dis"}, {"key": "15_CR109_15", "doi-asserted-by": "crossref", "first-page": "1573", "DOI": "10.1128/AAC.01488-07", "volume": "52", "author": "AS Ibrahim", "year": "2008", "unstructured": "Ibrahim AS, Gebremariam T, Husseiny MI, et al. Comparison of lipid amphotericin B preparations in treating murine zygomycosis. Antimicrob Agents Chemother. 2008;52:1573\u20136.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR110_15", "doi-asserted-by": "crossref", "first-page": "1581", "DOI": "10.1128/AAC.46.5.1581-1582.2002", "volume": "46", "author": "QN Sun", "year": "2002", "unstructured": "Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother. 2002;46:1581\u20132.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR111_15", "doi-asserted-by": "crossref", "first-page": "2161", "DOI": "10.1080/10428190410001700803", "volume": "45", "author": "N Blin", "year": "2004", "unstructured": "Blin N, Morineau N, Gaillard F, et al. Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin\u2019s lymphoma. Leuk Lymphoma. 2004;45:2161\u20133.", "journal-title": "Leuk Lymphoma"}, {"key": "15_CR112_15", "doi-asserted-by": "crossref", "first-page": "743", "DOI": "10.1086/423274", "volume": "39", "author": "A Imhof", "year": "2004", "unstructured": "Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis. 2004;39:743\u20136.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR113_15", "first-page": "ECR42", "volume": "89", "author": "K Kobayashi", "year": "2004", "unstructured": "Kobayashi K, Kami M, Murashige N, Kishi Y, Fujisaki G, Mitamura T. Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis. Haematologica 2004;89:ECR42.", "journal-title": "Haematologica"}, {"key": "15_CR114_15", "doi-asserted-by": "crossref", "first-page": "1350", "DOI": "10.1086/428780", "volume": "191", "author": "DP Kontoyiannis", "year": "2005", "unstructured": "Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis. 2005;191:1350\u201360.", "journal-title": "J Infect Dis"}, {"key": "15_CR115_15", "doi-asserted-by": "crossref", "first-page": "770", "DOI": "10.1086/427759", "volume": "40", "author": "I Oren", "year": "2005", "unstructured": "Oren I. Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia. Clin Infect Dis. 2005;40:770\u20131.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR116_15", "doi-asserted-by": "crossref", "first-page": "1032", "DOI": "10.1128/AAC.46.4.1032-1037.2002", "volume": "46", "author": "MA Pfaller", "year": "2002", "unstructured": "Pfaller MA, Messer SA, Hollis RJ, Jones RN. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother. 2002;46:1032\u20137.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR117_15", "doi-asserted-by": "crossref", "first-page": "3637", "DOI": "10.1128/AAC.00662-08", "volume": "52", "author": "C Lass-Florl", "year": "2008", "unstructured": "Lass-Florl C, Mayr A, Perkhofer S, et al. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother. 2008;52:3637\u201341.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR118_15", "first-page": "1", "volume": "12", "author": "S Arikan", "year": "2008", "unstructured": "Arikan S, Sancak B, Alp S, Hascelik G, McNicholas P. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus. Med Mycol. 2008;12:1\u20137.", "journal-title": "Med Mycol"}, {"key": "15_CR119_15", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.1128/AAC.50.2.658-666.2006", "volume": "50", "author": "AJ Ullmann", "year": "2006", "unstructured": "Ullmann AJ, Cornely OA, Burchardt A, et al. Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother. 2006;50:658\u201366.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR120_15", "doi-asserted-by": "crossref", "first-page": "1627", "DOI": "10.1592/phco.27.12.1627", "volume": "27", "author": "G Krishna", "year": "2007", "unstructured": "Krishna G, Martinho M, Chandrasekar P, Ullmann AJ, Patino H. Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease. Pharmacotherapy. 2007;27:1627\u201336.", "journal-title": "Pharmacotherapy"}, {"key": "15_CR121_15", "doi-asserted-by": "crossref", "first-page": "545", "DOI": "10.1185/030079906X167507", "volume": "23", "author": "G Krishna", "year": "2007", "unstructured": "Krishna G, Parsons A, Kantesaria B, Mant T. Evaluation of the pharmacokinetics of posaconazole and rifabutin following co-administration to healthy men. Curr Med Res Opin. 2007;23:545\u201352.", "journal-title": "Curr Med Res Opin"}, {"key": "15_CR122_15", "doi-asserted-by": "crossref", "first-page": "812", "DOI": "10.1128/AAC.00454-06", "volume": "51", "author": "G Krishna", "year": "2007", "unstructured": "Krishna G, Sansone-Parsons A, Martinho M, Kantesaria B, Pedicone L. Posaconazole plasma concentrations in juvenile patients with invasive fungal infection. Antimicrob Agents Chemother. 2007;51:812\u20138.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR123_15", "doi-asserted-by": "crossref", "first-page": "2310", "DOI": "10.1128/AAC.46.7.2310-2312.2002", "volume": "46", "author": "QN Sun", "year": "2002", "unstructured": "Sun QN, Najvar LK, Bocanegra R, Loebenberg D, Graybill JR. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother. 2002;46:2310\u20132.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR124_15", "doi-asserted-by": "crossref", "first-page": "3647", "DOI": "10.1128/AAC.47.11.3647-3650.2003", "volume": "47", "author": "E Dannaoui", "year": "2003", "unstructured": "Dannaoui E, Meis JF, Loebenberg D, Verweij PE. Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob Agents Chemother. 2003;47:3647\u201350.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR125_15", "doi-asserted-by": "crossref", "first-page": "772", "DOI": "10.1128/AAC.01124-08", "volume": "53", "author": "AS Ibrahim", "year": "2009", "unstructured": "Ibrahim AS, Gebremariam T, Schwartz JA, Edwards Jr JE, Spellberg B. Posaconazole mono- or combination therapy for treatment of murine zygomycosis. Antimicrob Agents Chemother. 2009;53:772\u20135.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR126_15", "doi-asserted-by": "crossref", "first-page": "3786", "DOI": "10.1128/AAC.00628-08", "volume": "52", "author": "MM Rodriguez", "year": "2008", "unstructured": "Rodriguez MM, Serena C, Marine M, Pastor FJ, Guarro J. Posaconazole combined with amphotericin B, an effective therapy for a murine-disseminated infection caused by Rhizopus oryzae. Antimicrob Agents Chemother. 2008;52:3786\u20138.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR127_15", "doi-asserted-by": "crossref", "first-page": "e61", "DOI": "10.1086/500212", "volume": "42", "author": "JA Burik van", "year": "2006", "unstructured": "van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis. 2006;42:e61\u20135.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR128_15", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1128/AAC.50.1.126-133.2006", "volume": "50", "author": "RN Greenberg", "year": "2006", "unstructured": "Greenberg RN, Mullane K, van Burik JA, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006;50:126\u201333.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR129_15", "doi-asserted-by": "crossref", "first-page": "3623", "DOI": "10.1128/JCM.41.8.3623-3626.2003", "volume": "41", "author": "DJ Diekema", "year": "2003", "unstructured": "Diekema DJ, Messer SA, Hollis RJ, Jones RN, Pfaller MA. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol. 2003;41:3623\u20136.", "journal-title": "J Clin Microbiol"}, {"key": "15_CR130_15", "first-page": "121", "volume": "20", "author": "A Espinel-Ingroff", "year": "2003", "unstructured": "Espinel-Ingroff A. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12, 052 fungal isolates: review of the literature. Rev Iberoam Micol. 2003;20:121\u201336.", "journal-title": "Rev Iberoam Micol"}, {"key": "15_CR131_15", "doi-asserted-by": "crossref", "first-page": "721", "DOI": "10.1128/AAC.49.2.721-727.2005", "volume": "49", "author": "AS Ibrahim", "year": "2005", "unstructured": "Ibrahim AS, Bowman JC, Avanessian V, et al. Caspofungin inhibits Rhizopus oryzae 1, 3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob Agents Chemother. 2005;49:721\u20137.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR132_15", "doi-asserted-by": "crossref", "first-page": "830", "DOI": "10.1128/AAC.49.2.830-832.2005", "volume": "49", "author": "B Spellberg", "year": "2005", "unstructured": "Spellberg B, Fu Y, Edwards Jr JE, Ibrahim AS. Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice. Antimicrob Agents Chemother. 2005;49:830\u20132.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR133_15", "doi-asserted-by": "crossref", "first-page": "1556", "DOI": "10.1128/AAC.01458-07", "volume": "52", "author": "AS Ibrahim", "year": "2008", "unstructured": "Ibrahim AS, Gebremariam T, Fu Y, Edwards Jr JE, Spellberg B. Combination echinocandin-polyene treatment of murine mucormycosis. Antimicrob Agents Chemother. 2008;52:1556\u20138.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR134_15", "doi-asserted-by": "crossref", "first-page": "186", "DOI": "10.1086/589305", "volume": "198", "author": "GA Lamaris", "year": "2008", "unstructured": "Lamaris GA, Lewis RE, Chamilos G, et al. Caspofungin-Mediated beta-Glucan Unmasking and Enhancement of Human Polymorphonuclear Neutrophil Activity against Aspergillus and Non-Aspergillus Hyphae. J Infect Dis. 2008;198:186\u201392.", "journal-title": "J Infect Dis"}, {"key": "15_CR135_15", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1016/j.beha.2004.09.002", "volume": "18", "author": "MD Cappellini", "year": "2005", "unstructured": "Cappellini MD. Iron-chelating therapy with the new oral agent ICL670 (Exjade). Best Pract Res Clin Haematol. 2005;18:289\u201398.", "journal-title": "Best Pract Res Clin Haematol"}, {"key": "15_CR136_15", "doi-asserted-by": "crossref", "first-page": "2649", "DOI": "10.1172/JCI32338", "volume": "117", "author": "AS Ibrahim", "year": "2007", "unstructured": "Ibrahim AS, Gebermariam T, Fu Y, et al. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest. 2007;117:2649\u201357.", "journal-title": "J Clin Invest"}, {"key": "15_CR137_15", "first-page": "873", "volume": "91", "author": "A Piga", "year": "2006", "unstructured": "Piga A, Galanello R, Forni GL, et al. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload. Haematologica. 2006;91:873\u201380.", "journal-title": "Haematologica"}, {"key": "15_CR138_15", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1007/s12185-008-0115-2", "volume": "88", "author": "K Miyazawa", "year": "2008", "unstructured": "Miyazawa K, Ohyashiki K, Urabe A, et al. A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade, ICL670) in patients with transfusion-dependent anemias and iron-overload: a Phase I study in Japan. Int J Hematol. 2008;88:73\u201381.", "journal-title": "Int J Hematol"}, {"key": "15_CR139_15", "doi-asserted-by": "crossref", "first-page": "3968", "DOI": "10.1128/AAC.01065-06", "volume": "50", "author": "C Reed", "year": "2006", "unstructured": "Reed C, Ibrahim A, Edwards Jr JE, Walot I, Spellberg B. Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis. Antimicrob Agents Chemother. 2006;50:3968\u20139.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR140_15", "doi-asserted-by": "crossref", "first-page": "3122", "DOI": "10.1128/AAC.00361-09", "volume": "53", "author": "B Spellberg", "year": "2009", "unstructured": "Spellberg B, Andes D, Perez M, et al. Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis. Antimicrob Agents Chemother. 2009;53:3122\u20135.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR141_15", "doi-asserted-by": "crossref", "first-page": "1585", "DOI": "10.1128/AAC.01611-07", "volume": "52", "author": "A Soummer", "year": "2008", "unstructured": "Soummer A, Mathonnet A, Scatton O, et al. Failure of deferasirox, an iron chelator agent, combined with antifungals in a case of severe zygomycosis. Antimicrob Agents Chemother. 2008;52:1585\u20136.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR142_15", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1001/archotol.1988.01860190095032", "volume": "114", "author": "L Couch", "year": "1988", "unstructured": "Couch L, Theilen F, Mader JT. Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy. Arch Otolaryngol Head Neck Surg. 1988;114:791\u20134.", "journal-title": "Arch Otolaryngol Head Neck Surg"}, {"key": "15_CR143_15", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1099/00221287-45-1-17", "volume": "45", "author": "SM Robb", "year": "1966", "unstructured": "Robb SM. Reactions of fungi to exposure to 10 atmospheres pressure of oxygen. J Gen Microbiol. 1966;45:17\u201329.", "journal-title": "J Gen Microbiol"}, {"key": "15_CR144_15", "doi-asserted-by": "crossref", "first-page": "1180", "DOI": "10.1086/428503", "volume": "191", "author": "C Gil-Lamaignere", "year": "2005", "unstructured": "Gil-Lamaignere C, Simitsopoulou M, Roilides E, Maloukou A, Winn RM, Walsh TJ. Interferon- gamma and Granulocyte-Macrophage Colony-Stimulating Factor Augment the Activity of Polymorphonuclear Leukocytes against Medically Important Zygomycetes. J Infect Dis. 2005;191:1180\u20137.", "journal-title": "J Infect Dis"}, {"key": "15_CR145_15", "doi-asserted-by": "crossref", "first-page": "769", "DOI": "10.1097/01.inf.0000134314.65398.bf", "volume": "23", "author": "MJ Abzug", "year": "2004", "unstructured": "Abzug MJ, Walsh TJ. Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children. Pediatr Infect Dis J. 2004;23:769\u201373.", "journal-title": "Pediatr Infect Dis J"}, {"key": "15_CR146_15", "doi-asserted-by": "crossref", "first-page": "192", "DOI": "10.1093/clinids/24.2.192", "volume": "24", "author": "CE Gonzalez", "year": "1997", "unstructured": "Gonzalez CE, Couriel DR, Walsh TJ. Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Clin Infect Dis. 1997;24:192\u20136.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR147_15", "doi-asserted-by": "crossref", "first-page": "478", "DOI": "10.1016/S0923-2494(98)80771-2", "volume": "149", "author": "BJ Kullberg", "year": "1998", "unstructured": "Kullberg BJ, Anaissie EJ. Cytokines as therapy for opportunistic fungal infections. Res Immunol. 1998;149:478\u201388. discussion 515.", "journal-title": "Res Immunol"}, {"key": "15_CR148_15", "doi-asserted-by": "crossref", "first-page": "1393", "DOI": "10.3109/10428190109097768", "volume": "42", "author": "B Ma", "year": "2001", "unstructured": "Ma B, Seymour JF, Januszewicz H, Slavin MA. Cure of pulmonary Rhizomucor pusillus infection in a patient with hairy-cell leukemia: role of liposomal amphotericin B and GM-CSF. Leuk Lymphoma. 2001;42:1393\u20139.", "journal-title": "Leuk Lymphoma"}, {"key": "15_CR149_15", "first-page": "278", "volume": "12", "author": "A Mastroianni", "year": "2004", "unstructured": "Mastroianni A. Paranasal sinus mucormycosis in an immunocompetent host: efficacy and safety of combination therapy with Liposomal Amphotericin B and adjuvant rHuGM-CSF. Infez Med. 2004;12:278\u201383.", "journal-title": "Infez Med"}, {"key": "15_CR150_15", "doi-asserted-by": "crossref", "first-page": "783", "DOI": "10.1007/s00520-005-0910-8", "volume": "14", "author": "L Grigull", "year": "2006", "unstructured": "Grigull L, Beilken A, Schmid H, et al. Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies. Support Care Cancer. 2006;14:783\u20136.", "journal-title": "Support Care Cancer"}, {"key": "15_CR151_15", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1080/10428190290006305", "volume": "43", "author": "MA Slavin", "year": "2002", "unstructured": "Slavin MA, Kannan K, Buchanan MR, Sasadeusz J, Roberts AW. Successful allogeneic stem cell transplant after invasive pulmonary zygomycosis. Leuk Lymphoma. 2002;43:437\u20139.", "journal-title": "Leuk Lymphoma"}, {"key": "15_CR152_15", "doi-asserted-by": "crossref", "first-page": "493", "DOI": "10.1258/0022215011908027", "volume": "115", "author": "A Thakar", "year": "2001", "unstructured": "Thakar A, Baruah P, Kumar S, Sharma MC. Rhinophycomycosis. J Laryngol Otol. 2001;115:493\u20136.", "journal-title": "J Laryngol Otol"}, {"issue": "4", "key": "15_CR153_15", "first-page": "369", "volume": "53", "author": "X Yang", "year": "2010", "unstructured": "Yang X, Li Y, Zhou X, et al. Rhinofacial conidiobolomycosis caused by Conidiobolus coronatus in a Chinese rice farmer. Mycoses. 2010;53(4):369\u201373.", "journal-title": "Mycoses"}, {"key": "15_CR154_15", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1007/BF00158574", "volume": "8", "author": "HC Gugnani", "year": "1992", "unstructured": "Gugnani HC. Entomophthoromycosis due to Conidiobolus. Eur J Epidemiol. 1992;8:391\u20136.", "journal-title": "Eur J Epidemiol"}, {"key": "15_CR155_15", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.4269/ajtmh.1971.20.449", "volume": "20", "author": "FD Martinson", "year": "1971", "unstructured": "Martinson FD. Chronic phycomycosis of the upper respiratory tract. Rhinophycomycosis entomophthorae. Am J Trop Med Hyg. 1971;20:449\u201355.", "journal-title": "Am J Trop Med Hyg"}, {"key": "15_CR156_15", "doi-asserted-by": "crossref", "first-page": "1274", "DOI": "10.1001/archinte.1978.03630330074022", "volume": "138", "author": "DL Dworzack", "year": "1978", "unstructured": "Dworzack DL, Pollock AS, Hodges GR, Barnes WG, Ajello L, Padhye A. Zygomycosis of the maxillary sinus and palate caused by Basidiobolus haptosporus. Arch Intern Med. 1978;138:1274\u20136.", "journal-title": "Arch Intern Med"}, {"key": "15_CR157_15", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1093/clinids/19.3.423", "volume": "19", "author": "TJ Walsh", "year": "1994", "unstructured": "Walsh TJ, Renshaw G, Andrews J, et al. Invasive zygomycosis due to Conidiobolus incongruus. Clin Infect Dis. 1994;19:423\u201330.", "journal-title": "Clin Infect Dis"}, {"key": "15_CR158_15", "doi-asserted-by": "crossref", "first-page": "447", "DOI": "10.1111/j.1365-2141.2005.05429.x", "volume": "129", "author": "DC Tan", "year": "2005", "unstructured": "Tan DC, Hsu LY, Koh LP, Goh YT, Koh M. Severe conidiobolomycosis complicating induction chemotherapy in a patient with acute lymphoblastic leukaemia. Br J Haematol. 2005;129:447.", "journal-title": "Br J Haematol"}, {"key": "15_CR159_15", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1080/00362178485380081", "volume": "22", "author": "JI Okafor", "year": "1984", "unstructured": "Okafor JI, Testrake D, Mushinsky HR, Yangco BG. A Basidiobolus sp. and its association with reptiles and amphibians in southern Florida. Sabouraudia. 1984;22:47\u201351.", "journal-title": "Sabouraudia"}, {"key": "15_CR160_15", "first-page": "303", "volume-title": "Medical mycology", "author": "JW Rippon", "year": "1982", "unstructured": "Rippon JW. Medical mycology. 2nd ed. Philadelphia: The W.B. Saunders Company; 1982. p. 303\u201314.", "edition": "2"}, {"key": "15_CR161_15", "doi-asserted-by": "crossref", "first-page": "368", "DOI": "10.1002/j.1537-2197.1960.tb07138.x", "volume": "47", "author": "C Dreschler", "year": "1960", "unstructured": "Dreschler C. Two new species of Conidiobolus found in the plant detritus. Am J Bot. 1960;47:368\u201377.", "journal-title": "Am J Bot"}, {"key": "15_CR162_15", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1007/BF00436414", "volume": "115", "author": "AR Costa", "year": "1991", "unstructured": "Costa AR, Porto E, Pegas JR, et al. Rhinofacial zygomycosis caused by Conidiobolus coronatus. A case report. Mycopathologia. 1991;115:1\u20138.", "journal-title": "Mycopathologia"}, {"key": "15_CR163_15", "author": "HM Cameroon", "first-page": "186", "year": "1990", "unstructured": "Cameroon HM. Entomophthoromycosis. In: Mahgoub ES, editor. Tropical mycoses. Beerse: Janssen Research Council; 1990. p. 186\u201398.", "volume-title": "Tropical mycoses"}, {"key": "15_CR164_15", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1080/00275514.1956.12024579", "volume": "48", "author": "C Dreschler", "year": "1956", "unstructured": "Dreschler C. Supplementary development stages of Basidiobolus ranarum and Basidiobolus haptosporus. Mycologia. 1956;48:655\u201377.", "journal-title": "Mycologia"}, {"key": "15_CR165_15", "first-page": "674", "volume-title": "Manual of clinical microbiology", "author": "NL Goodman", "year": "1991", "unstructured": "Goodman NL, Rinaldi MG. Agents of zygomycosis. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ, editors. Manual of clinical microbiology. 5th ed. Washington: ASM Press; 1991. p. 674\u201392.", "edition": "5"}, {"key": "15_CR166_15", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1111/j.1525-1470.1991.tb00943.x", "volume": "8", "author": "AL Bittencourt", "year": "1991", "unstructured": "Bittencourt AL, Arruda SM, de Andrade JA, Carvalho EM. Basidiobolomycosis: a case report. Pediatr Dermatol. 1991;8:325\u20138.", "journal-title": "Pediatr Dermatol"}, {"key": "15_CR167_15", "author": "FW Chandler", "first-page": "85", "year": "1987", "unstructured": "Chandler FW, Watts JC. Pathologic diagnosis of fungal infections. Chicago: ASCP Press; 1987. p. 85\u201395.", "volume-title": "Pathologic diagnosis of fungal infections"}, {"key": "15_CR168_15", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1080/00362178485380471", "volume": "22", "author": "A Kamalam", "year": "1984", "unstructured": "Kamalam A, Thambiah AS. Muscle invasion by Basidiobolus haptosporus. Sabouraudia. 1984;22:273\u20137.", "journal-title": "Sabouraudia"}, {"key": "15_CR169_15", "doi-asserted-by": "crossref", "first-page": "140", "DOI": "10.1186/1471-2334-6-140", "volume": "6", "author": "GE Berk van den", "year": "2006", "unstructured": "van den Berk GE, Noorduyn LA, van Ketel RJ, van Leeuwen J, Bemelman WA, Prins JM. A fatal pseudo-tumour: disseminated basidiobolomycosis. BMC Infect Dis. 2006;6:140.", "journal-title": "BMC Infect Dis"}, {"key": "15_CR170_15", "doi-asserted-by": "crossref", "first-page": "250", "DOI": "10.1016/S0016-5085(97)70242-7", "volume": "112", "author": "TM Pasha", "year": "1997", "unstructured": "Pasha TM, Leighton JA, Smilack JD, Heppell J, Colby TV, Kaufman L. Basidiobolomycosis: an unusual fungal infection mimicking inflammatory bowel disease. Gastroenterology. 1997;112:250\u20134.", "journal-title": "Gastroenterology"}, {"key": "15_CR171_15", "doi-asserted-by": "crossref", "first-page": "1007", "DOI": "10.1097/01.inf.0000095166.94823.11", "volume": "22", "author": "A Jarie Al", "year": "2003", "unstructured": "Al Jarie A, Al-Mohsen I, Al Jumaah S, et al. Pediatric gastrointestinal basidiobolomycosis. Pediatr Infect Dis J. 2003;22:1007\u201314.", "journal-title": "Pediatr Infect Dis J"}, {"key": "15_CR172_15", "doi-asserted-by": "crossref", "first-page": "926", "DOI": "10.1016/j.mycres.2007.06.009", "volume": "111", "author": "MR Hussein", "year": "2007", "unstructured": "Hussein MR, Musalam AO, Assiry MH, Eid RA, El Motawa AM, Gamel AM. Histological and ultrastructural features of gastrointestinal basidiobolomycosis. Mycol Res. 2007;111:926\u201330.", "journal-title": "Mycol Res"}, {"key": "15_CR173_15", "doi-asserted-by": "crossref", "first-page": "1367", "DOI": "10.1128/JCM.42.3.1367-1369.2004", "volume": "42", "author": "C Bigliazzi", "year": "2004", "unstructured": "Bigliazzi C, Poletti V, Dell\u2019Amore D, Saragoni L, Colby TV. Disseminated basidiobolomycosis in an immunocompetent woman. J Clin Microbiol. 2004;42:1367\u20139.", "journal-title": "J Clin Microbiol"}, {"key": "15_CR174_15", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.4103/0255-0857.42044", "volume": "26", "author": "R Singh", "year": "2008", "unstructured": "Singh R, Xess I, Ramavat AS, Arora R. Basidiobolomycosis: a rare case report. Indian J Med Microbiol. 2008;26:265\u20137.", "journal-title": "Indian J Med Microbiol"}, {"key": "15_CR175_15", "doi-asserted-by": "crossref", "first-page": "657", "DOI": "10.1017/S0022215100080865", "volume": "89", "author": "WI Onuigbo", "year": "1975", "unstructured": "Onuigbo WI, Gugnani HC, Okafor BC, Misch KA. Nasal entomophthorosis in an Igbo from Nigeria. J Laryngol Otol. 1975;89:657\u201361.", "journal-title": "J Laryngol Otol"}, {"key": "15_CR176_15", "first-page": "33", "volume": "69", "author": "P Ravisse", "year": "1976", "unstructured": "Ravisse P, Destombes P, Le Gonidec G. 10 new clinical cases of mycoses caused by Entomophorales in Cameroon. Bull Soc Pathol Exot Filiales. 1976;69:33\u201340.", "journal-title": "Bull Soc Pathol Exot Filiales"}, {"key": "15_CR177_15", "doi-asserted-by": "crossref", "first-page": "370", "DOI": "10.4269/ajtmh.1982.31.370", "volume": "31", "author": "AL Bittencourt", "year": "1982", "unstructured": "Bittencourt AL, Serra G, Sadigursky M, Araujo MG, Campos MC, Sampaio LC. Subcutaneous zygomycosis caused by Basidiobolus haptosporus: presentation of a case mimicking Burkitt\u2019s lymphoma. Am J Trop Med Hyg. 1982;31:370\u20133.", "journal-title": "Am J Trop Med Hyg"}, {"key": "15_CR178_15", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1111/j.1439-0507.1983.tb03241.x", "volume": "26", "author": "BC Okafor", "year": "1983", "unstructured": "Okafor BC, Gugnani HC, Jacob A. Nasal entomophthorosis with laryngeal involvement. Mykosen. 1983;26:471\u20137.", "journal-title": "Mykosen"}, {"key": "15_CR179_15", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.1016/0002-9343(83)90512-0", "volume": "74", "author": "E Drouhet", "year": "1983", "unstructured": "Drouhet E, Dupont B. Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. Am J Med. 1983;74:30\u201347.", "journal-title": "Am J Med"}, {"key": "15_CR180_15", "doi-asserted-by": "crossref", "first-page": "S91", "DOI": "10.1016/S0190-9622(08)81277-7", "volume": "31", "author": "A Restrepo", "year": "1994", "unstructured": "Restrepo A. Treatment of tropical mycoses. J Am Acad Dermatol. 1994;31:S91\u2013102.", "journal-title": "J Am Acad Dermatol"}, {"key": "15_CR181_15", "first-page": "14", "volume": "101", "author": "F Barro-Traore", "year": "2008", "unstructured": "Barro-Traore F, Ouedraogo D, Konsem T, et al. Conidiobolomycosis, a rare fungal tumor: a case report in Ouagadougou, Burkina Faso. Bull Soc Pathol Exot. 2008;101:14\u20136.", "journal-title": "Bull Soc Pathol Exot"}, {"key": "15_CR182_15", "doi-asserted-by": "crossref", "first-page": "572", "DOI": "10.1111/j.1365-4632.2004.02419.x", "volume": "44", "author": "R Mathew", "year": "2005", "unstructured": "Mathew R, Kumaravel S, Kuruvilla S, et al. Successful treatment of extensive basidiobolomycosis with oral itraconazole in a child. Int J Dermatol. 2005;44:572\u20135.", "journal-title": "Int J Dermatol"}, {"key": "15_CR183_15", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1128/AAC.25.4.413", "volume": "25", "author": "BG Yangco", "year": "1984", "unstructured": "Yangco BG, Okafor JI, TeStrake D. In vitro susceptibilities of human and wild-type isolates of Basidiobolus and Conidiobolus species. Antimicrob Agents Chemother. 1984;25:413\u20136.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "15_CR184_15", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1016/S0385-8146(12)80113-1", "volume": "22", "author": "D Mukhopadhyay", "year": "1995", "unstructured": "Mukhopadhyay D, Ghosh LM, Thammayya A, Sanyal M. Entomophthoromycosis caused by Conidiobolus coronatus: clinicomycological study of a case. Auris Nasus Larynx. 1995;22:139\u201342.", "journal-title": "Auris Nasus Larynx"}, {"key": "15_CR185_15", "doi-asserted-by": "crossref", "first-page": "258", "DOI": "10.1159/000246260", "volume": "193", "author": "NT Foss", "year": "1996", "unstructured": "Foss NT, Rocha MR, Lima VT, Velludo MA, Roselino AM. Entomophthoramycosis: therapeutic success by using amphotericin B and terbinafine. Dermatology. 1996;193:258\u201360.", "journal-title": "Dermatology"}, {"key": "15_CR186_15", "doi-asserted-by": "crossref", "first-page": "594", "DOI": "10.1007/s15010-008-8056-5", "volume": "36", "author": "N Fischer", "year": "2008", "unstructured": "Fischer N, Ruef C, Ebnother C, Bachli EB. Rhinofacial Conidiobolus coronatus infection presenting with nasal enlargement. Infection. 2008;36:594\u20136.", "journal-title": "Infection"}], "container-title": ["Essentials of Clinical Mycology"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4419-6640-7_15", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 7]], "date-time": "2019-06-07T19:24:45Z", "timestamp": 1559935485000}, "score": 25.5786, "issued": {"date-parts": [[2010, 11, 27]]}, "ISBN": ["9781441966391", "9781441966407"], "references-count": 186, "URL": "http://dx.doi.org/10.1007/978-1-4419-6640-7_15", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T13:27:11Z", "timestamp": 1574429231260}, "reference-count": 0, "publisher": "American Thoracic Society", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Proceedings of the American Thoracic Society"], "published-print": {"date-parts": [[2010, 5, 15]]}, "DOI": "10.1513/pats.200906-033al", "type": "journal-article", "created": {"date-parts": [[2010, 5, 12]], "date-time": "2010-05-12T18:30:46Z", "timestamp": 1273689046000}, "page": "210-215", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Mucormycosis, Pseudallescheriasis, and Other Uncommon Mold Infections"], "prefix": "10.1513", "volume": "7", "author": [{"given": "C.", "family": "Quan", "sequence": "first", "affiliation": []}, {"given": "B.", "family": "Spellberg", "sequence": "additional", "affiliation": []}], "member": "19", "published-online": {"date-parts": [[2010, 5, 12]]}, "container-title": ["Proceedings of the American Thoracic Society"], "language": "en", "deposited": {"date-parts": [[2010, 5, 12]], "date-time": "2010-05-12T18:31:57Z", "timestamp": 1273689117000}, "score": 25.291029, "issued": {"date-parts": [[2010, 5, 12]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2010, 5, 12]]}, "published-print": {"date-parts": [[2010, 5, 15]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1513/pats.200906-033al", "ISSN": ["1546-3222"], "issn-type": [{"value": "1546-3222", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T17:37:06Z", "timestamp": 1574444226211}, "reference-count": 58, "publisher": "Oxford University Press (OUP)", "issue": "suppl_1", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 2, 1]]}, "DOI": "10.1093/cid/cir884", "type": "journal-article", "created": {"date-parts": [[2012, 1, 13]], "date-time": "2012-01-13T18:56:48Z", "timestamp": 1326481008000}, "page": "S67-S72", "source": "Crossref", "is-referenced-by-count": 36, "title": ["How Does Antifungal Pharmacology Differ for Mucormycosis Versus Aspergillosis?"], "prefix": "10.1093", "volume": "54", "author": [{"given": "Russell E.", "family": "Lewis", "sequence": "first", "affiliation": []}, {"given": "Olivier", "family": "Lortholary", "sequence": "additional", "affiliation": []}, {"given": "Brad", "family": "Spellberg", "sequence": "additional", "affiliation": []}, {"given": "Emmanuel", "family": "Roilides", "sequence": "additional", "affiliation": []}, {"given": "Dimitrios P.", "family": "Kontoyiannis", "sequence": "additional", "affiliation": []}, {"given": "Thomas J.", "family": "Walsh", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2012, 2, 1]]}, "reference": [{"key": "key\n\t\t\t\t20171013233019_bib1", "doi-asserted-by": "crossref", "first-page": "644", "DOI": "10.3324/haematol.2009.012054", "article-title": "Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study", "volume": "95", "author": "Pagano", "year": "2010", "journal-title": "Haematologica"}, {"key": "key\n\t\t\t\t20171013233019_bib2", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1086/595846", "article-title": "Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry", "volume": "48", "author": "Neofytos", "year": "2009", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib3", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1086/510592", "article-title": "Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality", "volume": "44", "author": "Upton", "year": "2007", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib4", "doi-asserted-by": "crossref", "first-page": "1395", "DOI": "10.3201/eid1509.090334", "article-title": "Increasing incidence of zygomycosis (mucormycosis), France, 1997\u20132006", "volume": "15", "author": "Bitar", "year": "2009", "journal-title": "Emerg Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib5"}, {"key": "key\n\t\t\t\t20171013233019_bib6", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1086/432579", "article-title": "Epidemiology and outcome of zygomycosis: a review of 929 reported cases", "volume": "41", "author": "Roden", "year": "2005", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib7", "doi-asserted-by": "crossref", "first-page": "e1000549", "DOI": "10.1371/journal.pgen.1000549", "article-title": "Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication", "volume": "5", "author": "Ma", "year": "2009", "journal-title": "PLoS Genet"}, {"key": "key\n\t\t\t\t20171013233019_bib8", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1080/mmy.40.1.61.71", "article-title": "Molecular cloning of an extracellular aspartic proteinase from Rhizopus microsporus and evidence for its expression during infection", "volume": "40", "author": "Schoen", "year": "2002", "journal-title": "Med Mycol"}, {"key": "key\n\t\t\t\t20171013233019_bib9", "doi-asserted-by": "crossref", "first-page": "723", "DOI": "10.1080/13693780600936399", "article-title": "Characterization of an extracellular subtilisin protease of Rhizopus microsporus and evidence for its expression during invasive rhinoorbital mycosis", "volume": "44", "author": "Spreer", "year": "2006", "journal-title": "Med Mycol"}, {"key": "key\n\t\t\t\t20171013233019_bib10", "doi-asserted-by": "crossref", "first-page": "1109", "DOI": "10.2337/diacare.31.12.1109", "article-title": "A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability", "volume": "31", "author": "Artis", "year": "1982", "journal-title": "Diabetes"}, {"key": "key\n\t\t\t\t20171013233019_bib11", "first-page": "1269", "article-title": "Fungistatic mechanism of human transferrin for Rhizopus oryzae and Trichophyton mentagrophytes: alternative to simple iron deprivation", "volume": "41", "author": "Artis", "year": "1983", "journal-title": "Infect Immun"}, {"key": "key\n\t\t\t\t20171013233019_bib12", "doi-asserted-by": "crossref", "first-page": "e61", "DOI": "10.1086/500212", "article-title": "Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases", "volume": "42", "author": "van Burik", "year": "2006", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib13", "doi-asserted-by": "crossref", "first-page": "1889", "DOI": "10.1128/EC.00151-07", "article-title": "Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates", "volume": "6", "author": "Coste", "year": "2007", "journal-title": "Eukaryot Cell"}, {"key": "key\n\t\t\t\t20171013233019_bib14", "doi-asserted-by": "crossref", "first-page": "624", "DOI": "10.1111/j.1365-2958.2008.06176.x", "article-title": "An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1", "volume": "68", "author": "Selmecki", "year": "2008", "journal-title": "Mol Microbiol"}, {"key": "key\n\t\t\t\t20171013233019_bib15", "doi-asserted-by": "crossref", "first-page": "2009", "DOI": "10.1128/AAC.00163-06", "article-title": "In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts", "volume": "50", "author": "Sabatelli", "year": "2006", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib16", "doi-asserted-by": "crossref", "first-page": "1581", "DOI": "10.1128/AAC.46.5.1581-1582.2002", "article-title": "In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B and fluconazole against 37 clinical isolates of zygomycetes", "volume": "46", "author": "Sun", "year": "2002", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib17", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1093/jac/dkg020", "article-title": "In vitro susceptibilities of zygomycetes to conventional and new antifungals", "volume": "51", "author": "Dannaoui", "year": "2003", "journal-title": "J Antimicrob Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib18", "doi-asserted-by": "crossref", "first-page": "1573", "DOI": "10.1128/AAC.01488-07", "article-title": "Comparison of lipid amphotericin B preparations in treating murine zygomycosis", "volume": "52", "author": "Ibrahim", "year": "2008", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib19", "doi-asserted-by": "crossref", "first-page": "1350", "DOI": "10.1086/428780", "article-title": "Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases", "volume": "191", "author": "Kontoyiannis", "year": "2005", "journal-title": "J Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib20", "doi-asserted-by": "crossref", "first-page": "1002", "DOI": "10.1086/605445", "article-title": "Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome", "volume": "200", "author": "Singh", "year": "2009", "journal-title": "J Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib21", "doi-asserted-by": "crossref", "first-page": "24", "DOI": "10.1128/AAC.00705-08", "article-title": "Antifungal therapeutic drug monitoring: established and emerging indications", "volume": "53", "author": "Andes", "year": "2009", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib22", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1093/jac/dkn224", "article-title": "Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis", "volume": "62", "author": "Lamaris", "year": "2008", "journal-title": "J Antimicrob Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib23", "doi-asserted-by": "crossref", "first-page": "702", "DOI": "10.1097/00006454-199908000-00010", "article-title": "Amphotericin B lipid complex in pediatric patients with invasive fungal infections", "volume": "18", "author": "Walsh", "year": "1999", "journal-title": "Pediat Inf Dis J"}, {"key": "key\n\t\t\t\t20171013233019_bib24", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.1086/590004", "article-title": "Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis", "volume": "47", "author": "Chamilos", "year": "2008", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib25", "doi-asserted-by": "crossref", "first-page": "1289", "DOI": "10.1086/514341", "article-title": "Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)", "volume": "44", "author": "Cornely", "year": "2007", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib26", "doi-asserted-by": "crossref", "first-page": "1253", "DOI": "10.1128/AAC.01449-06", "article-title": "Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis", "volume": "51", "author": "Lewis", "year": "2007", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib27", "doi-asserted-by": "crossref", "first-page": "1298", "DOI": "10.1128/AAC.01222-09", "article-title": "Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis", "volume": "54", "author": "Lewis", "year": "2010", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib28", "doi-asserted-by": "crossref", "first-page": "3637", "DOI": "10.1128/AAC.00662-08", "article-title": "Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing", "volume": "52", "author": "Lass-Florl", "year": "2008", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib29", "doi-asserted-by": "crossref", "first-page": "3418", "DOI": "10.1128/AAC.00241-06", "article-title": "Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations", "volume": "50", "author": "Groll", "year": "2006", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib30", "doi-asserted-by": "crossref", "first-page": "274", "DOI": "10.1086/315643", "article-title": "Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system", "volume": "182", "author": "Groll", "year": "2000", "journal-title": "J Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib31", "doi-asserted-by": "crossref", "first-page": "2068", "DOI": "10.1128/AAC.44.8.2068-2076.2000", "article-title": "Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbits", "volume": "44", "author": "Walsh", "year": "2000", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib32", "doi-asserted-by": "crossref", "first-page": "2391", "DOI": "10.1128/AAC.42.9.2391", "article-title": "Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients", "volume": "42", "author": "Walsh", "year": "1998", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib33", "doi-asserted-by": "crossref", "first-page": "3487", "DOI": "10.1128/AAC.45.12.3487-3496.2001", "article-title": "Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study", "volume": "45", "author": "Walsh", "year": "2001", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib34", "doi-asserted-by": "crossref", "first-page": "830", "DOI": "10.1128/AAC.49.2.830-832.2005", "article-title": "Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice", "volume": "49", "author": "Spellberg", "year": "2005", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib35", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1086/589857", "article-title": "Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis", "volume": "47", "author": "Reed", "year": "2008", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib36", "doi-asserted-by": "crossref", "first-page": "3968", "DOI": "10.1128/AAC.01065-06", "article-title": "Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis", "volume": "50", "author": "Reed", "year": "2006", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib37", "doi-asserted-by": "crossref", "first-page": "3122", "DOI": "10.1128/AAC.00361-09", "article-title": "Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis", "volume": "53", "author": "Spellberg", "year": "2009", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib38"}, {"key": "key\n\t\t\t\t20171013233019_bib39", "doi-asserted-by": "crossref", "first-page": "721", "DOI": "10.1128/AAC.49.2.721-727.2005", "article-title": "Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis", "volume": "49", "author": "Ibrahim", "year": "2005", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib40", "doi-asserted-by": "crossref", "first-page": "1556", "DOI": "10.1128/AAC.01458-07", "article-title": "Combination echinocandin-polyene treatment of murine mucormycosis", "volume": "52", "author": "Ibrahim", "year": "2008", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib41"}, {"key": "key\n\t\t\t\t20171013233019_bib42", "doi-asserted-by": "crossref", "first-page": "e1000040", "DOI": "10.1371/journal.ppat.1000040", "article-title": "Stimulation of chitin synthesis rescues Candida albicans from echinocandins", "volume": "4", "author": "Walker", "year": "2008", "journal-title": "PLoS Pathog"}, {"key": "key\n\t\t\t\t20171013233019_bib43", "doi-asserted-by": "crossref", "first-page": "1555", "DOI": "10.1128/AAC.00854-09", "article-title": "Transcriptional regulation of chitin synthases by calcineurin controls paradoxical growth of Aspergillus fumigatus in response to caspofungin", "volume": "54", "author": "Fortwendel", "year": "2010", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib44", "doi-asserted-by": "crossref", "first-page": "226", "DOI": "10.1086/589290", "article-title": "Immunocompromised hosts: immunopharmacology of modern antifungals", "volume": "47", "author": "Ben-Ami", "year": "2008", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib45", "doi-asserted-by": "crossref", "first-page": "186", "DOI": "10.1086/589305", "article-title": "Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae", "volume": "198", "author": "Lamaris", "year": "2008", "journal-title": "J Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib46", "doi-asserted-by": "crossref", "first-page": "4938", "DOI": "10.4049/jimmunol.0804250", "article-title": "Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus", "volume": "182", "author": "Werner", "year": "2009", "journal-title": "J Immunol"}, {"key": "key\n\t\t\t\t20171013233019_bib47", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1200/JCO.1997.15.1.139", "article-title": "Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery", "volume": "15", "author": "Caillot", "year": "1997", "journal-title": "J Clin Oncol"}, {"key": "key\n\t\t\t\t20171013233019_bib48", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1086/509917", "article-title": "Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign", "volume": "44", "author": "Greene", "year": "2007", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib49", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1007/s10156-004-0315-5", "article-title": "Pathophysiology of pulmonary aspergillosis", "volume": "10", "author": "Shibuya", "year": "2004", "journal-title": "J Infect Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib50", "doi-asserted-by": "crossref", "first-page": "1079", "DOI": "10.1164/ajrccm.152.3.7663787", "article-title": "Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression", "volume": "152", "author": "Berenguer", "year": "1995", "journal-title": "Am J Respir Crit Care Med"}, {"key": "key\n\t\t\t\t20171013233019_bib51", "doi-asserted-by": "crossref", "first-page": "134", "DOI": "10.1016/j.jinf.2009.06.002", "article-title": "A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response", "volume": "59", "author": "Ben-Ami", "year": "2009", "journal-title": "J Infect"}, {"key": "key\n\t\t\t\t20171013233019_bib52", "doi-asserted-by": "crossref", "first-page": "e101", "DOI": "10.1086/521245", "article-title": "The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients", "volume": "45", "author": "Lass-Florl", "year": "2007", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib53"}, {"key": "key\n\t\t\t\t20171013233019_bib54", "doi-asserted-by": "crossref", "first-page": "1743", "DOI": "10.1086/599105", "article-title": "Recent advances in the management of mucormycosis: from bench to bedside", "volume": "48", "author": "Spellberg", "year": "2009", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233019_bib55", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1128/CMR.6.1.1", "article-title": "Compounds active against cell walls of medically important fungi", "volume": "6", "author": "Hector", "year": "1993", "journal-title": "Clin Microbiol Rev"}, {"key": "key\n\t\t\t\t20171013233019_bib56", "doi-asserted-by": "crossref", "first-page": "3310", "DOI": "10.1128/AAC.45.12.3310-3321.2001", "article-title": "Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus", "volume": "45", "author": "Chiou", "year": "2001", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib57", "doi-asserted-by": "crossref", "first-page": "3549", "DOI": "10.1128/AAC.00184-09", "article-title": "In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes", "volume": "53", "author": "Dannaoui", "year": "2009", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233019_bib58", "doi-asserted-by": "crossref", "first-page": "1843", "DOI": "10.1016/0006-2952(94)90314-X", "article-title": "Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus", "volume": "47", "author": "de Locht", "year": "1994", "journal-title": "Biochem Pharmacol"}], "container-title": ["Clinical Infectious Diseases"], "language": "en", "link": [{"URL": "http://academic.oup.com/cid/article-pdf/54/suppl_1/S67/20911134/cir884.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 22]], "date-time": "2019-06-22T11:58:56Z", "timestamp": 1561204736000}, "score": 23.989391, "issued": {"date-parts": [[2012, 2, 1]]}, "references-count": 58, "journal-issue": {"published-online": {"date-parts": [[2012, 2, 1]]}, "published-print": {"date-parts": [[2012, 2, 1]]}, "issue": "suppl_1"}, "URL": "http://dx.doi.org/10.1093/cid/cir884", "relation": {"cites": []}, "ISSN": ["1537-6591", "1058-4838"], "issn-type": [{"value": "1058-4838", "type": "print"}, {"value": "1537-6591", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T05:48:07Z", "timestamp": 1575265687363}, "reference-count": 24, "publisher": "Mary Ann Liebert Inc", "issue": "1", "license": [{"URL": "https://www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/", "start": {"date-parts": [[2014, 2, 1]], "date-time": "2014-02-01T00:00:00Z", "timestamp": 1391212800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Population Health Management"], "published-print": {"date-parts": [[2014, 2]]}, "DOI": "10.1089/pop.2013.0002", "type": "journal-article", "created": {"date-parts": [[2013, 8, 21]], "date-time": "2013-08-21T20:02:24Z", "timestamp": 1377115344000}, "page": "28-34", "source": "Crossref", "is-referenced-by-count": 28, "title": ["Impact of Hospital Variables on Case Mix Index as a Marker of Disease Severity"], "prefix": "10.1089", "volume": "17", "author": [{"given": "Carmen M.", "family": "Mendez", "sequence": "first", "affiliation": [{"name": "Division of General Internal Medicine, Harbor-University of California Los Angeles (UCLA) Medical Center, Los Angeles, California."}, {"name": "David Geffen School of Medicine at UCLA, Los Angeles, California."}]}, {"given": "Darrell W.", "family": "Harrington", "sequence": "additional", "affiliation": [{"name": "Division of General Internal Medicine, Harbor-University of California Los Angeles (UCLA) Medical Center, Los Angeles, California."}, {"name": "David Geffen School of Medicine at UCLA, Los Angeles, California."}]}, {"given": "Peter", "family": "Christenson", "sequence": "additional", "affiliation": [{"name": "Clinical and Translational Science Institute Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles (UCLA) Medical Center, Los Angeles, California."}]}, {"given": "Brad", "family": "Spellberg", "sequence": "additional", "affiliation": [{"name": "Division of General Internal Medicine, Harbor-University of California Los Angeles (UCLA) Medical Center, Los Angeles, California."}, {"name": "David Geffen School of Medicine at UCLA, Los Angeles, California."}]}], "member": "278", "container-title": ["Population Health Management"], "language": "en", "link": [{"URL": "https://www.liebertpub.com/doi/full-xml/10.1089/pop.2013.0002", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://www.liebertpub.com/doi/pdf/10.1089/pop.2013.0002", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 28]], "date-time": "2018-08-28T04:15:31Z", "timestamp": 1535429731000}, "score": 23.379625, "issued": {"date-parts": [[2014, 2]]}, "references-count": 24, "journal-issue": {"published-print": {"date-parts": [[2014, 2]]}, "issue": "1"}, "alternative-id": ["10.1089/pop.2013.0002"], "URL": "http://dx.doi.org/10.1089/pop.2013.0002", "ISSN": ["1942-7891", "1942-7905"], "issn-type": [{"value": "1942-7891", "type": "print"}, {"value": "1942-7905", "type": "electronic"}], "subject": ["Public Health, Environmental and Occupational Health", "Health Policy", "Leadership and Management"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T22:25:50Z", "timestamp": 1574375150006}, "reference-count": 23, "publisher": "Oxford University Press (OUP)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CLIN INFECT DIS"], "published-print": {"date-parts": [[2008, 8]]}, "DOI": "10.1086/589857", "type": "journal-article", "created": {"date-parts": [[2008, 6, 17]], "date-time": "2008-06-17T21:49:52Z", "timestamp": 1213739392000}, "page": "364-371", "source": "Crossref", "is-referenced-by-count": 232, "title": ["Combination Polyene\u2010Caspofungin Treatment of Rhino\u2010Orbital\u2010Cerebral Mucormycosis"], "prefix": "10.1093", "volume": "47", "author": [{"given": "Caitlin", "family": "Reed", "sequence": "first", "affiliation": []}, {"given": "Richard", "family": "Bryant", "sequence": "additional", "affiliation": []}, {"given": "Ashraf\u00a0S.", "family": "Ibrahim", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "Edwards, Jr.", "sequence": "additional", "affiliation": []}, {"given": "Scott\u00a0G.", "family": "Filler", "sequence": "additional", "affiliation": []}, {"given": "Robert", "family": "Goldberg", "sequence": "additional", "affiliation": []}, {"given": "Brad", "family": "Spellberg", "sequence": "additional", "affiliation": []}], "member": "286", "reference": [{"key": "rf1_41", "DOI": "10.1128/CMR.18.3.556-569.2005", "doi-asserted-by": "publisher"}, {"key": "rf2_42", "DOI": "10.1086/432579", "doi-asserted-by": "publisher"}, {"key": "rf3_43", "DOI": "10.1086/339202", "doi-asserted-by": "publisher"}, {"key": "rf4_44", "DOI": "10.1086/313803", "doi-asserted-by": "publisher"}, {"key": "rf5_45", "DOI": "10.1080/10428190310001653691", "doi-asserted-by": "publisher"}, {"key": "rf6_46", "author": "Espinel-Ingroff A", "volume": "36", "first-page": "2950", "year": "1998", "journal-title": "J Clin Microbiol"}, {"key": "rf7_47", "DOI": "10.1016/S0732-8893(97)00246-0", "doi-asserted-by": "publisher"}, {"key": "rf8_48", "author": "Del Poeta M", "volume": "41", "first-page": "1835", "year": "1997", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.41.8.1835", "doi-asserted-by": "crossref"}, {"key": "rf9_49", "DOI": "10.1016/S0140-6736(03)14472-8", "doi-asserted-by": "publisher"}, {"key": "rf10_50", "DOI": "10.1093/jac/dkg117", "doi-asserted-by": "publisher"}, {"key": "rf11_51", "author": "Kurtz MB", "volume": "38", "first-page": "1480", "year": "1994", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.38.7.1480", "doi-asserted-by": "crossref"}, {"key": "rf12_52", "DOI": "10.1128/AAC.49.2.721-727.2005", "doi-asserted-by": "publisher"}, {"key": "rf13_53", "DOI": "10.1128/AAC.49.2.830-832.2005", "doi-asserted-by": "publisher"}, {"key": "rf14_54", "DOI": "10.1086/323335", "doi-asserted-by": "publisher"}, {"key": "rf15_55", "DOI": "10.1128/AAC.01458-07", "doi-asserted-by": "publisher"}, {"key": "rf16_56", "DOI": "10.1128/AAC.46.9.3001-3012.2002", "doi-asserted-by": "publisher"}, {"key": "rf17_57", "DOI": "10.1128/AAC.45.12.3310-3321.2001", "doi-asserted-by": "publisher"}, {"key": "rf18_58", "DOI": "10.1128/AAC.00563-06", "doi-asserted-by": "publisher"}, {"key": "rf19_59", "DOI": "10.1189/jlb.1206753", "doi-asserted-by": "publisher"}, {"key": "rf20_60", "DOI": "10.1016/j.trsl.2006.07.001", "doi-asserted-by": "publisher"}, {"key": "rf21_61", "DOI": "10.1038/ni1408", "doi-asserted-by": "publisher"}, {"key": "rf22_62", "DOI": "10.1086/315643", "doi-asserted-by": "publisher"}, {"key": "rf23_63", "DOI": "10.1086/423389", "doi-asserted-by": "publisher"}], "container-title": ["Clinical Infectious Diseases"], "language": "en", "link": [{"URL": "http://academic.oup.com/cid/article-pdf/47/3/364/895904/47-3-364.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 12]], "date-time": "2019-05-12T04:28:31Z", "timestamp": 1557635311000}, "score": 21.789326, "issued": {"date-parts": [[2008, 8]]}, "references-count": 23, "journal-issue": {"published-print": {"date-parts": [[2008, 8]]}, "issue": "3"}, "alternative-id": ["10.1086/589857"], "URL": "http://dx.doi.org/10.1086/589857", "relation": {"cites": []}, "ISSN": ["1058-4838", "1537-6591"], "issn-type": [{"value": "1058-4838", "type": "print"}, {"value": "1537-6591", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T17:37:06Z", "timestamp": 1574444226263}, "reference-count": 54, "publisher": "Oxford University Press (OUP)", "issue": "suppl_1", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 2, 1]]}, "DOI": "10.1093/cid/cir885", "type": "journal-article", "created": {"date-parts": [[2012, 1, 13]], "date-time": "2012-01-13T18:56:48Z", "timestamp": 1326481008000}, "page": "S73-S78", "source": "Crossref", "is-referenced-by-count": 78, "title": ["Combination Therapy for Mucormycosis: Why, What, and How?"], "prefix": "10.1093", "volume": "54", "author": [{"given": "Brad", "family": "Spellberg", "sequence": "first", "affiliation": []}, {"given": "Ashraf", "family": "Ibrahim", "sequence": "additional", "affiliation": []}, {"given": "Emmanuel", "family": "Roilides", "sequence": "additional", "affiliation": []}, {"given": "Russel E.", "family": "Lewis", "sequence": "additional", "affiliation": []}, {"given": "Olivier", "family": "Lortholary", "sequence": "additional", "affiliation": []}, {"given": "George", "family": "Petrikkos", "sequence": "additional", "affiliation": []}, {"given": "Dimitrios P.", "family": "Kontoyiannis", "sequence": "additional", "affiliation": []}, {"given": "Thomas J.", "family": "Walsh", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2012, 2, 1]]}, "reference": [{"key": "key\n\t\t\t\t20171013233036_bib1", "doi-asserted-by": "crossref", "first-page": "556", "DOI": "10.1128/CMR.18.3.556-569.2005", "article-title": "Novel perspectives on mucormycosis: pathophysiology, presentation, and management", "volume": "18", "author": "Spellberg", "year": "2005", "journal-title": "Clin Microbiol Rev"}, {"key": "key\n\t\t\t\t20171013233036_bib2", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1086/432579", "article-title": "Epidemiology and outcome of zygomycosis: a review of 929 reported cases", "volume": "41", "author": "Roden", "year": "2005", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233036_bib3", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.1128/CMR.13.2.236-301.2000", "article-title": "Zygomycetes in human disease", "volume": "13", "author": "Ribes", "year": "2000", "journal-title": "Clin Microbiol Rev"}, {"key": "key\n\t\t\t\t20171013233036_bib4", "doi-asserted-by": "crossref", "first-page": "909", "DOI": "10.1086/339202", "article-title": "Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients", "volume": "34", "author": "Marr", "year": "2002", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233036_bib5", "doi-asserted-by": "crossref", "first-page": "851", "DOI": "10.1086/313803", "article-title": "Zygomycosis in the 1990s in a tertiary-care cancer center", "volume": "30", "author": "Kontoyiannis", "year": "2000", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233036_bib6", "doi-asserted-by": "crossref", "first-page": "1351", "DOI": "10.1080/10428190310001653691", "article-title": "Improved outcome of zygomycosis in patients with hematological diseases?", "volume": "45", "author": "Gleissner", "year": "2004", "journal-title": "Leuk Lymphoma"}, {"key": "key\n\t\t\t\t20171013233036_bib7", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.3109/13693780903311944", "article-title": "Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases", "volume": "48", "author": "Shoham", "year": "2009", "journal-title": "Med Mycol"}, {"key": "key\n\t\t\t\t20171013233036_bib8", "doi-asserted-by": "crossref", "first-page": "1743", "DOI": "10.1086/599105", "article-title": "Recent advances in the management of mucormycosis: from bench to bedside", "volume": "48", "author": "Spellberg", "year": "2009", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233036_bib9", "doi-asserted-by": "crossref", "first-page": "3569", "DOI": "10.1128/AAC.00456-09", "article-title": "Efficacy of liposomal amphotericin B combined with gamma interferon or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice", "volume": "53", "author": "Rodriguez", "year": "2009", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib10", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.7326/0003-4819-137-2-200207160-00008", "article-title": "Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS", "volume": "137", "author": "Johnson", "year": "2002", "journal-title": "Ann Intern Med"}, {"key": "key\n\t\t\t\t20171013233036_bib11", "doi-asserted-by": "crossref", "first-page": "1463", "DOI": "10.1097/00002030-199712000-00010", "article-title": "Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis", "volume": "11", "author": "Leenders", "year": "1997", "journal-title": "AIDS"}, {"key": "key\n\t\t\t\t20171013233036_bib12", "doi-asserted-by": "crossref", "first-page": "535", "DOI": "10.1093/jac/30.4.535", "article-title": "Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients", "volume": "30", "author": "Moreau", "year": "1992", "journal-title": "J Antimicrob Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib13", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1046/j.1365-2141.1997.2473063.x", "article-title": "A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients", "volume": "98", "author": "Prentice", "year": "1997", "journal-title": "Br J Haematol"}, {"key": "key\n\t\t\t\t20171013233036_bib14", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1093/clinids/22.2.315", "article-title": "Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS", "volume": "22", "author": "Sharkey", "year": "1996", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233036_bib15", "doi-asserted-by": "crossref", "first-page": "342", "DOI": "10.1111/j.1600-0609.2004.00239.x", "article-title": "Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies\u2014a randomized, controlled trial", "volume": "72", "author": "Subira", "year": "2004", "journal-title": "Eur J Haematol"}, {"key": "key\n\t\t\t\t20171013233036_bib16", "doi-asserted-by": "crossref", "first-page": "764", "DOI": "10.1056/NEJM199903113401004", "article-title": "Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group", "volume": "340", "author": "Walsh", "year": "1999", "journal-title": "N Engl J Med"}, {"key": "key\n\t\t\t\t20171013233036_bib17", "doi-asserted-by": "crossref", "first-page": "3343", "DOI": "10.1128/AAC.47.10.3343-3344.2003", "article-title": "Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae", "volume": "47", "author": "Ibrahim", "year": "2003", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib18", "doi-asserted-by": "crossref", "first-page": "1155", "DOI": "10.1086/317451", "article-title": "A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group", "volume": "31", "author": "Wingard", "year": "2000", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233036_bib19", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1086/589857", "article-title": "Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis", "volume": "47", "author": "Reed", "year": "2008", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013233036_bib20", "doi-asserted-by": "crossref", "first-page": "274", "DOI": "10.1086/315643", "article-title": "Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system", "volume": "182", "author": "Groll", "year": "2000", "journal-title": "J Infect Dis"}, {"key": "key\n\t\t\t\t20171013233036_bib21", "doi-asserted-by": "crossref", "first-page": "3487", "DOI": "10.1128/AAC.45.12.3487-3496.2001", "article-title": "Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study", "volume": "45", "author": "Walsh", "year": "2001", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib22", "doi-asserted-by": "crossref", "first-page": "721", "DOI": "10.1128/AAC.49.2.721-727.2005", "article-title": "Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis", "volume": "49", "author": "Ibrahim", "year": "2005", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib23", "doi-asserted-by": "crossref", "first-page": "830", "DOI": "10.1128/AAC.49.2.830-832.2005", "article-title": "Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice", "volume": "49", "author": "Spellberg", "year": "2005", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib24", "doi-asserted-by": "crossref", "first-page": "1556", "DOI": "10.1128/AAC.01458-07", "article-title": "Combination echinocandin-polyene treatment of murine mucormycosis", "volume": "52", "author": "Ibrahim", "year": "2008", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib25", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1016/j.beha.2004.09.002", "article-title": "Iron-chelating therapy with the new oral agent ICL670 (Exjade)", "volume": "18", "author": "Cappellini", "year": "2005", "journal-title": "Best Pract Res Clin Haematol"}, {"key": "key\n\t\t\t\t20171013233036_bib26", "doi-asserted-by": "crossref", "first-page": "2649", "DOI": "10.1172/JCI32338", "article-title": "The iron chelator deferasirox protects mice from mucormycosis through iron starvation", "volume": "117", "author": "Ibrahim", "year": "2007", "journal-title": "J Clin Invest"}, {"key": "key\n\t\t\t\t20171013233036_bib27", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1128/AAC.00792-10", "article-title": "Activity of deferasirox in Mucorales: influences of species and exogenous iron", "volume": "55", "author": "Lewis", "year": "2011", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib28", "doi-asserted-by": "crossref", "first-page": "3968", "DOI": "10.1128/AAC.01065-06", "article-title": "Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis", "volume": "50", "author": "Reed", "year": "2006", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib29", "author": "Cappellini", "year": "2006", "volume-title": "Long-term safety and tolerability of the once-daily, oral iron chelator deferasirox (Exjade, ICL670) in patients with transfusional iron overload. Abstract 896"}, {"key": "key\n\t\t\t\t20171013233036_bib30", "author": "Spellberg", "year": "2011", "article-title": "The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study: a randomized, double-blinded, placebo-controlled trial", "journal-title": "J Antimicrob Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib31", "doi-asserted-by": "crossref", "first-page": "3455", "DOI": "10.1182/blood-2005-08-3430", "article-title": "A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia", "volume": "107", "author": "Cappellini", "year": "2006", "journal-title": "Blood"}, {"key": "key\n\t\t\t\t20171013233036_bib32", "doi-asserted-by": "crossref", "first-page": "398", "DOI": "10.1002/ajh.21119", "article-title": "Clinical application of deferasirox: practical patient management", "volume": "83", "author": "Vichinsky", "year": "2008", "journal-title": "Am J Hematol"}, {"key": "key\n\t\t\t\t20171013233036_bib33"}, {"key": "key\n\t\t\t\t20171013233036_bib34", "doi-asserted-by": "crossref", "first-page": "1585", "DOI": "10.1128/AAC.01611-07", "article-title": "Failure of deferasirox, an iron chelator agent, combined with antifungals in a case of severe zygomycosis", "volume": "52", "author": "Soummer", "year": "2008", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib35", "doi-asserted-by": "crossref", "first-page": "1581", "DOI": "10.1128/AAC.46.5.1581-1582.2002", "article-title": "In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes", "volume": "46", "author": "Sun", "year": "2002", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib36", "doi-asserted-by": "crossref", "first-page": "1032", "DOI": "10.1128/AAC.46.4.1032-1037.2002", "article-title": "Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000", "volume": "46", "author": "Pfaller", "year": "2002", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib37", "doi-asserted-by": "crossref", "first-page": "2587", "DOI": "10.1128/AAC.00452-07", "article-title": "In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents", "volume": "51", "author": "Almyroudis", "year": "2007", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib38", "doi-asserted-by": "crossref", "first-page": "3637", "DOI": "10.1128/AAC.00662-08", "article-title": "Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing", "volume": "52", "author": "Lass-Florl", "year": "2008", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib39", "first-page": "1", "article-title": "Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus", "volume": "12", "author": "Arikan", "year": "2008", "journal-title": "Med Mycol"}, {"key": "key\n\t\t\t\t20171013233036_bib40", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.1128/AAC.50.2.658-666.2006", "article-title": "Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection", "volume": "50", "author": "Ullmann", "year": "2006", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib41", "doi-asserted-by": "crossref", "first-page": "812", "DOI": "10.1128/AAC.00454-06", "article-title": "Posaconazole plasma concentrations in juvenile patients with invasive fungal infection", "volume": "51", "author": "Krishna", "year": "2007", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib42", "doi-asserted-by": "crossref", "first-page": "1627", "DOI": "10.1592/phco.27.12.1627", "article-title": "Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease", "volume": "27", "author": "Krishna", "year": "2007", "journal-title": "Pharmacotherapy"}, {"key": "key\n\t\t\t\t20171013233036_bib43", "doi-asserted-by": "crossref", "first-page": "5224", "DOI": "10.1128/AAC.00939-09", "article-title": "Therapeutic drug monitoring of posaconazole: a monocentric study with 54 adults", "volume": "53", "author": "Lebeaux", "year": "2009", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib44", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1128/AAC.48.1.137-142.2004", "article-title": "Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis", "volume": "48", "author": "Andes", "year": "2004", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib45", "doi-asserted-by": "crossref", "first-page": "2310", "DOI": "10.1128/AAC.46.7.2310-2312.2002", "article-title": "In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model", "volume": "46", "author": "Sun", "year": "2002", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib46", "doi-asserted-by": "crossref", "first-page": "3647", "DOI": "10.1128/AAC.47.11.3647-3650.2003", "article-title": "Activity of posaconazole in treatment of experimental disseminated zygomycosis", "volume": "47", "author": "Dannaoui", "year": "2003", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib47", "doi-asserted-by": "crossref", "first-page": "3786", "DOI": "10.1128/AAC.00628-08", "article-title": "Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae", "volume": "52", "author": "Rodriguez", "year": "2008", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib48", "doi-asserted-by": "crossref", "first-page": "772", "DOI": "10.1128/AAC.01124-08", "article-title": "Posaconazole mono- or combination therapy for treatment of murine zygomycosis", "volume": "53", "author": "Ibrahim", "year": "2009", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib49", "doi-asserted-by": "crossref", "first-page": "1645", "DOI": "10.1128/AAC.01530-08", "article-title": "In vitro activity of isavuconazole against Aspergillus species and zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing", "volume": "53", "author": "Perkhofer", "year": "2009", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib50", "doi-asserted-by": "crossref", "first-page": "3453", "DOI": "10.1128/AAC.01601-08", "article-title": "Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect", "volume": "53", "author": "Warn", "year": "2009", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib51", "doi-asserted-by": "crossref", "first-page": "272", "DOI": "10.1179/joc.2009.21.3.272", "article-title": "In vitro antifungal activity of isavuconazole against 345 Mucorales isolates collected at study centers in eight countries", "volume": "21", "author": "Verweij", "year": "2009", "journal-title": "J Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib52", "doi-asserted-by": "crossref", "first-page": "1768", "DOI": "10.1128/AAC.01577-10", "article-title": "Combination therapy of murine mucormycosis or aspergillosis with iron chelation, polyenes, and echinocandins", "volume": "55", "author": "Ibrahim", "year": "2011", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013233036_bib53", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1097/MPH.0b013e3181ca0dcf", "article-title": "Successful triple combination therapy of disseminated Absidia corymbifera infection in an adolescent with osteosarcoma", "volume": "32", "author": "Roux", "year": "2010", "journal-title": "J Pediatr Hematol Oncol"}, {"key": "key\n\t\t\t\t20171013233036_bib54", "doi-asserted-by": "crossref", "first-page": "1395", "DOI": "10.3201/eid1509.090334", "article-title": "Increasing incidence of zygomycosis (mucormycosis), France, 1997\u20132006", "volume": "15", "author": "Bitar", "year": "2009", "journal-title": "Emerg Infect Dis"}], "container-title": ["Clinical Infectious Diseases"], "language": "en", "link": [{"URL": "http://academic.oup.com/cid/article-pdf/54/suppl_1/S73/20911193/cir885.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 10, 14]], "date-time": "2017-10-14T03:30:48Z", "timestamp": 1507951848000}, "score": 21.789326, "issued": {"date-parts": [[2012, 2, 1]]}, "references-count": 54, "journal-issue": {"published-online": {"date-parts": [[2012, 2, 1]]}, "published-print": {"date-parts": [[2012, 2, 1]]}, "issue": "suppl_1"}, "URL": "http://dx.doi.org/10.1093/cid/cir885", "relation": {"cites": []}, "ISSN": ["1537-6591", "1058-4838"], "issn-type": [{"value": "1058-4838", "type": "print"}, {"value": "1537-6591", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T17:37:06Z", "timestamp": 1574444226424}, "reference-count": 61, "publisher": "Oxford University Press (OUP)", "issue": "suppl_1", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 2, 1]]}, "DOI": "10.1093/cid/cir886", "type": "journal-article", "created": {"date-parts": [[2012, 1, 13]], "date-time": "2012-01-13T18:56:48Z", "timestamp": 1326481008000}, "page": "S79-S85", "source": "Crossref", "is-referenced-by-count": 28, "title": ["Future Directions in Mucormycosis Research"], "prefix": "10.1093", "volume": "54", "author": [{"given": "Dimitrios P.", "family": "Kontoyiannis", "sequence": "first", "affiliation": []}, {"given": "Russell E.", "family": "Lewis", "sequence": "additional", "affiliation": []}, {"given": "Oliver", "family": "Lotholary", "sequence": "additional", "affiliation": []}, {"given": "Brad", "family": "Spellberg", "sequence": "additional", "affiliation": []}, {"given": "Georgios", "family": "Petrikkos", "sequence": "additional", "affiliation": []}, {"given": "Emmanuel", "family": "Roillides", "sequence": "additional", "affiliation": []}, {"given": "Ashraf", "family": "Ibrahim", "sequence": "additional", "affiliation": []}, {"given": "Thomas J.", "family": "Walsh", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2012, 2, 1]]}, "reference": [{"key": "key\n\t\t\t\t20171013235635_bib1", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1086/595846", "article-title": "Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry", "volume": "48", "author": "Neofytos", "year": "2009", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib2", "doi-asserted-by": "crossref", "first-page": "1350", "DOI": "10.1086/428780", "article-title": "Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases", "volume": "191", "author": "Kontoyiannis", "year": "2005", "journal-title": "J Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib3", "first-page": "2973", "article-title": "Agents of mucormycosis and related species", "volume-title": "Principles and practice of infectious diseases", "author": "Kontoyiannis", "year": "2005", "edition": "6th ed"}, {"key": "key\n\t\t\t\t20171013235635_bib4", "first-page": "986", "article-title": "Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989\u20132003)", "volume": "91", "author": "Chamilos", "year": "2006", "journal-title": "Haematologica"}, {"key": "key\n\t\t\t\t20171013235635_bib5", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1086/524324", "article-title": "Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis", "volume": "29", "author": "Chang", "year": "2008", "journal-title": "Infect Control Hosp Epidemiol"}, {"key": "key\n\t\t\t\t20171013235635_bib6", "doi-asserted-by": "crossref", "first-page": "1395", "DOI": "10.3201/eid1509.090334", "article-title": "Increasing incidence of zygomycosis (mucormycosis), France, 1997\u20132006", "volume": "15", "author": "Bitar", "year": "2009", "journal-title": "Emerg Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib7", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1086/432579", "article-title": "Epidemiology and outcome of zygomycosis: a review of 929 reported cases", "volume": "41", "author": "Roden", "year": "2005", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib8", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1111/j.1469-0691.2009.02988.x", "article-title": "Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?", "volume": "15", "author": "Pongas", "year": "2009", "journal-title": "Clin Microbiol Infect"}, {"key": "key\n\t\t\t\t20171013235635_bib9", "doi-asserted-by": "crossref", "first-page": "851", "DOI": "10.1086/313803", "article-title": "Zygomycosis in the 1990s in a tertiary-care cancer center", "volume": "30", "author": "Kontoyiannis", "year": "2000", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib10", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1086/525258", "article-title": "Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America", "volume": "46", "author": "Walsh", "year": "2008", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib11", "doi-asserted-by": "crossref", "first-page": "1627", "DOI": "10.1592/phco.27.12.1627", "article-title": "Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease", "volume": "27", "author": "Krishna", "year": "2007", "journal-title": "Pharmacotherapy"}, {"key": "key\n\t\t\t\t20171013235635_bib12", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1586/14787210.7.2.165", "article-title": "Posaconazole\u2019s impact on prophylaxis and treatment of invasive fungal infections: an update", "volume": "7", "author": "Smith", "year": "2009", "journal-title": "Expert Rev Anti Infect Ther"}, {"key": "key\n\t\t\t\t20171013235635_bib13", "doi-asserted-by": "crossref", "first-page": "24", "DOI": "10.1128/AAC.00705-08", "article-title": "Antifungal therapeutic drug monitoring: established and emerging indications", "volume": "53", "author": "Andes", "year": "2009", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013235635_bib14", "doi-asserted-by": "crossref", "first-page": "577", "DOI": "10.1128/AAC.47.2.577-581.2003", "article-title": "Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase", "volume": "47", "author": "Mann", "year": "2003", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013235635_bib15", "doi-asserted-by": "crossref", "first-page": "991", "DOI": "10.1016/j.bbmt.2009.04.007", "article-title": "Fatal rhizopus pneumonia in allogeneic stem cell transplant patients despite posaconazole prophylaxis: two cases and review of the literature", "volume": "15", "author": "Lekakis", "year": "2009", "journal-title": "Biol Blood Marrow Transplant"}, {"key": "key\n\t\t\t\t20171013235635_bib16", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.3324/haematol.2009.017244", "article-title": "Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation", "volume": "95", "author": "Koreth", "year": "2010", "journal-title": "Haematologica"}, {"key": "key\n\t\t\t\t20171013235635_bib17"}, {"key": "key\n\t\t\t\t20171013235635_bib18", "doi-asserted-by": "crossref", "first-page": "398", "DOI": "10.1002/ajh.21119", "article-title": "Clinical application of deferasirox: Practical patient management", "volume": "83", "author": "Vichinsky", "year": "2007", "journal-title": "Am J Hematol"}, {"key": "key\n\t\t\t\t20171013235635_bib19", "doi-asserted-by": "crossref", "first-page": "620", "DOI": "10.1097/QCO.0b013e3283165fd1", "article-title": "Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment", "volume": "21", "author": "Ibrahim", "year": "2008", "journal-title": "Curr Opin Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib20", "doi-asserted-by": "crossref", "first-page": "2649", "DOI": "10.1172/JCI32338", "article-title": "The iron chelator deferasirox protects mice from mucormycosis through iron starvation", "volume": "117", "author": "Ibrahim", "year": "2007", "journal-title": "J Clin Invest"}, {"key": "key\n\t\t\t\t20171013235635_bib21", "doi-asserted-by": "crossref", "first-page": "1089", "DOI": "10.1086/512817", "article-title": "Decrease in the number of reported cases of zygomycosis among patients with diabetes mellitus: a hypothesis", "volume": "44", "author": "Kontoyiannis", "year": "2007", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib22", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1128/AAC.50.1.96-103.2006", "article-title": "Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole", "volume": "50", "author": "Chamilos", "year": "2006", "journal-title": "Antimicrob Agents Chemother"}, {"key": "key\n\t\t\t\t20171013235635_bib23", "doi-asserted-by": "crossref", "first-page": "1091", "DOI": "10.1086/651263", "article-title": "Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database", "volume": "50", "author": "Kontoyiannis", "year": "2010", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib24", "doi-asserted-by": "crossref", "first-page": "1588", "DOI": "10.1086/652761", "article-title": "Geoclimatic influences on invasive aspergillosis rates following hematopoietic stem cell transplantation", "volume": "15", "author": "Panackal", "year": "2010", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib25", "doi-asserted-by": "crossref", "first-page": "296", "DOI": "10.1093/jac/dkp430", "article-title": "Forty-one recent cases of invasive zygomycosis from a global clinical registry", "volume": "65", "author": "R\u00fcping", "year": "2010", "journal-title": "J Antimicrob Chemother"}, {"key": "key\n\t\t\t\t20171013235635_bib26", "doi-asserted-by": "crossref", "first-page": "e100", "DOI": "10.1016/j.ijid.2009.11.024", "article-title": "Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors", "volume": "14 Suppl 3", "author": "Ambrosioni", "year": "2010", "journal-title": "Int J Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib27", "doi-asserted-by": "crossref", "first-page": "1002", "DOI": "10.1086/605445", "article-title": "Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome", "volume": "200", "author": "Singh", "year": "2009", "journal-title": "J Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib28", "doi-asserted-by": "crossref", "first-page": "2166", "DOI": "10.1111/j.1600-6143.2009.02754.x", "article-title": "Pulmonary zygomycosis in solid organ transplant recipients in the current era", "volume": "9", "author": "Sun", "year": "2009", "journal-title": "Am J Transplant"}, {"key": "key\n\t\t\t\t20171013235635_bib29", "doi-asserted-by": "crossref", "first-page": "556", "DOI": "10.1128/CMR.18.3.556-569.2005", "article-title": "Novel perspectives on mucormycosis: pathophysiology, presentation, and management", "volume": "18", "author": "Spellberg", "year": "2005", "journal-title": "Clin Microbiol Rev"}, {"key": "key\n\t\t\t\t20171013235635_bib30", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.1128/CMR.13.2.236-301.2000", "article-title": "Zygomycetes in human disease", "volume": "13", "author": "Ribes", "year": "2000", "journal-title": "Clin Microbiol Rev"}, {"key": "key\n\t\t\t\t20171013235635_bib31", "doi-asserted-by": "crossref", "first-page": "1109", "DOI": "10.2337/diacare.31.12.1109", "article-title": "A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability", "volume": "31", "author": "Artis", "year": "1982", "journal-title": "Diabetes"}, {"key": "key\n\t\t\t\t20171013235635_bib32", "first-page": "1269", "article-title": "Fungistatic mechanism of human transferrin for Rhizopus oryzae and Trichophyton mentagrophytes: alternative to simple iron deprivation", "volume": "41", "author": "Artis", "year": "1983", "journal-title": "Infect Immun"}, {"key": "key\n\t\t\t\t20171013235635_bib33", "doi-asserted-by": "crossref", "first-page": "1979", "DOI": "10.1172/JCI116419", "article-title": "Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies", "volume": "91", "author": "Boelaert", "year": "1993", "journal-title": "J Clin Invest"}, {"key": "key\n\t\t\t\t20171013235635_bib34", "doi-asserted-by": "crossref", "first-page": "1743", "DOI": "10.1086/599105", "article-title": "Recent advances in the management of mucormycosis: from bench to bedside", "volume": "48", "author": "Spellberg", "year": "2009", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib35", "doi-asserted-by": "crossref", "first-page": "e1000549", "DOI": "10.1371/journal.pgen.1000549", "article-title": "Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication", "volume": "5", "author": "Ma", "year": "2009", "journal-title": "PLoS Genet"}, {"key": "key\n\t\t\t\t20171013235635_bib36", "doi-asserted-by": "crossref", "first-page": "1833", "DOI": "10.1021/jf048147n", "article-title": "Secondary metabolite and mycotoxin production by the Rhizopus microsporus group", "volume": "53", "author": "Jennessen", "year": "2005", "journal-title": "J Agric Food Chem"}, {"key": "key\n\t\t\t\t20171013235635_bib37", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1093/jac/dkg020", "article-title": "In vitro susceptibilities of zygomycetes to conventional and new antifungals", "volume": "51", "author": "Dannaoui", "year": "2003", "journal-title": "J Antimicrob Chemother"}, {"key": "key\n\t\t\t\t20171013235635_bib38", "doi-asserted-by": "crossref", "first-page": "134", "DOI": "10.1016/j.jinf.2009.06.002", "article-title": "A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response", "volume": "59", "author": "Ben-Ami", "year": "2009", "journal-title": "J Infect"}, {"key": "key\n\t\t\t\t20171013235635_bib39", "doi-asserted-by": "crossref", "first-page": "778", "DOI": "10.1128/IAI.73.2.778-783.2005", "article-title": "Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro", "volume": "73", "author": "Ibrahim", "year": "2005", "journal-title": "Infect Immun"}, {"key": "key\n\t\t\t\t20171013235635_bib40", "doi-asserted-by": "crossref", "first-page": "1914", "DOI": "10.1172/JCI42164", "article-title": "The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice", "volume": "120", "author": "Liu", "year": "2010", "journal-title": "J Clin Invest"}, {"key": "key\n\t\t\t\t20171013235635_bib41", "doi-asserted-by": "crossref", "first-page": "5393", "DOI": "10.1182/blood-2009-07-231209", "article-title": "Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites", "volume": "114", "author": "Ben-Ami", "year": "2009", "journal-title": "Blood"}, {"key": "key\n\t\t\t\t20171013235635_bib42", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1023/A:1011900630987", "article-title": "Mycopathologia animal models of zygomycosis\u2014Absidia, Rhizopus, Rhizomucor, and Cunninghamella", "volume": "152", "author": "Kamei", "year": "2001", "journal-title": "Mycopathologia"}, {"key": "key\n\t\t\t\t20171013235635_bib43", "doi-asserted-by": "crossref", "first-page": "9367", "DOI": "10.1073/pnas.0709578105", "article-title": "Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis", "volume": "105", "author": "Chamilos", "year": "2008", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "key\n\t\t\t\t20171013235635_bib44", "doi-asserted-by": "crossref", "first-page": "186", "DOI": "10.1086/589305", "article-title": "Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae", "volume": "198", "author": "Lamaris", "year": "2008", "journal-title": "J Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib45", "doi-asserted-by": "crossref", "first-page": "226", "DOI": "10.1086/589290", "article-title": "Immunocompromised hosts: immunopharmacology of modern antifungals", "volume": "47", "author": "Ben-Ami", "year": "2008", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib46", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.1086/590004", "article-title": "Delaying amphotericin B-based front-line therapy significantly increases mortality in hematologic malignancy patients with zygomycosis", "volume": "47", "author": "Chamilos", "year": "2008", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib47", "doi-asserted-by": "crossref", "first-page": "854", "DOI": "10.1309/EXBVYAUPENBM285Y", "article-title": "Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination", "volume": "119", "author": "Tarrand", "year": "2003", "journal-title": "Am J Clin Pathol"}, {"key": "key\n\t\t\t\t20171013235635_bib48", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1080/13693780701796973", "article-title": "Workload and clinical significance of the isolation of zygomycetes in a tertiary general hospital", "volume": "46", "author": "Torres-Narbona", "year": "2008", "journal-title": "Med Mycol"}, {"key": "key\n\t\t\t\t20171013235635_bib49", "author": "Haurany", "year": "2010", "article-title": "Interobserver reproducibility and concordance between culture and histopathology in invasive mold infections: a multicenter study [abstract 78]", "volume-title": "4th Advances Against Aspergillosis"}, {"key": "key\n\t\t\t\t20171013235635_bib50", "doi-asserted-by": "crossref", "first-page": "208", "DOI": "10.1309/7KU5XWURYM0151YN", "article-title": "Increased culture recovery of zygomycetes under physiologic temperature conditions", "volume": "127", "author": "Kontoyiannis", "year": "2007", "journal-title": "Am J Clin Pathol"}, {"key": "key\n\t\t\t\t20171013235635_bib51", "doi-asserted-by": "crossref", "first-page": "1650", "DOI": "10.1128/JCM.00036-09", "article-title": "Spectrum of zygomycete species identified in clinically significant specimens in the United States", "volume": "47", "author": "Alvarez", "year": "2009", "journal-title": "J Clin Microbiol"}, {"key": "key\n\t\t\t\t20171013235635_bib52", "doi-asserted-by": "crossref", "first-page": "1433", "DOI": "10.1128/JCM.02219-06", "article-title": "Carbon assimilation profiles as a tool for identification of zygomycetes", "volume": "45", "author": "Schwarz", "year": "2007", "journal-title": "J Clin Microbiol"}, {"key": "key\n\t\t\t\t20171013235635_bib53", "doi-asserted-by": "crossref", "first-page": "3690", "DOI": "10.1128/JCM.00917-08", "article-title": "Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis", "volume": "46", "author": "Kasai", "year": "2008", "journal-title": "J Clin Microbiol"}, {"key": "key\n\t\t\t\t20171013235635_bib54", "doi-asserted-by": "crossref", "first-page": "2043", "DOI": "10.1128/JCM.02319-09", "article-title": "Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) evaluation", "volume": "48", "author": "Dannaoui", "year": "2010", "journal-title": "J Clin Microbiol"}, {"key": "key\n\t\t\t\t20171013235635_bib55", "doi-asserted-by": "crossref", "first-page": "340", "DOI": "10.1128/JCM.44.2.340-349.2006", "article-title": "Molecular identification of zygomycetes from culture and experimentally infected tissues", "volume": "44", "author": "Schwarz", "year": "2006", "journal-title": "J Clin Microbiol"}, {"key": "key\n\t\t\t\t20171013235635_bib56", "doi-asserted-by": "crossref", "first-page": "60", "DOI": "10.1086/430710", "article-title": "Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer", "volume": "41", "author": "Chamilos", "year": "2005", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib57", "doi-asserted-by": "crossref", "first-page": "1733", "DOI": "10.1086/587991", "article-title": "Reversed halo sign in invasive pulmonary fungal infections", "volume": "46", "author": "Wahba", "year": "2008", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib58", "doi-asserted-by": "crossref", "first-page": "e61", "DOI": "10.1086/500212", "article-title": "Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases", "volume": "42", "author": "van Burik", "year": "2006", "journal-title": "Clin Infect Dis"}, {"key": "key\n\t\t\t\t20171013235635_bib59", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1002/sim.4780140302", "article-title": "Adaptive assignment versus balanced randomization in clinical trials: a decision analysis", "volume": "14", "author": "Berry", "year": "1995", "journal-title": "Stat Med"}, {"key": "key\n\t\t\t\t20171013235635_bib60", "doi-asserted-by": "crossref", "first-page": "408", "DOI": "10.1056/NEJMoa020191", "article-title": "Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis", "volume": "347", "author": "Herbrecht", "year": "2002", "journal-title": "N Engl J Med"}, {"key": "key\n\t\t\t\t20171013235635_bib61"}], "container-title": ["Clinical Infectious Diseases"], "language": "en", "link": [{"URL": "http://academic.oup.com/cid/article-pdf/54/suppl_1/S79/20911248/cir886.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 10, 14]], "date-time": "2017-10-14T03:56:48Z", "timestamp": 1507953408000}, "score": 21.789326, "issued": {"date-parts": [[2012, 2, 1]]}, "references-count": 61, "journal-issue": {"published-online": {"date-parts": [[2012, 2, 1]]}, "published-print": {"date-parts": [[2012, 2, 1]]}, "issue": "suppl_1"}, "URL": "http://dx.doi.org/10.1093/cid/cir886", "relation": {"cites": []}, "ISSN": ["1537-6591", "1058-4838"], "issn-type": [{"value": "1058-4838", "type": "print"}, {"value": "1537-6591", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T05:09:09Z", "timestamp": 1574226549513}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Antimicrobial Chemotherapy"], "DOI": "10.1093/jac/dkl350", "type": "journal-article", "created": {"date-parts": [[2006, 8, 24]], "date-time": "2006-08-24T00:24:28Z", "timestamp": 1156379068000}, "page": "1070-1073", "source": "Crossref", "is-referenced-by-count": 68, "title": ["Deferiprone iron chelation as a novel therapy for experimental mucormycosis"], "prefix": "10.1093", "volume": "58", "author": [{"given": "A. S.", "family": "Ibrahim", "sequence": "first", "affiliation": []}, {"given": "J. E.", "family": "Edwards", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Fu", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Spellberg", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2006, 9, 6]]}, "container-title": ["Journal of Antimicrobial Chemotherapy"], "language": "en", "link": [{"URL": "http://academic.oup.com/jac/article-pdf/58/5/1070/2211265/dkl350.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 23]], "date-time": "2017-08-23T07:54:56Z", "timestamp": 1503474896000}, "score": 20.73211, "issued": {"date-parts": [[2006, 9, 6]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2006, 9, 6]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1093/jac/dkl350", "ISSN": ["0305-7453", "1460-2091"], "issn-type": [{"value": "0305-7453", "type": "print"}, {"value": "1460-2091", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T04:18:40Z", "timestamp": 1574828320649}, "reference-count": 45, "publisher": "Human Kinetics", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2008, 3]]}, "abstract": "<jats:p>Modified children\u2019s sport programs are intended to increase opportunities for participation, skill acquisition, satisfaction, and enjoyment. Unfortunately, teams in modified programs sometimes consist of more players than can participate at any one time. Barker and Gump\u2019s (1964) manning theory is used to analyze the effects of a modified children\u2019s soccer program that excludes children from game participation by relegating them to the role of substitutes. Participant observation and interviews with coaches, parents, and players were conducted over 2 seasons. Findings are consistent with propositions from manning theory. Children\u2019s teams provide a better social climate, more skill development, and greater enjoyment and satisfaction when teams are not allocated substitutes. These advantages are not reduced, and are sometimes elevated, when teams must sometimes play short handed. Administrative concerns about the potential risks of fielding teams without substitutes are found to be unwarranted, and the presence of substitutes restricts opportunities for youth-sport organizations to attract and retain members. These findings suggest a framework for the design and maintenance of modified children\u2019s sport.</jats:p>", "DOI": "10.1123/jsm.22.2.184", "type": "journal-article", "created": {"date-parts": [[2016, 8, 10]], "date-time": "2016-08-10T12:21:41Z", "timestamp": 1470831701000}, "page": "184-204", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Give the Bench the Boot! Using Manning Theory to Design Youth-Sport Programs"], "prefix": "10.1123", "volume": "22", "author": [{"given": "Brad", "family": "Hill", "sequence": "first", "affiliation": [{"name": "1Griffith University"}]}, {"given": "B. Christine", "family": "Green", "sequence": "additional", "affiliation": [{"name": "2University of Texas"}]}], "member": "100", "container-title": ["Journal of Sport Management"], "link": [{"URL": "https://journals.humankinetics.com/view/journals/jsm/22/2/article-p184.xml", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 12]], "date-time": "2019-09-12T11:09:24Z", "timestamp": 1568286564000}, "score": 20.727709, "issued": {"date-parts": [[2008, 3]]}, "references-count": 45, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.1123/jsm.22.2.184", "ISSN": ["0888-4773", "1543-270X"], "issn-type": [{"value": "0888-4773", "type": "print"}, {"value": "1543-270X", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}